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SCHOOL OF CHEMISTRY 
ABSTRACT 
Doctor of Philosophy 
NOVEL LUMINESCENT PLATINUM (II) AND LANTHANIDE (III) 
COMPLEXES TOWARDS IMAGING, DIAGNOSTICS AND 
THERAPEUTICS 
By Oliver James Stacey 
This thesis discusses the development and synthesis of ligands for coordination to d- 
and f- block metal ions. The subsequent coordination chemistry to PtII and a range of 
LnIII metal ions is outlined, along with the photophysical properties of the resultant 
compounds towards bimodal imaging agents and probes for diagnostic and 
therapeutic applications. 
 Chapter 2 presents the synthesis and characterisation of a range of PtII 
complexes using functionalised 2-phenylquinoline ligands. A range of products were 
synthesised by utilising a variety of ancillary ligands, including β-diketones, 8-
hydroxyquinoline, 2,2′-bipyridine and pyridine, in order to investigate any effects on 
the photophysical properties. X-ray crystallography confirmed the anticipated 
structures of several compounds whilst 195Pt NMR was employed to probe the metal 
environment in the different complexes.  
 Chapter 3 builds on the investigations in the previous chapter by altering the 
functionality of the 2-phenylquinoline ligand in order to tune the solubility. The 
second part of Chapter 3 exploits the facile coordination of pyridine, as found in 
Chapter 2, by introducing pendant pyridine-appended macrocycles encapsulating LnIII 
ions. This provided bimetallic complexes with good water solubility, which allowed 
relaxivity measurements to be carried out. Photophysical measurements also gave 
evidence of direct sensitisation of the LnIII ion by PtII based 3MLCT emission. 
Chapter 4 extends the 2-phenylquinoline functionality to incorporate naphthyl, 
anthracenyl and pyrenyl chromophores with suitable solubility in common organic 
solvents. The complexes were  investigated to determine whether it was possible to 
observe interactions between the excited state of the chromophore and the metal-
centred excited state. Low temperature and degassed steady state luminescence and 
lifetime measurements were obtained in order to build energy level diagrams to 
explain the interplay of excited states. 
Chapter 5 discusses the development of anthraquinone-based polypyridyl 
ligand scaffolds for the incorporation of LnIII ions. The ligands possess subtle 
differences that result in changes in the coordination sphere of the LnIII ion. This was 
confirmed by determining the inner-sphere hydration of the LnIII ions through 
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1.1. Coordination chemistry 
Coordination chemistry has been investigated since the nineteenth century when 
workers such as Werner, who disbanded the link between metal oxidation state and 
coordination number and coined the term coordination compounds, started to develop 
coordination chemistry into its current state.1 Coordination chemistry is the study of 
coordination compounds or complexes, which are distinguished, according to IUPAC 
recommendations, as having a coordination entity: “an ion or neutral molecule that is 
composed of a central atom, usually that of a metal, to which is attached a 
surrounding array of other atoms or groups of atoms, each of which is called a 
ligand.”2  
Another feature of almost all metal complexes is the incomplete filling of the valence 
shell of electrons: more specifically, the partially filled d orbitals in transition metal 
complexes and the incomplete filling of the f orbitals in lanthanide and actinide 
complexes. This leads to the rich array of coordination compounds that frequent the 
literature with interesting spectroscopic properties. It is this relationship between 
coordination compounds and their photophysical properties that has led to the 
investigation into the development of the photophysical characteristic of transition 
metal ion and lanthanide ion complexes within this thesis. 
1.1.1. Transition metal coordination complexes 
As mentioned in the previous paragraphs, transition metal complexes are often 
brightly coloured due to the incomplete filling of the d orbitals; it is the partially filled 
nature of these orbitals that influences physical attributes such as the coordination 
geometry, the types of ligands likely to associate with the metal ion, the stability of 
the complexes, including the susceptibility to oxidation and reduction, and the 
photophysical properties of the compounds. 
If molecular orbital (MO) theory is assumed, the bonds between ligand and metal ion 
can be treated as having mostly covalent character, whereby a ligand approaches a 
metal ion resulting in the overlap of s, p and d orbitals of the ligand group orbitals and 
the central ion, where the symmetry is suitable. According to crystal-field theory 
(CFT) this interaction results in the loss in degeneracy of the d orbitals due to the 
orientation of these orbitals in relation to the electron density of the bonding orbitals.3  
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In six-coordinate, octahedral (Oh) complexes, for example, such as those 
incorporating ReI, RuII and IrIII, the five d orbitals split into two non-degenerate 
energies where three non-bonding orbitals, with t2g symmetry lie at lower energies 
and correspond to dxy, dxz, and dyz whilst the two eg symmetric anti-bonding orbitals, 
dx2-y2 and dz2, orbitals lie at higher energy (Figure 1.1). The energy difference between 
the t2g and eg sets is known as the crystal-field splitting parameter (Δo) and is due to 
the degree of overlap between the metallic orbitals and the ligand orbitals; in CFT this 
is known as the field strength.4 The crystal-field strength is determined by the ligand 
types involved in the coordination; CN-, CO and PPh3 result in a large Δo, whilst I- 
and Br- are weak field ligands.5 It is the partial filling of these orbitals that allows for 
electronic transitions (t2g → eg) to occur when the energy of irradiation is equal to Δo. 
The release of energy from the excited electron in the eg orbital to reoccupy a t2g 
orbital (covered in depth later) is what often gives transition metal complexes their 
characteristically colourful appearance. 
 
Figure 1.1 MO diagram for the σ-bonds of an Oh complex.6 
The filling of the orbitals follows the Aufbau principle, which dictates that orbitals 
with the lowest energy are filled first. This means that the twelve electrons from the 
ligands occupy the lowest energy bonding orbitals, which leaves the t2g and eg sets to 
be filled by the d electrons from the metal ion. Complexes with unfilled d orbitals can 
form high spin and low spin complexes depending upon the magnitude of Δo and the 
energy required to overcome the electrostatic repulsion associated with pairing 
electrons, the pairing energy (P). The d electron configuration in high field complexes 
follow Hund’s rule, whereby available orbitals are singularly occupied before 
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additional electrons pair up with those in the singularly occupied orbitals; this is only 
favourable when Δo < P. When the crystal-field splitting energy is much greater, 
which is often the case for ligands such as phenylpyridine (ppyH), it is more 
energetically favourable to pair electrons rather than ‘placing’ them in orbitals of 
higher energy.7 
 
     cisplatin                             Zeise’s salt                         Vaska’s complex              Wilkinson’s catalyst 
Figure 1.2 Selection of well-known square planar d8 transition metal complexes. 
In the case of d8 metals, which are more applicable to the type of complexes that will 
be discussed in this thesis, the Ni triad is the most well known. Famous examples of 
PtII complexes include cisplatin (discussed in greater detail in Chapter 2) and Zeise’s 
salt (Figure 1.2).4 There are also other famous examples in the +1 oxidation state of d8 
metal complexes such as Vaska’s complex and Wilkinson’s catalyst (Figure 1.2) for 
IrI and RhI, respectively.4 These all form four-coordinate square planar complexes as 
they have relatively high field ligands so form low spin complexes. Where low field 
ligands are coordinated, tetrahedral complexes are usually favourable, especially for 
NiII complexes. Unlike most other inert complexes, which have an electron count of 
18 (thus filling the bonding and non-bonding orbitals in an Oh geometry), d8 square 
planar complexes most often deviate from the 18-electron rule and have an electron 
count of just 16, which is the most stable configuration as it leaves the anti-bonding 
dx2-y2 orbitals unoccupied (Figure 1.3). 
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1.1.2. Chelate effect 
The type of ligand, as it has been shown, can affect the physical properties of a metal 
complex. Ligands range from simple monoatomic structures, such as halides to large 
macromolecules with many coordination sites. The number of sites on a molecule that 
are capable of coordinating is known as the denticity. Compounds with one 
coordination site, such as pyridine, are referred to as being monodentate whilst 
compounds with more than one are classed as polydentate. These polydentate ligands 
lend themselves to a phenomenon known as the chelate effect, outlined in 1964 by 
Curtis.8 Simply put, the chelate effect results in an Oh complex, for example, being 
more stable with three bidentate ligands than with six monodentate ligands with the 
same characteristics (such as pyridine and 2,2′-bipyridine).4 The reason for this 
increased stability is due to the thermodynamically favourability for polydentate 
ligands over monodentate ligands.  
ΔG = ΔH −TΔS  (1) 
The thermodynamic stability can be related to the Gibbs free energy of a system, 
denoted in equation (1) by G. The stability is often increased (lower ΔG) in 
polydentate complexes through a favourable change in the entropy, ΔS, and enthalpy, 
ΔH. 
From an entropic perspective, which is commonly referred to as the disorder of a 
system, forming a complex whereby MX6 becomes ML3 (where X is a monodentate 
ligand and L is a bidentate ligand) results in the formation of seven molecules from 
four, leading to an increase in the disorder of the system, which is favourable as the 
universe tends towards disorder.  
 If we consider the reaction of [Ni(NH3)6]2+ with ethylene diamine (en) to give 
[Ni(en)3]2+, the change in the Gibbs free energy (ΔG) is -53 kJ mol-1. This reaction is 
driven mostly by the increase in entropy, with TΔS having a value of 36.2 kJ mol-1 (at 
298 K), whilst ΔH has a smaller value of -16.8 kJ mol-1. This greatly increased 
entropy means that replacing just two NH3 molecules for one ethylene diimine results 
in a roughly 300-fold increase in stability.3 Stability increases more with the 
introduction of each additional chelating ligand, as can be seen in Table 1.1. 
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Monodentate ΔG / kJ mol-1 Bidentate ΔG / kJ mol-1 
with pyridine (py) or 2,2′-bipyridine (bpy) 
2 py -20 1 bpy -39 
4 py -32 2 bpy -78 
6 py -56 3 bpy -110 
with ammonia (NH3) or ethylene diamine (en) 
2 NH3 -28 1 en -43 
4 NH3 -44 2 en -79 
6 NH3 -49 3 en -104 
Table 1.1 Comparison of the change in the Gibbs free energies upon ligand exchange with various 
monodentate and related bidentate ligands from [Ni(OH2)6]2+.3  
The enthalpic contribution comes from the fact that, in order to fully dissociate a 
polydentate ligand, each of the coordinative bonds must be broken. For example, in 
order to dissociate 2,2′-bipyridine from RuII two Ru-N bonds must be broken, which 
requires more energy than breaking a single Ru-N bond, as would be the case for 
pyridine. Further to this, once a polydentate ligand has successfully coordinated 
through one binding site, the local concentration of unbound coordinating sites are 
increased, allowing for a greater chance of reaction of the subsequent coordination 
sites as less translational energy is required. Not only are the coordination sites in 
closer proximity, they are often much more restricted in their rotation meaning that 
they are more frequently in the correct orientation to coordinate. This is especially the 
case with molecules such as 1,10-phenanthroline (phen), where the rigidity allows for 
the instant creation of a 5-membered chelate ring. Bpy, on the other hand, often has to 
rearrange itself in order to coordinate successfully (Figure 1.4). 
 
Figure 1.4 Preorganisation of a 5-membered chelate ring in phen compared with the rearrangement 
required by bpy in order to form a 5-membered chelate. 
From a dissociative perspective, if one coordinative bond is broken there is a very 
high chance that, due to the restriction in the ligand’s movement by the other 
coordinative bond(s), the rate of bond reformation is greatly increased. In other 
words, in order for a polydentate ligand to be successfully removed from a metal 
centre, all coordinative bonds need to be broken almost instantaneously. With the case 
of square planar complexes, a dissociative mechanism is unlikely as this would result 
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a vacant axial position will result in displacement of a coordinated ligand in the xy 
plane. In order for associative ligand displacement to release a bidentate ligand, the 
association must provide enough of a driving force to break both of the coordinative 
bonds within the chelate ring. This is much more unlikely than when the ligands being 
removed are monodentate. 
 
Figure 1.5 Examples of chelating square planar PtII complexes in the literature. 
In square planar PtII complexes there are a range of examples of chelating motifs that 
have been employed to tune the photophysical properties (discussed below and in 
Chapter 2) and to increase the stability of the complexes. These chelates range from 
bidentate donors such as bpy,9 ppy and 2,4-acetylacetonate (acac)10, 11 to tridentate 
complexes, including functionalised 1,3-dipyridylbenzene (N^C^N) derived ligands.12 
There are also examples of tetradentate complexes in which the entire square planar 
ligand is one molecule, which encapsulates the metal ion to further increase the 
stability. The ligand systems drawn both have N2O4 coordination modes, where one is 
the classic ligand of this type, salen,13, 14 and the other is a bpy-derived compound 
with additional phenol moieties appended to yield a salen-like coordination site.15 
1.1.3. Lanthanide coordination 
In order to go into detail about the coordination of lanthanides, it is useful to provide 
some background into the physical properties of lanthanides as, unlike the d-block 
metals, their properties are very similar and their trends are very uniform across the 

















[Pt(N^C^N)Cl] [Pt(salen)] [Pt(N2O2)] 
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metals, which aren’t in fact rare at all, were not discovered until as recently as 1907 
(for lutetium).16 
Lanthanides are located in the f-block of the periodic table due to the fact that their 
valence electrons fill the 4f-orbitals. Initially, the 5d subshell is lower in energy than 
the 4f however, as the effective nuclear charge increases, the 4f orbitals contract and it 
becomes more energetically favourable to fill these closer lying orbitals (Figure 
1.6).17 The only exception to this is Gd, which has the electron configuration 
[Xe]6s25d14f 7 due to the fact that the half-filled 4f shell’s stability results in the next 
electron being placed in the 5d shell.16 After this anomaly, the trend continues with 
terbium’s configuration being [Xe]6s24f 9. The reason for their similar properties and 
following trends is mainly down to the fact that most lanthanide chemistry is 
dominated by the +3 oxidation state. This is due, in part, to the fact that the fourth 
ionisation energy is greater than the sum of the first three ionisation energies.18 This 
renders the +4 oxidation state almost completely inaccessible, as bond formation 
alone cannot provide the energy to remove a fourth electron. The electrons lost in the 
ionisation to the +3 oxidation state are from the 6s and 5d shells, giving the Ln3+ ions 
an electron configuration of [Xe]4f n (where n = 1 – 14). The only exceptions to this 
are Eu and Yb where the +2 oxidation state is preferred as this results in a half-filled 
and fully-filled 4f shell, respectively, which are more favourable than the 4f 6 and 4f 13 
configurations.16 
 
Figure 1.6 Radial part of the hydrogenic wave functions for the 4f, 5d and 6s orbitals of cerium.19 
The contraction of the 4f orbitals, as mentioned above, is due to the poor ability of f 
electrons to screen other valence electrons from the nuclear charge. The poor 
screening is predominantly because of the high angular nodality of the f-orbitals,18 
of Table 2. The hexagonal bipyramid is formed as 
shown in Figure 12 by arranging six ligands in a xagon 
in the xy-plane, and putting the other two ligands on 
the z-axis above and below the hexagon. It can be seen 
that the fi orbital points directly toward the two z-axis 
ligands and fi points toward the six xy-plane ligands, so 
these must be of highest energy. On the other hand, 
Figure 11. Four ligandr arranged in a regular tetrahedron, ,how" or o 
cube with a iigand mt every other corner. 
z 
t 
Figure 12. Eight ligands arranged in a hexagonal bipyramid. Six 
ligandr are a t  the corners of o hexagon in the xy-pime. The other two 
ore on ther-axir above and below the xy-plane. 
the two ja orbitals point away from all eight ligands, and 
therefore must he of lowest energy. The f3 orbital 
points between the ligands in the xy-plane, so it must be 
low in energy. Finally, the j4 orbitals point toward 
some of the ligands, but do not extend very far directly 
toward any of them; these must be raised only slightly 
in energy. These considerations are summarized in 
Figure 13. A possible example of this arrangement is 
the complex UOa(N03)a- and other complexes of the 
uranyl ion. These are discussed in detail by Coulson 
and Lester (1 0). 
Table 2. Symmetry Species of the f Orbitals in Various 
Fields 
Octahedron point group 01 Tetrahedron paint group Td 
Hexagonal hipyramid point group DBI~ 
We have discussed here only the manner in which the 
j orbitals split in a given ligand field, but have said 
nothing about the amount of splitting. In the Ian- 
thanides, this splitting is very slight, probably not more 
than about 10% ( S ) .  
Radial Part of the f Orbitals 
The radial part of the j orbitals is interesting prin- 
cipally in comparing the size of the f orbitals and the 
outermost occupied orbitals of a given atom. Of p r-
ticular importance for the lanthanide elements is a 
con~parison of the 4f orbitals with the 5d and 6s valence 
orbitals. For this purpose, we have used the hydro- 
genic radial functions, R.,(r), as applied to cerium, the 
first member of the lanthanide serie . Thi  is only an 
approximation, principally because the interactions he- 
tween electrons are ignored in the hydrogenic radial 
functions. Furthermore, the functions have been cal- 
culated for the neutral atom, not for the trivalent ion. 
I<. Rajnak (11) has calculated more precise radial func- 
tions for the ions Pr3+ and Tm3+ from the self-consistent 
field calculations of E. C. Ridley (12). These functions 
are qualitatively similar to the hydrogenic functions 
used in this discussion. 
The hydrogenic radial functions 
I, . $3 - of cerium give us a qualitative pic- - I ture of the 4 j  orbitals at the begin- 
: + ning f the lanthanide series. This 
is indicated in Figure 14, in which ". .. $'ly13iPl , - the probability, 4sr2RnL2, f find- 
", f,. ing an electron a t  the distance r 
' &  from the nucleus is plotted as a 
Figure 13. Splitting function of r for the 4f, 5d, and 6s .. . of the f orbitals in o 
hexagonal bipyrami- orbitals of cerium. The region 
d d  ligond fleld. in which the 4f orbitals are impor- 
Figure 14. The rodiol ports of the hydr genic 4f. Sd, an  6s orbitalr o f  
cerium plotted as the probability.4r PR.?, of finding on electron a t  the dir- 
lance r from the nucleus. 
tant is seen to b  de p within the atom, compar d to the 
5dand Gsorhitals. Indeed, the 5s and 5p orbitals, which 
are not valence electrons in the lanthanides, extend out 
beyond the 4f and about as far as the 5d. Thus, it can 
be understood qualitatively why the 4 j  orbitals do not 
participate in bonding in the lanthanide series to any 
great degree. These orbitals are unavailable spatially, 
not energetically, as they simply do not extend out far 
enough to join in bonding to any appreciable extent. 
Similarly, they are so well shielded that they are not 
greatly affected by ligaud fields, and so do not split ap- 
preciably. 
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however relativistic effects also play a part due to the heavier mass of the lanthanide 
atoms. The result of both of these is a phenomenon known as lanthanide 
contraction.16  
As mentioned, relativity plays a small part in lanthanide contraction and, although 
relativity is usually associated with very large objects, it also has a significant impact 
at the atomic level.20 There are two main consequences of relativity: modification of 
the atomic orbital energies and the effects of spin-orbit coupling.16, 21 Whilst the 
modification of atomic orbital energies is not as important in the context of this thesis, 
spin-orbit coupling is something that plays a profound impact on the photophysical 
properties of luminescent compounds incorporating heavy atoms as spin-orbit 
coupling, in a simplified manner, increases with nuclear charge. The states produced 
by spin-orbit coupling are described based on their spin and orbital angular 
momenta.16 When the spin-orbit coupling is weak in comparison with the 
interelectronic repulsion, as is the case for all examples in this thesis, LS or Russell-
Saunders coupling is the most useful approach.22  
This coupling considers that the individual orbital angular momenta of all the 
electrons combine into a total atomic orbital angular momentum with quantum 
number L. This is also the case for the electronic spin component so that all of the 
electronic spin angular momenta are combined to give a total spin angular momenta 
for the atom with quantum number S. The total atomic angular momentum is given by 
the coupling of L and S, which is described by quantum number J. The energy levels 
of atoms or ions are characterised by a term symbol with the general form (2S+1)LJ.16 
This notation is used to describe the (f → f) transitions in luminescent lanthanide 
complexes in both Chapters 3 and 5. 
The contraction of the lanthanides has a direct impact on the means in which 
lanthanide ions coordinate to ligands as it results in the inability of the 4f orbitals to 
overlap with ligand orbitals. Consequently, they do not participate in bonding to any 
significant degree and their isolation from the ligands means the crystal-field effects, 
which gives rise to the spectroscopic properties of transition metal complexes, are 
very small.23 This leads to the lanthanides’ electronic spectra and magnetic properties 
(discussed in more detail later in this chapter) being almost completely unaffected by 
the environment. It also means that these hard Lewis acids bond mostly through ionic 
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or electrostatic means, in contrast to the d-block elements, which typically form 
covalent bonds.18, 24 The hard Lewis acid nature of the LnIII ions means they favour 
coordination to hard bases such as oxygen and nitrogen donors. The charge densities 
are also relatively high and this property is exacerbated across the period due to the 
lanthanide contraction phenomenon, resulting in stronger ionic bonds across the row 
due to the increase in charge density.16, 18  
 
Figure 1.7 Tricapped trigonal primsmatic structure of a nonaaqualanthanide ion.25 
Lanthanides typically form eight or nine coordinate species, especially in aqueous 
solution where water molecules often coordinate to any vacant sites around the ion. 
The complexes also exhibit rapid ligand exchange, except in the case of multidentate 
ligands, with water coordination residency times of around 10-9 s, essentially meaning 
that the rate of exchange is determined by the diffusion of water molecules about the 
inner coordination sphere.18 This means that monodentate ligands are extremely 
unstable and highly kinetically inert lanthanide complexes can only be obtained 
through the incorporation of the ion into a macrocycle-based or rigid polydentate 
ligand, due to the factors outlined above for the chelate effect and below for the 
macrocyclic effect. 
There are a wide range of examples of polydentate ligands that have been 
incorporated into lanthanide complexes, including bidentate ligands such as phen and 
acac,26, 27 tridentate ligands like 2,2′;6′,2′′-terpyridine (tpy),28 polydentate open chain 
ligands such as ethylenediaminetetraacetic acid (EDTA)29 and macrocyclic ligands 
including crown ethers,30 and DOTA-like compounds (where DOTA = 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetacetic acid) with N4O4 donors.31 
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Figure 4. Plots of k, vs atomic number for M-O,, (A) and M a d l  (0) 
bonds. 
which can be attributed largely to distor ons arising through hydrogen 
bonding in the lattice. The eo values for the angles about oxygen were 
chosen to enforce a geometry where all three aqua atoms are coplanar 
with the metal atom. 
X-ray data for 70 nitrato ligands in 19 structures3z47 were averaged, 
and the resulting bond lengths and angles are summarized in Figure 2. 
The observed strict planarity of the nitrato ligand is maintained in cal- 
culated structures by three types of interaction: the sum of eo values 
about the nitrogen is 360°, torsional interactions about the N-O bonds 
have minima at 0 and 180°, and the out-of-plane be ding about the N 
atom is at a minimum when the oxygens are coplanar with nitrogen. The 
force constants for MQN bending interactions were set to zero. 
The nonbonded parameters, e and d, were taken directly from the 
MM2 parameter set where possible. Nonbonded interactions between 
any atom-metal pair were omitted by setting all metal t values to zero. 
In the MM2 program, H-C bonds are shortened to 0.915 of their length 
by moving the hydrogen in toward the carbon prior  calculating n n- 
bonded interactions between any atom-hydrogen pairs. This is done to 
place the center of hydrogen repulsion closer to the actual position of 
electron density.% The same foreshortening of H-O bonds was em- 
ployed in this study by assigning the aqua hydrogen to atom type 5 .  
MetaCDcpcndent Parameters. Following the assignment of the met- 
al-independent parameters presented in Table I, the only missing pa- 
rameters were the M 4  stretching constants, &, and r,. Initial estimates 
of these metal-dependent parameters were adjusted to yield the best 
agreement between calculated and observed M-O bond lengths for 
available aqua and nitrato complexes. These adjustments were accom- 
plished through manual inspection. For each M-O bond type, the dis- 
crepancies between the calculated and observed bond lengths were ex- 
amined in all complexes which contained that bond type and t e param- 
eters were adjusted in such a way as to minimize those discrepancies. 
Successive iterations yielded the M-O stretching constants given in Table 
11. Plots of ro vs atomic number (Figure 3) and k, vs atomic number 
(Figure 4) revealed expected trends upon moving across the lanthanide 
series from La to Lu; i.e., a decrease in ro and an increase in k, accom- 
(M) Allioger, N. L. J .  Am. Chrm. Soc. 1977, 99,8127. 
Table 11. Metal-Dewndent Parameters" 
metal(II1) M-O,, M-OniP 
ion k, mdyn A-' ro. A k, mdyn A-' rb A 
La 0.090 2.434 0.049 2.475 
Ce 0.092 2.390 0.053 2.451 
Pr 0.094 2.353 0.056 2.427 
Nd 0.096 2.330 0.058 2.407 
Pm [0.098] [2.317] [0.062] t2.3801 
Sm 0.099 2.289 0.064 2.350 
Eu 0.100 2.269 [0.067] [2.338] 
Gd 0.101 2.250 0.069 2.310 
Tb 0.102 2.227 [0.071] [2.295] 
DY 0.102 2.040 0.072 2.275 Ho 0.103 2.181 0.073 2.255 
Er 0.103 2.158 0.074 2.237 
Tm 0.104 2.136 [0.075] [2.215] 
Yb 0.104 2.114 [0.076] [2.195] 
Lu 0.104 2.092 [0.076] [2.175] 
"Brackets indicate parameters that were estimated from pl t  of k, 
and ro vs atomic number. bNit = nitrato. 
e 
Figure 5. Geometry of an ideal tricapped trigonal prism. 
pany the shift to smaller metals with lower size to charge ratios. These 
plots allow the estimation of M-O stretching parameters in cases where 
there was a lack of structural data. 
Comparison of Calculat d and Observed Structures 
The principal objective of the present work was to test the ability 
of a simple force field to generate the geometries of the 8- to 
1Zwrdinate  aqua and nitrato complexes of the lanthanide(II1) 
metal ions. In the following discussion, th  calculated structures 
are compared to the observed structures for these complexes. It 
is emphasized that the calculated structures do not necessarily 
represent the most stable arrangement of ligands but merely the 
arrang ment of ligan s most clos ly resembling the observed 
structures. Attempts to locate energy minima representing possible 
structural isomers for these complexes are limited only to the cases 
where crystallographic data on such isomers are available. 
The strain energies associated with each complex are also 
reported. Given the harmonic stretching and bending potentials used in this model and the uncertainty concerning the correct form 
of the potential function for the repulsions between ligand donor 
atoms, these energies must be viewed as approximate in value. 
Nevertheless, the results obtained in other studiesI2-l6 strongly 
suggest that these approximate strain energies can be used to 
identify the more stable arrangement of ligands when more than 
one isomer exists. This approach is employed here to assign the 
relative stability to the two structures observed for the nonaaqua, 
octaaqua, M(N03)3(OH2)3, M(N03)5(OH2)2-, and M(N03)5- 
(OH2)22- complexes. 
(i) The Nonaaqua Ion. The structures of the lanthanide(II1) 
hydrates, M(OH2),.X3, have been extensively investigated, and 
X-ray data are available for every nonaaqua complex, except Pm  
over the series La to Lu. The data consist of 38 structures that 
can be classified by counterion into three groups: counterion 
(number of structures); ethyl sulfates ( 19);17-20 triflates (1 5);21-u 
bromates (4).17924*2s In addition, a nonaaqua ion is observed in 
the structure [Nd(OH2),] C13.1 5 - c r o ~ n - 5 - H ~ O . ~ ~  
Chapter 1: Introduction 
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Figure 1.8 Structures of some chelating and macrocyclic LnIII complexes. 
1.1.4. Macrocyclic effect 
For the scope of this thesis, a macrocycle can be thought of as being a large cyclic 
molecule containing donor atoms capable of forming coordinate bonds to metal 
centres. In order to exclude compounds such as ethylene oxide and 1,3-dithiane, a 
macrocycle is typically thought to contain at least three donor atoms in a ring 
consisting of at least nine atoms. This means that a macrocycle is capable of binding a 
metal within the central cavity of the ring although this is not always strictly 
necessary as the term macrocycle is often used to describe a range of coordination 
compounds where the metal ion sits slightly above (or below) the plane of the cyclic 
component, as is the case with [Ln(DOTA)]-like complexes discussed above.32  
 













stability, even in water solution, of lanthanide complexes 
of a macrocyclic hexaimine.16 
I N  frured Spectra.-These were obtained from Nujol 
and hexachlorobutadiene mulls. The nitrate bands are 
typical of co-ordinated groups in all cases (Table 2). 
The E stretching mode at  1350-1 390 cm-l charac- 
teristic of non-bonded nitrate ion is nowhere present. 
TABLE 1 
Hydrogen- 1 n.m.r. spectra of lanthanide nitrate complexes 
with L = 18-crown-6. Values (p.p.m.) relate to 













a AT is the shift relative 
uncomplexed L also present. 
A7 AT/A TD,O 
6.5 
0 6.66 -0.555 
3.94 -0.488 
3.13 -0.387 
0.79 c 6.5 
-4.28 c 6.5 
- 30.1 -0.768 6.5 
- 0.12 
11.63 -0.562 6.5 
to [La(NO,),L]. Peak due to 
c First-order theory not valid. 
The nitrate groups are known from X-ray structural data 
to  be co-ordinated in [M(NO,),L] and [M(NO3),(OH,),]*L, 
and would be co-ordinated in M4(N0,),,L, if the for- 
mulation [M(NO,),L],[M(NO,),] should be correct. The 
extensive splitting of the nitrate frequencies in M,- 
(NOJl2L, indicates that in this structure there are a 
number of nitrate groups which differ in their local 
symmetry. The bands caused by the crown ether are 
unremarkable except that the C-0 stretch at  1 105 cm-l 
in the free ligand is a good indicator of whether co- 
ordination occurs. Thus in [M(NO,),L] and M4(NO,)12- 
L,, this band occurs in the range 1 072-1 082 cm-l 
while in [M(N0,),(OH2),]*L there is an almost unshifted 
band at  1 098 cm-l. The lowering of ca. 23-33 cm-l is 
doubtless caused by the inductive effect of the metal 
cation on the C-0 bond. 
Structures of the CompZexes.-The complex [La(NO,),L] 
has 12-co-ordinated La, the metal ion being co-ordinated 
to the six ether oxygen atoms and to two bidentate 
nitrate ions on one side of the crown ring arid to the re- 
maining bidentate nitrate ion on the other (see Figures 
1 and 2). Bond lengths and angles are given in Table 3, 
least-squares plane data in Table 4. The crown ether 
ring is folded away from the pair of nitrate ions; such an 
arrangement clearly results in greater equalisation of 
O(nitrate)-O(ether) interligand contacts, Thus, re- 
lative to the 0(1) * * * O(6) mean plane, La, 0(2),  and 
O(5) are almost equidistant below it (-0.466, -0.519, 
and -0.484 A respectively) with 0(2)-La-0(5) = 178.4", 
FIGURE 1 The molecular structure of [La(N03),(C,,H,40,)] 
showing atom-numbering scheme 
while O(3) and O(6) are almost in the plane (-0.026 and 
-0.062A with 0(3)-La-O(6) = 162.5", and Ojl) and O(4) 
are above i t  (0.564 and 0.528 A) with 0(1)-La-0(4) = 
136.4'. 
The La-O(nitrate) distances are closely similar 
(2.644-2.680 A) but the La-O(ether) distances cover a 
range of 0.118 A (2.662-2.780 A). It is possibly 
significant that the two shortest La-O(ether) distances 
relate to the only two oxygen atoms [0(2) and 0 ( 5 ) ]  
which do not have close (< 2.9 A) interligand approach 
to a nitrate oxygen atom, implying that in the case of a 
close approach, e.g. O(6)-O(11) = 2.772 A, it is the ether 
oxygen which has to some extent relieved repulsion by an 
increase in its bond distance [La-O(6) = 2.771 A]. This 
would further imply that the La-O(ether) force constant 
is smaller than that of La-O(nitrate), which is in accord 
with the observed extreme weakness of lanthanide- 
TABLE 2 
Infrared frequencies (cm-1) of a selection of complexes of lanthanide nitrates with L = 18-crown-6 
NO3 
r t 
Bl  A1 A1 B2 v ( C - 0 )  H2O 
M = La 1494, 1464, 1443 1 328, 1318 1049 827 1082 
M = Nd 1 498, 1 465, 1 447 1 332, 1 323 1050 825 1082 
[M(NO3) &I
[M4"(M,,L,I M =- Sm 1 532, 1515, 1480, 1332, 1 295, 1277 1050, 828, 821 1072 
M = Gd 1534, 1520, 1515, 1337, 1298, 1282 1053, 829,822 1072 
1 461, 1 438 1029 
1483, 1 465, 1 442 1032 
[M(N03),(OH2),].L M = Gd 1544, 1510 1292, 1277 1026 822 1 098 3 360. 3 240, 1 635 
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TABLE I1 
ESTIMATED STANDARD DEVIATIONS 
A l O M I C  P A R A M E T E R S  O F  La(CsH70L)a(H20)2 \!'ITH 
Alum 7 Y B ,  A2 
La 0 2321 ( I )  0.3847 ( I )  0.2179 (1) a 
0(1 )  0.0513 (11) 0.2966 (7) -0.0326 (14) 4 . 4  (6) 
O(2) 0.2845(15) 0.1922 (8) 0.1539 (17) 4 .9  (3) 
O ( 3 )  -0.0053 (15) 0.2790 (8) 0.2573 (9) 4 . 5 ( 2 )  
O(4) 0.3307 (10) 0.2996 ( 8 )  0.4348 ( 8 )  3 . 6  (4) 
O(5) 0.3110 (13) 0.5436 (11) 0.1029 (8) 3 .6  (2) 
O(6) 0.5423 (17) 0.4474 (7) 0.3042 (9) 4 . 0  (2) 
O ( 8 )  0.3407 (9) 0.5694 (7) 0.4176 (18) 3 . 4 ( 2 )  
O ( 7 )  -0.0020 (9) 0.4979 (7) 0.1403 (8) 3 . 3  (2)  
C ( l )  0.0182(18) 0.1991(13) -0.1234(18) 4 .2 (4 )  
C(2) 0.1009(18) 0.1044(14) -0.0820(19) 4 .6 (6 )  
(213) 0.2276 (17) 0.1067 (15) 0.0479 (15) 4 .2  ( 3 )  
C(4) 0.3074 (30) -0.0043 (12) 0.0735 (15) 5.1 (3) 
C(5) -0.1113(19) 0.1886(13) -0.2699(21) 5 .6(4)  
C(6) -0.0288 (17) 0.2017 (16) 0.3309 (15) 4 . 1  (3) 
C(7) 0.1004 (27) 0.1582 (13) 0.4263 (19) 5 . 0  (3) 
C(8) 0.2739 (19) 0.2060 (12) 0.4721 (14) 4 . 1  (4) 
C(9) 0.3961 (19) 0 .  I480 (14) 0.5727 (18) 5.8 (4) 
C i l l )  0.4399 (15) 0.6133 (16) 0.0970 (13) 3 . 4  (5) 
C(12) 0.6072 (16) 0.6037 (17) 0.1866(14) 4 .0 (3 )  
C(13) 0 .6464(40)  0.5237(27)  0 .2802(27)  3 . 3 ( 3 )  
C(14) 0.8323 116) 0.5298 (11) 0.3690 (14)  4 . 2  ( 3 )  
C(15) 0,4191 (16) 0.7062 (18) 0.0049 (14) 4.3 (3) 
H(1) 0.125 0.558 0.180 6 . 0  
H(2) 0.450 0.590 0.430 6 .0  
H(3) 0.300 0.500 0.335 6 . 0  
C(10) -0.2144 (17) 0.1551 (12) 0.3068 (15) 5 . 5  (2) 
For lanthanum the anisotropic temperature factor is of the 
form esp[ -zh,h,pj ,  JT-itli ,81i = 0.0084 14), p 2 *  = 0.0058 ( 3 ) ,  
P33  = 0.0074 (16), biz = 0.0016 ( 8 ) ,  P I 3  = 0.0034 (IO), Oz3 = 
0.0018 ( I ) .  
Figure I.-Projection of one molecule along [OIO]. 
and angles were computed by the method of Sands,ll 
and these standard deviations were used in calculating 
the weighted averages of the distances and angles which 
are given in Table 111. The positional parameters of 
the two crystals sometimes differed by several standard 
deviations. The anisotropic temperature factors 
for the lanthanum ion were also quite different for the 
two crystals. This comparison of the two crystals 
(11) D. E. Sands, Acta Cvysl . ,  21, 868 (1966). 
'r.4IJI.E 111 
B O S D  LEXGTHS A S D  h G L E S  
Lengths, d Angles, r ieg 
La-O( 1) 2.475 O( 1 1-La-O( 2) 69 .1  
La-0(2) 2 ,427  O( 3)-La-0 (4)  68,O 
La-0(3) 2 .487  O( 5)-La-0 (6) 68.5 
La-0 (4) 2.484 Mean 68.5 (6) 
La-0 (5) 2 '468 0(7)-La-0(8) 76 l ( 5 )  La-0(6) 2.496 
Mean 2 .473  (24) La-o(lj-C(l) 141.2 
562 La-O(2)-C(3) 137.4 




O(lj-C(1) 1.303 La-(B)-C( 13) I37,l 
2.584 
2 ,  573 (16) La-0(41-C(8) Mean La-O(5j-C( 11) 
0(2)-C(3j 1 274 Mean 138.1 (25) 
C(l)-C(2) 1.428 0(6)-C(13)-C(l2l 126.9 
\ ,  > ,  j ,  
C("bC(3) 1.389 Mean 123.5 (32) 
C(6)-C(7) 1.397 
C(7)-C(8) 1 411 C( 1 )-C(2)-C(3 11 126.3 
c(ii)-c(i~) 1,436 C(6j-Ci7)-C(8) 125.1 
C(l2)-C(13) 1,396 c(11)-c(12)-c(13) 125.6 
Mean 1.410 (19) Mean 125.7 (6) 




C( 11 )-C( 15) 
C(13)-C( 14) 
Mean 
0 (7)-€1 i 1 ) 
0 (8)-H (2) 







1,532 (39 j 
1 .11  
0 ,92  





0(5)-c( l l)-C( 15) 




C(9 )-C(8)-C( 7) 
C( 10)-C(o)-C(7) 
C(14)-C(l3)-C( 12) 
C( I5)-C( 11)-C( 12) 
Mean 
















serves to illustrate the unreliability of standard devia- 
tions and temperature factors obkdined by least-squares 
fitting of data containing systematic errors such as un- 
corrected absorption. In order to avoid false and mis. 
leading claims of accuracy, the standard deviations 
listed in Tables 11-IV were based on appraisals of the 
variations observed between the two crystals and be- 
tween chemically equivalent bonds and angles. 
Each lanthanum ion is bonded to eight oxygen atoms, 
contributed by three bidentate acetylacetonate groups 
and two water molecules [ 0 ( 7 )  and 0 ( 8 ) ] .  The aver- 
age distance from a lanthanum ion to a carbonyl oxygen 
atom is 2.473 A, while the average distance of lantha- 
num to coordinated water is 2.573 A ;  the corresponding 
values in Y(CbH702)3.3Hz0 were 2.366 and 2.409 
k5 The empirical relationship of Lingafelter and 
Braun,12 based on a study of distances in acetylacetone 
chelates of metal ions having noble gas configurations, 
predicts 2.54 A for the lanthanum-carbonyl oxygen 
(12) E. C.  Lingafelter and I<. I,. Braun, J .  A m .  Chetn. Soc., 88 ,  2Y5l 
(1966). 
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between 6 and the umber of coordinated ligands with N or 0 
atoms have been previously observed with ethylenediamine and 
diethylenediamineI6 and with several polycarboxylates.I2 This 
constancy of the 13% NMR chemical shift variation when passing 
from Lat1' to La"I(phen) and then to La"'(phen), suggests that 
either the same ligands are substituted by phen during the first 
and second complexation steps or the ligands displaced have the 
same shielding effect. However, if the character of the possibly 
substituted species NO), H20,  and CH3CN is considered, and 
because substantial differences are observed in the 6 139La of the 
unmixed complexes L B ( N O ~ ) ~ ~ - ,  La(H20),3+, and La- 
(CHsCN),3+, respectively, of -60, 0, and -129 ppm,I6 the first 
hypothesis is far more reasonable and was borne out by the 170 
results as will be shown below. 
The results in Table IV also show decreasing values of v I  , when 
passing from La"' to La"'(phen) and then to LalI1(phen$,. For 
a quadrupolar nucleus such as 139La, in the absence of ex- 
change-broadening effects that was checked by a temperature 
study, the line-width variation should result essentially from two 
factors: a change in the symmetry of the first coordination shell, 
and a change in the size of the La(II1) species,I6 with higher 
symmetry and smaller size leading to narrower resonances. Thus, 
because an increase of the complex size is expected with the 
addition of phen in the inner sphere of La(III), the decrease of 
vI/, results from a greater local electronic symmetry at the 139La 
nucleus. This is in agreement with a C, structure for the 1:2 
complex, as shown in Figure 7. 
On the basis of the 170 NMR data, two important conclusions 
can be reached and are helpful to determine which other ligands 
than phen belong to the first coordination sphere of the La(II1) 
species. First, each La(II1) species has three nitrate groups bound 
in its coordination sphere. This is indicated by the presence of 
three coordinated nitrate molecules in the crystalline (phen), 
complex and by the constant 170 6 value of NO< obtained when 
phen was increasingly added to the La(II1) solutions. The presence 
of the three nitrate groups in the inner sphere of free La(II1) is 
supported by the results of Evans and Missen who, by adding 
NBu4N03 to a solution of La(C104)s in CH3CN, showed that 
the chemical shift varied linearly by 54 ppm for the three first 
equivalents of NO3- added.I6 This indicates a full addition of the 
three NOs- ions in the inner sphere of La(II1) based on the 
additivity hypothesis. Furthermore, in a recent study, Bunzli et 
alas3 mentioned significant inner sphere interactions between 
La(II1) and the anion NO; in CH30H with probably two NO; 
ions belonging to the La(II1) inner sphere. In CH3CN, a less 
effective donor solvent, the interactions between La(II1) and NO; 
should be even stronger, so that all three NO3- groups should 
logically be bound. Finally, the presence of three coordinated 
NO; in the inner sphere of the free and of the complexed La(II1) 
species is in agreement wi h the calorimetric study of Forsberg 
and M~el le r ,~  who reported the absence of competition between 
nitrate ions and en for the coordination sites before the addition 
of the first two en molecules. In the present study, the NMR 
results show that ther  is no such competition between nitrate ions 
and phen. This is reasonable, due to the weaker basicity of phen 
compared to en. 
The second conclusion deduced from the I7O NMR data is the 
participation of water in the inner sphere of La"' and La"'(phen) 
whereas La"'(phen), is water-free. The absence of water in the 
1:2 complex agrees very well with the corresponding crystal 
structure and indicates a strong similarity between the 1:2 com- 
plexes in so ution and in the solid state. 
At this point, the stoichiometry of the La(II1) species can be 
determined on the basis of both the crystal structure data and the 
'39La and 1 7 0  NMR results. The indication of the presence of 
two phen molecule  and three NO3- groups nd the absence of 
water in the inner sphere of the 1:2 complex suggests identical 
molecular formulas for the solvated and the crystalline complexes, 
[La(N03)3(phen)2]. The coordination number would be 10, which 
Figure 7. ORTEP drawing and numbering scheme of the La(N03)3(phen)2 
complex. 
The N-La-N chelate angle in the (phen), complex is 61.33 
(lO)O, comparable to the corresponding angle of 60.1' in the 
(bpy), complex. All other N-La-N angles are smaller in the 
(phen)* complex than in the (bpy), complex by at least 5 O .  
Concerning the geometry of the whole polyhedron, a 2-fold axis 
of symmetry, C,, joins 0(2), N(l), and La and on the basis of 
the angle values, the geometry of the 10-coordinated polyhedron 
should be closest of the idealized geometry of the bicapped do- 
decahedr~n.,~ Formation CoastanQ. The "apparent" formation constants for 
the 1:l and 1:2 complexes were calculated from the respective 
populations of the three La(II1) species (Figure 2) (coordinated NO< not indicated). These values were obtained according to 
eqs 1-3, in which all species are solvated. Here [phen] = [phenIo 
(1) La3+(s) + phen(s) F! La(~hen)~+(s)  
[La(Phen)3+(s)l - P B  
[La(Phen)23+(s)l - P C  
[La(phen)?+(s)l - P C  
K1 
[La3+(s)] [phen(s)] P~[Phen(s)l 
La(~hen)~+(s)  + phen(s) $ La(~hen),~+(s) (2) 
K2 
[La(phen)'+(s)] [phen(s)] PB[phen(s)l 
La3+(s) + 2phen(s) F! La(~hen),~+(s) (3) 
82 [La3+(s)] [phen(s)12 PA[phen(s)12 
- PBILa(III)]o - 2P&a(III)l0. PA, Pe, and Pc are the respective 
populations of La3+ (La(N03)3(s)), La (~hen)~+  (La(N03),- 
(phen) (s) ) , and La( phen) 23+ (La( NO3) ,(phen) ,( s) ) . [ phen] , and 
[La(III)lO are the total concentrations of phen and of the La(II1) 
cation, respectively. 
The mean values of log K l ,  log K,, and log 8, with their cor- 
responding standard deviations are respectively 3.3 f 0.3 (obtained 
from 38 independent values), 2.2 f 0.2 (13 values), and 5.8 f 
0.2 (1 1 values). 
Discussion 
The addition of each phenanthroline ligand in the inner co- 
ordination sphere of '39La(III) results in a constant high frequency 
shift of 70 ppm (Table IV). Similar monotonic relationships 
(33) Blinzli, J. C. G.; Merbach, A. E.; Nielson, R. M. Inorg. Chim. Acro 
1987, 139, 151. 
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The Crystal Structure of Tris- (2,2’,6’,2”- terpyridyl)europium( 111) Perchlorate 
By G. H. FROST, F. A. HART, C. HEATH, and M. B. HURSTKOUSE* 
(Department of Chemistry, Queen Mary College, Mile E n d ,  London E.l) 
Summary An X-ray crystallographic analysis of tris- 
(2,2’,6’,2”-terpyridyleuropium( 111) perchlorate has con- 
firmed the nona-co-ordination of the metal ion, believed 
to be the first example of nine-co-ordination involving 
only nitrogen ligands. 
EARLIER studies1 on the fluorescence spectrum of tris- 
(2,2’,6’,2’’-terpyridyl)europium( 111) perchlorate suggested 
that the cation was a nona-co-ordinate [Eu (terpy)I3+ species, 
with distorted D, symmetry. We have now confirmed this 
through an X-ray diffraction analysis. 
Crystallisation from acetonitrile gives two distinct 
crystal forms, acicuIar and polyhedral, representing two 
different crystal structures. Both, however, appear to be 
unsolvated complexes. We report here the results of our 
analysis of the polyhedral crystals, powder photographs of 
which are identical with those of the material described 
previous1y.l 
Crystal data: [Eu(Cl,N3Hll),](C10,)3; M = 1150. 
Monoclinic, C2/c with a = 17.78, b = 21.33, c = 12.30 A, 
p = 94-4”, Z = 4, Dm = 1.67, D, = 1.65 g.cm.-3 The 
structure was solved by conventional techniques using 
ca. 3800 independent reflections, visually estimated from 
Cu-K, Weissenberg photographs. At the present stage of 
refinement, R is 0.118. 
The cation, depicted in the Figure, has C,  symmetry only. 
The EuN, co-ordination polyhedron approximates most 
closely to an s-tricapped trigonal prism, the distortions of the 
whole cation from idealised D3 symmetry being caused 
mainly by th  non-planarity of the ligands. The ligands 
are of two crystallographically distinct types, but both are 
distorted in a similar manner, differing only in magnitude. 
The distortion consists of (i) a rotation of both terminal 
m l d  O C  
FIGURE 
pyridine rings about the inter-ring C-C bonds and (ii) a 
slight bending of these bonds. Dihedral angl s between 
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Fig. 2 The structure f th C i-symmetric molecule 5.
Fig. 3 (a) The molecular structure of the cation present in the crystals of 8. (b) The coordinat on spher ar und the gadolinium atom in the structure of
8 s wing the mono-capped Archimedean antiprismatic coordination geometry.
Fig. 4 (a) Themolecular structu e of theC2-symmetric ca ioni complex present in the crystals of 11, viewed along the crystallographicC2 axis direction.
(b) The coordination sphere around the cadmium atom in the structure of 11 showing the intermediate between cubic and Archimedean antiprismatic
coordination geometry.
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It has been made known that polydentate ligands form more stable complexes than 
those with the same number of equivalent monodentate ligands. The macrocyclic 
effect,33 as described by Cabbiness et al. in 1969, (or multiple juxtapositional 
fixedness)34 is an extension of the chelate effect whereby cyclic ligands give more 
stable complexes than the corresponding open-chain ligands do. Two CuII complexes 
(Figure 1.9) with very similar ligand structures, where one is an open chain and the 
other a macrocycle, differ in stability hugely: the macrocyclic compound is ca. 104 
times more stable. It was also noted that the macrocyclic compound coordinated much 
slower (103 – 104 times) than the open chain ligand.32 Both of these trends are not 
exclusive to this example and both the increase in stability and decrease in 
coordination rates are commonplace throughout macrocyclic coordination chemistry.7  
This increase in stability, as with the chelate effect, is proposed to come from the 
entropic and enthalpic effects favouring macrocyclic compounds. The change in 
enthalpy has been related to the difference in the solvation of open-chain and 
macrocyclic compounds, although Kodama et al. found that the increased stability in 
[Cu(cyclen)], compared to [Cu(trien)] (trien = triethylenetetramine), was solely due to 
the entropic term.35 They proposed that this was due to the fact that, in the trien 
complex, disorder is lost upon complexation as the trien loses its ability to rotate 
freely whilst cyclen is already restricted due to the steric constraints of cyclic 
compounds. The distorted coordination geometry associated with cyclic ligands also 
reduces the inner-sphere solvation,36 which favourably results in less molecules 
becoming ordered upon complexation and reduces the enthalpic cost of desolvating 
the ligand. The addition of a cation to the macrocycle also reduces the unfavourable 
interaction of the donor lone pairs, which is not seen in open chain systems where the 
ligands can freely change orientation to prevent unfavourable donor interactions. 
 
Figure 1.10 Cyclam (left) and a corresponding open chain derivative (right) that have been used to 
demonstrate the enthalpic and entropic contributions towards the macrocyclic effect using NiII. 
Despite Kodama et al.’s results, there are data for low spin NiII complexes of cyclam 
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enthalpic contribution in some complexes even if, as with the chelate effect, the 
entropic contribution dominates the increase in stability (Table 1.2).32 
Ligand ΔH / kJ mol-1 TΔS / kJ mol-1 
cyclam -78.2 49.3 
open-chain tetramine -66.1 21.7 
Table 1.2 Changes in the enthalpic and entropic effects between a cyclic and open-chain NiII complex. 
From the perspective of lanthanides, the macrocyclic effect is extremely important as 
the complexes can often form up to 9 coordinate species and are therefore often 
encapsulated in polydentate macrocyclic ligand architectures. Of particular interest is 
the GdIII ion, as this is where most of the research has focussed due to the 
incorporation of GdIII in many contrast agents for magnetic resonance imaging 
(covered in more depth in Chapter 3).  
 
In the above example,24 if an aquated GdIII ion is reacted with a macrocyclic ligand, 
entropically speaking, the reaction is extremely favourable as the reaction generates at 
least eight molecules from the reaction of two. As described earlier, the LnIII ions 
have a very high charge density and the incorporation of this strong Lewis acid into a 
ligand with nucleophiles such as amines and basic hydroxide moieties (as is found in 
DOTA-type ligands) results in a highly favourable electrostatic interaction, further 
enhancing the stability of the complexes (especially when the release of 3H+ ions is 
also accounted for in the enhanced entropic effect).  
 
Figure 1.11 Diagramatic representation of the reason for slow formation of macrocylic compounds.24 
From a dissociative point of view, the removal of a metal ion, such as GdIII, from a 
macrocycle takes much longer than it does to remove the same metal ion from a 
corresponding linear polydentate ligand. This is due to the principle of microscopic 
Gd(H2O)83+ +HnL!GdL(H2O)+nH++7H2O
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reversibility,37 which states that for any reversible reaction, the mechanism in one 
direction is the exact opposite of the mechanism in the other direction. This means 
that, as it takes much longer for the macrocyclic compounds to form due to the strain 
required to encapsulate the metal ion within the cavity, as shown diagrammatically in 
Figure 1.11, it also takes much longer for them to dissociate as the same strain must 
be imposed in order to release the ion. 
The results of the chelate and macrocyclic effects can be summarised in the stability 
constants seen below (Table 1.3) for a range of GdIII complexes.16, 38 Although there is 
not a direct likeness between the ligands, it highlights the increase in stability from a 
monodentate ligand to a polydentate open chain ligand to macrocyclic ligand, utilised 
as a contrast agent in magnetic resonance imaging (see Chapter 3). 





Table 1.3 Stability constants of GdIII complexes with a range of monodentate, polydentate and 
macrocyclic ligand architectures.  
1.2. Luminescence 
This thesis aims to design, synthesise and develop a series of luminescent transition 
metal and lanthanide ion complexes in order to assess their photophysical properties, 
amongst other attributes. In order to fully appreciate their photophysics, it is 
important to understand the fundamental aspects that are associated with 
luminescence and the factors that can influence the emissive properties of these 
complexes. 
1.2.1. Light 
For the purposes of this thesis, photophysics and photochemistry can be thought of as 
the study of how light influences the structure and chemistry at the molecular level. 
Given this, it is imperative to outline the fundamental properties of light and how it 
interacts with molecules. 
 Light can be thought of as electromagnetic radiation, defined by three intimately 
related quantities, wavelength, λ, frequency, ν, and velocity, c, which can be used to 
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form equation (2), below. Both wavelength and frequency are variable over a wide 
range of values (Figure 1.12), whilst c, commonly known as the speed of light, is a 
fixed quantity with a value of 2.998 x 108 m s-1 in a vacuum.  
λν = c  (2) 
Light can also be thought of as a stream of discreet packets of energy, called photons. 
These photons have a specific energy, E, which is related to the frequency of the 
radiation, ν. This gives us a second equation, (3), which relates these two properties 
through Planck’s constant, h, which has a value of 6.63 x 10-34 J s. 
E = hv  (3) 
In the field of photochemistry and photophysics, the term use of ‘light’ is limited to 
the range of electromagnetic radiation energetically suitable to invoke electronic 
excitation (discussed below); this is typically energy between 1.5 x 1015 to 3 x 1014 
Hz (200 to 1000 nm), although there are some exceptions. This means that light 
suitable of exciting an electron falls within the ultraviolet (UV), visible or infra-red 
(IR) regions. 
 
Figure 1.12 Electromagnetic spectrum with relevant frequencies for the different categories of light.39 
When light interacts with a molecule, it most frequently involves one molecule and 
one photon. This can be represented through equation (4) where the molecule in the 
ground state, A, is excited by a photon of light, hν, promoting the molecule to its 
electronically excited state, A*. This means that A* possesses hν more energy than A, 
where hν is between 9.95 x 10-19 and 1.99 x 10-19 J, using equations (2) and (3) given 
the range of energy suitable for electronic excitation.  
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A+ hv→ A*  (4) 
Only photons of light absorbed by molecules can promote molecules from A to A*, 
which is never the entire photon flux. It is fundamentally important, as it will become 
apparent, to know how much light of a certain wavelength is absorbed by a given 
number of molecules in a transparent medium. Equation (5), the Beer-Lambert law, 
provides a relationship between the incident light, I0, the transmitted light, I, the molar 
absorption coefficient, ε, which is the ability of a molecule to absorb light of a given 
wavelength (in mol-1 dm3 cm-1), the path length, l, and the concentration of the 
photophysically active molecules, c, in solution. These values can be rearranged to 
give the absorbance, in equation (6), which describes how much light has been 
absorbed at each given wavelength, and is typically the form of the values given by 
spectrophotometers. 
I = I0 ×10−εcl  (5)                       A = log I0 I( ) = εcl  (6) 
1.2.2. Fluorescence 
Luminescence is the emission of light from a molecule upon its relaxation to the 
ground state, S0, from its electronically excited state, S1 or T1.40 The Jablonski 
diagram (Figure 1.13) is used to demonstrate the processes that can occur upon 
excitation into the higher energy levels.41 
 
Figure 1.13 Jablonski diagram illustrating the radiative (solid arrows) and non-radiative (dashed 
arrows) processes that can occur within a molecule. 
Energy, in the form of a photon, can only be absorbed by a molecule, or ion, when a 
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A is a molecule in the ground state, S0, and A* is in an excited state, S1,2,…, which is 
summarized in the Bohr equation (7). 
hv = EA* − EA  (7) 
As well as this necessity, there is a requirement for a specific interaction between the 
electromagnetic field and the molecule. In most cases the magnetic field can be 
disregarded, as the transitions generated by the oscillating magnetic field are weaker 
(by ca. 105 times) than the electric-dipole transitions. This means it is only necessary 
to focus on the interaction between the electric vector of the electromagnetic wave 
and the electric dipole of the molecule as, in the presence of light, the light’s 
sinusoidal electric vector results in oscillating forces on the charged particles of the 
excited state molecule. 
 
Figure 1.14 Diagram representing the vertical transitions outlined in the Franck-Condon principle.42 
Upon excitation to the excited state, the electronic spins retain their spin-paired 
(opposite spin) configuration, resulting in a spin-conserved process (ΔS = 0). The 
Franck-Condon principle dictates that these transitions be represented as vertical lines 
(Figure 1.14) due to the fact that, during the timeframe of the electronic transition (10-
15 s), the nuclear framework remains the same, as the vibrational transitions occur 
much slower (10-8 s).43 This results in vibronic relaxation after the excitation has 
occurred, via internal conversion (IC) to the lowest vibrational energy level of the 
corresponding excited state (often S1). This relaxation results in the emission being of 
lower energy than the excitation, and the difference between these two energies is 
referred to as the Stokes’ shift.44 
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Repopulation of S0 results in the emission of a photon of equal energy to the energy 
gap between the two energy levels. This emission is defined as fluorescence given 
that it is a spin-allowed process resulting in short lifetimes (typically < 50 ns).41  
1.2.3. Phosphorescence 
It is also possible to populate the triplet excited state (T1) via intersystem crossing 
(ISC), a non-radiative process that results in the electron in the ground and excited 
state having the same spin orientation. Decay to the ground state requires a spin-
forbidden process, according to Laporte’s parity selection rules, which facilitates a 
much longer lifetime. Emission by this process is classified as phosphorescence and 
both the ISC and emission are facilitated by spin-orbit coupling whereby the spin’s 
magnetic interaction and the orbital angular momenta of individual electrons couple 
with one another.18 As discussed above, this is often more prevalent in the presence of 
a heavy atom such as a transition metal, lanthanide or halogen due to the heavy atom 
effect.45 
1.2.4. Lifetimes 
As mentioned, different systems (fluorescence and phosphorescence) have very 
different emissive characteristics, dominated by the length of the emissive lifetime. 
The lifetime (τ) is the average time molecules spend in the excited state before 
relaxing to the ground state. There are several ways that a molecule can relax from the 
excited state to the ground state. Using the paradigm set out above in equation (4),44 
these deactivation processes can be expressed in the scheme below (Figure 1.15).41 kp 
denotes a unimolecular chemical process to give a chemically different product, A′, kr 
is the radiative process whereby A* relaxes to the ground state to give A and light at a 
lower energy, hv′, due to IC (Figure 1.13), whilst knr describes a non-radiative 
physical process whereby energy is released from A* as heat in order for relaxation to 
S0 to occur. 




Figure 1.15 Intermolecular interactions leading to the deactivation of excited state molecules.             
The lifetime of the excited state can therefore be expressed in terms of the rates of the 
three relaxation processes highlighted above (Figure 1.15) to give equation (8).20 
τ (A*)= 1kp + kr + knr
 (8) 
Given that one of the main interests of this thesis are the luminescent properties of 
metal complexes, the lifetime that matters within the scope of the research is the 
luminescence lifetime, a first-order kinetic process referred to hereon in as τ. This can 




Γ+ kISC + kIC
  (9) 
Along with the aforementioned difference in lifetimes between fluorescence and 
phosphorescence, there are other factors that can have a profound effect on the 
emissive lifetime. One of these is a change in temperature; it is commonly observed 
that a decrease in temperature results in an extended emissive lifetime, primarily 
through a reduced rate of non-radiative decay, knr, which incorporates kIC and kISC.46, 47   
1.2.5. Quenching 
Another very important factor that affects the emissive lifetime, as well as non-
radiative processes, is quenching. This is a process in which a molecule in an excited 
state releases energy to a quencher in order to return to the ground state.41 Quenching 
can occur intramolecularly, especially in supramolecular systems, where the excited 
states can be very short lived due to the efficient cascade of energy transfer from one 
component to another.44 
A + heat 
kr 
A + hν′ A* 
A′ 
A + hν 
kp 
knr 
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Where intramolecular deactivation is not too fast, quenching can also take place in an 
intermolecular manner through second-order rate kinetics. This can occur through 
either energy-transfer or electron-transfer processes, the latter of which involves 
oxidation or reduction of the excited state, A*. In systems where intermolecular 
energy-transfer occurs the excited quencher, B*, undergoes its own deactivation 
mechanism which, as with the deactivation of A*, can involve radiative decay, known 
as sensitised luminescence.44 This means that, in the presence of a quencher, B, 
Figure 1.15 has an additional arrow where the rate of quenching, kq, also leads to 
deactivation of A*. 
The rate of change of [A*] in the presence and absence of a quencher can be 
expressed in equations (10) and (11), respectively, where τ0(A*) is the lifetime of A* 
in the absence of a quencher and τ(A*) is in the presence of a quencher, B. This gives 
equation (12) for the overall lifetime of A* in the presence of B. 
− d[A*]intradt = (kr + kp + knr )[A*]=
1
τ 0 (A*)[A*]  (10) 
− d[A*]interdt = kq[A*][B]  (11) 
  τ (A*) = 1kr + kp + knr + kq[B]
 (12) 
These can be combined to give a ratio of the lifetimes in the absence and presence of 
B to give a Stern-Volmer plot using equation (13).20 The Smoluchowski Equation, 
(14), expresses the diffusion rate constant, kd, which, in conjunction with equation 
(13) makes it possible to calculate how much effect the concentration of quencher will 
have on the lifetime of A*, where RA and RB are the collision radii of A* and B and DA 
and DB are the diffusion coefficients of A* and B.44 
τ 0 (A*)
τ (A*) = 1+τ
0kq[B]  (13) 
kd = 4πNA(RA + RB)(DA + DB)  (14) 
Using a very simple example, in a system where the excited state decays via 
fluorescence (τ0 = 10-6 s), in order to quench 50% of A*, [B] ~ 10-2 M, whereas in a 
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system where decay is via phosphorescence (τ0 = 10-3 s), the same degree of 
quenching requires [B] ~ 10-6 M.44 This is why, for phosphorescent systems, the 
lifetimes observed, τ, are often considerably less than the unquenched lifetimes, τ0. In 
order to get values closer to τ0, systems are often degassed to remove dissolved 
oxygen, which is the most common quenching species and can quench through 
various means, including energy-transfer, electron-transfer and catalysed deactivation. 
When energy-transfer occurs, the oxygen molecule can undergo ISC from the triplet 
ground state (3O2) to the highly reactive oxygen singlet state (1O2).  
Quenching can also happen through a static mechanism where non-emissive 
structures are formed between the fluorophores and quenching molecules; this means 
that this form of quenching is not dependent upon diffusion or collision of 
quenchers.41 
1.2.6.  Solvent effects 
When the absorption spectra of samples in solution are measured, it is often found 
that varying the solvent results in changes in the observed spectra. This is due to the 
fact that irradiation by light leads to the redistribution of electron density within a 
molecule.44 This alters the interactions between the solute and any molecules that are 
solvating the excited molecule. The perturbation of the absorption or emission band is 
referred to as solvatochromism and the extent of its effect varies depending upon the 
solvent nature, the chromophoric molecule and the type of transition that occurs. The 
effect is more pronounced when a molecule’s excitation induces a change in the 
dipole moment, which is common in samples that show charge transfer (CT) 
character.48 The timeframe in which the electronic transition occurs means that there 
is not time for the solvent molecules to rearrange themselves around the excited state 
in order to most efficiently stabilise the altered dipole moment until after the 
transition to the excited state has occured. This increases the energy of the transition 
and these effects are exaggerated with increasingly polar solvents, especially when 
solvents such as methanol and water are involved as the hydrogen bonding 
interactions are much stronger than the dipolar contacts.44 This leads to the (n → π*) 
transition in acetone (Table 1.4) ranging from 279 nm in hexane to 265 nm in water, 
as the n orbital of the oxygen is only half filled and, as such, cannot participate in 
hydrogen bonding. Due to the Franck-Condon principle, the solvent dipoles remain 
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orientated in such a way as to hydrogen bond with the oxygen atom so are distributed 
unfavourably when the molecule is in its excited state, destabilising this state and 
resulting in larger excitation energies.  
Solvent Water Methanol Ethanol Chloroform Hexane 
λmax / nm 265 270 272 277 279 
Table 1.4 The effect of solvent polarity on the (n → π*) transition in acetone.49 
The effect of dissolved oxygen on the nature of the luminescent lifetime has already 
been discussed, but it is important to note that the concentration of dissolved oxygen 
in solution is solvent dependent and, as a result, the solvent can impact on the lifetime 
through its capacity to dissolve oxygen. DMSO, for example, has an oxygen 
concentration of 2.1 mM at 25 °C, whilst the capacity for pyridine to dissolve oxygen 
is much greater with concentrations approaching 5 mM.50 
1.2.7. Quantum yields 
Another important parameter in fluorescence is quantum yield, Φ, which is the 
number of emitted photons in relation to the number of photons absorbed, as 
portrayed by equation (15). It describes the efficiency of the radiative emission 
process and takes into account the emissive rate, Γ, and also and the rate of non-
radiative decay, knr, as shown in equation (16).20 A high quantum yield (close to 
unity), requires that Γ be much greater than knr, although it is not possible to reach 
unity because of factors such as quenching.41 
 (15)                       (16)  
The quantum yields can be calculated experimentally by comparison with a standard, 
denoted by subscript R, such as [Ru(bpy)3](PF6)2, by using equation (17), where S is 
the area below the emission spectrum, A is the absorbance at the excitation 









Φ = number of emitted photonsnumber of absorbed photons Φ =
Γ
Γ + knr
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1.2.8. Luminescent transition metal complexes 
Luminescent transition metal (TM) complexes have, in the past, focussed on diimine 
coordinated compounds utilising d6 metals like ReI, RuII and IrIII. The classical 
example is [Ru(bpy)3]2+, from which many hundreds of derivatives have been 
synthesised and assessed for their photophysical properties.51-53 These luminescent 
complexes typically emit from a triplet metal-to-ligand charge transfer (3MLCT) state 
which, due to the parity forbidden nature of the transition, have much longer lifetimes 
(10 ns – 10 µs) than those of the corresponding ligand fluorescence. In the case of 
[Ru(bpy)3]2+, the absorption of a photon results in oxidation of the metal, whilst the 
diimine is simultaneously reduced. Despite the majority of work in the literature being 
based on d6 metals, complexes of d8 metals, such as PtII, RhII and AuIII are also known 
and often offer a range of photophysical features unique to their electronic 
configuration. The photophysical properties of PtII complexes are discussed in much 
more detail in Chapter 2. Whilst luminescent RuII complexes have focussed on 
diimine-based ligands, many luminescent PtII complexes incorporate cyclometallated 
ligands due to the increased stability of this type of chelate. This is primarily due to 
the strong ligand field influence of the aromatic carbon atom and the increased 
stabilisation of π donation from the metal to the ligand.54 
d8 transition metal complexes are often low spin, square planar complexes, which 
lend themselves to intermolecular metallic interactions, which can provide a wealth of 
photophysical diversity.55 Although they do not always boast the high stability found 
with the d6 metal complexes, this has often been utilised to facilitate intentional ligand 
exchange and dissociation for applications in DNA and peptide binding, such as 
cisplatin. More recently this concept has been expanded to drug delivery systems by 
exploiting the reducing nature of tumour cells to reduce octahedral PtIV complexes in 
order to form the square planar PtII complexes and liberate the axially coordinated 
ligand species into solution.56  
1.2.9. Luminescent lanthanide complexes 
Lanthanides are most often found in their +3 oxidation state forming hard metal ions 
with 4f valence electrons.16 These orbitals are shielded by outlying 5s25p6 subshells, 
which results in the emission from (4f → 4f) transitions being very well defined and 
unresponsive to environmental changes.57 A poor shielding of the valence electrons 
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from the increased nuclear charge associated with an increase in atomic number also 
results in a reduced ionic radius which, as mentioned, is known as lanthanide 
contraction and results in a large change in the ionic size across a period.4  
 
Figure 1.16 Normalised emission spectra of LnIII ion complexes demonstrating the breadth of the 
lanthanide series’ emission and the narrow emission profile of the individual lanthanide ions.18 
The fact that the f orbitals are buried within the more diffuse 5s25p6 subshells prevents 
meaningful interaction between the f orbitals with the ligand orbitals. This means that 
luminescence is dependent upon (4f → 4f) transitions, which are parity forbidden. 
These transitions are characteristically sharp and unique for each lanthanide ion 
making them readily distinguishable (Figure 1.16). The range at which emission 
occurs is much broader than most fluorescent and TM phosphorescent species with 
high energy emission coming from TbIII and DyIII ions at ca. 500 – 550 nm and low 
energy emission from ErIII at ca. 1530 nm; the near-IR emitting examples (YbIII, NdIII 
and ErIII) are ideal candidates for biological systems where tissue possesses an optical 
window in the near-IR region. The fact they are Laporte forbidden also means their 
lifetimes are very long lived (µs – ms). The Stokes’ shifts are also very large due to 
their need for sensitisation (detailed in Chapter 3) in order to access the luminescent 
potential of the ions, again making them ideal for biological imaging applications. 
As mentioned, accessing the luminescent emission through an MLCT-type state is not 
possible due to the weakly interacting f and ligand orbitals. It is also difficult to 
directly excite electrons in the f orbitals due to fact that they are parity forbidden and, 
as a result, suffer from extremely low molar absorptions.58 In order to combat this, an 
antenna can be utilised to sensitise the emission (discussed in greater detail in Chapter 
3). Although electric dipole transitions usually dominate in TM complexes, magnetic 
dipole transitions are more often observed in LnIII complexes due to spin-orbit 
coupling.16  
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Chapter 2: Tuning the photophysical properties of platinum 
(II) complexes  
  




Chapter 2 aims to investigate the photophysical properties of a class of PtII complexes 
incorporating functionalised cyclometallating 2-phenylpyridine ligands and how 
adaptation of the functionality in the 4-position modulates the photophysical 
attributes. As well as altering the cyclometallating ligand’s functionalisation, this 
chapter will also aim to provide a greater understanding of how different ancillary 
ligands can affect the photophysical properties. Alongside these measurements, the 
chapter will detail how these adaptations alter the δPt in the 195Pt NMR spectra and 
shed light on the electronic properties of the PtII ion in different coordinative 
environments. 
2.1.1. Use of platinum (II) complexes in cancer treatment 
One of the primary reasons for investigating PtII complexes is because of the profound 
impact platinum, in its +2 oxidation state, has had on the medical world. PtII has been 
used therapeutically for decades since the approval of cisplatin in the United States of 
America in 1978 for the treatment of various cancers.1, 2 Since then other compounds 
such as carboplatin and oxaliplatin have also shown great promise in chemotherapy, 
with carboplatin being similar in utility to cisplatin but having less side effects.3 Upon 
injection of the drug into a cancer patient, relative concentrations of chloride and 
water within cells results in aquation, whereby ligand exchange of a chloride with a 
water molecule occurs.4 The relatively weak coordination of water allows for further 
ligand exchange with much stronger coordinating donors such as nitrogen. Guanine 
(G) is a base pair within DNA that is particularly susceptible to interactions with 
cisplatin due to the nitrogen at the 7-position being favoured by cisplatin as a 
coordination site. This results in the formation of intrastrand cross-linkage by 
cisplatin to form a [Pt(NH3)(G2)]2+ complex.2 The coordination to DNA results in a 
local bend in the structure that unwinds the double helix by ca. 25%, arresting the 
transcription process and resulting in apoptosis.2, 5  





Figure 2.1 Structures of some PtII complexes used as chemotherapy drugs.  
Cisplatin, however, is not without limitations and risks. The low relative selectivity 
for tumour cells over healthy cells means it is highly toxic and causes various side 
effects to patients undergoing chemotherapy, which include kidney damage and 
seizures.6 Some patients also show resistance to treatment with cisplatin through 
reduced drug transport or improved DNA repair or tolerance for platinum-DNA 
adducts, which has resulted in the development of cisplatin-like analogues to combat 
the weak links found in the first generation drug.7, 8  
  
Figure 2.2 Cisplatin pathways into, within and out of cells as well as means of inactivation.9 
To combat these flaws, many attempts have been made to synthesise structurally 
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carboplatin and oxaliplatin however, despite more than 3000 compounds being tested 
by Ziegler et al. in 2000, only four of these were deemed suitable for further study 
based on their promising activity against tumour cells.10 This has led to a shift from 
the traditional approach whereby complexes were made based on the structural 
properties of cisplatin (cis geometry, charge neutrality and minimal steric bulk).11 
Since the first generation compounds were discovered, complexes involving trans 
orientations, such as trans-[PtCl2(tz)2] (tz = thiazole), have shown higher activity than 
cisplatin against certain tumours, whilst the more bulky AMD473 has shown activity 
within cells that have become resistant to cisplatin.12  
2.1.2. Photophysical properties of platinum (II) complexes 
So that we can have a greater understanding of the factors that will contribute to the 
photophysical properties of the cyclometallated PtII complexes, it is important to 
firstly understand how the physical and electronic structure of PtII complexes lend 
themselves to luminescent compounds. It is also important to put the photophysical 
characteristics of cyclometallated PtII complexes into context in line with different 
coordinative motifs that have been found to give emissive PtII complexes.  
The photophysical properties of PtII, as with other d-block metals, are defined by the 
ligand character, the interaction of the ligand with the metal’s valence electrons and 
the oxidation state of the metal. It is possible to modulate both the excitation and 
emission profile of PtII complexes by changing the type of coordination sphere around 
the metal ion or by altering the functionality of the ligand itself. PtII complexes most 
commonly adopt square planar geometries, as described in Chapter 1, which results in 
the formation of non-degenerate molecular orbitals. This gives rise to the emission of 
photons in the visible spectrum after electronic excitation. As well as d-d, metal-
centred (MC), transitions, there are other means by which PtII complexes can emit 
visible light (Figure 2.3). An electron can be excited from a strongly bonded ligand-
centred orbital to an antibonding metal-centred orbital, known as ligand-to-metal 
charge transfer (LMCT). Transitions can also occur from a metal-centred orbital to an 
antibonding ligand-centred orbital, known as metal-to-ligand charge transfer (MLCT), 
and through ligand-centred (LC) transitions. 
MC transitions occur more frequently in first row transition metal complexes whilst 
LC transitions can be preferred when there are large aromatic systems with extended 
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π and π* orbitals. MLCT occurs most frequently when the metal can be readily 
oxidised and the ligand reduced, and LMCT exists in systems where the ligand can be 
oxidised and the metal reduced.13 
 
Figure 2.3 Charge transfer processes within a generic transition metal complex.14  
As it has been noted above, certain emissive states require specific characteristics of 
the ligand, such as easy reducibility for MLCT states. Valiente et al. found that the 
red luminescence from [Pt(bpy)Cl2] derives from a 3MLCT state due to dσ*(bpy) → 
π*(Pt) transition, in which the bpy ligand is reduced whilst PtII is simultaneously 
oxidized to PtIII.15 This is in contrast to tetracyanidoplatinates where the emissive state 
is MC through a pσ*(Pt) → dσ*(Pt) transition.16, 17 Cyclometallated phenylpyridine 
compounds, on the other hand, have been shown to be almost entirely 3LC in 
character, which is strongly perturbed by admixing with the 1MLCT through spin-
orbit coupling.18-23 Reports by Mou et al. contradict these findings, to some extent, 
claiming that the excited states of their [Pt(ppy)(O^O)] complexes can be mostly 
attributed to charge-transfer states, due to the temperature sensitivity, including 
3MLCT and 3LLCT states.24 They claim that there is only a small contribution from a 
3LC on the cyclometallated ring.25 
The emissive wavelength of cyclometallating complexes is also very sensitive to local 
perturbation of the ligand either through, for example, the addition of fluorine atoms 
in the 4- and 6-position of the phenyl ring or by extension of the conjugation on the 
cyclometallated ligand to give hypsochromic and bathocromic shifts, respectively.26, 
27 
The square planar nature of PtII complexes leaves their vacant axial sites prone to 
interaction with solvent molecules as well as intermolecular Pt-Pt contacts. The 
formation of Pt-Pt bridged dimers can lead to favourable physical properties whereby 
This journal is©The Royal Society of Chemistry 2014 Chem. Soc. Rev., 2014, 43, 4144--4166 | 4147
2.2 Self-assembly
2.2.1 Basic aspects. S lf-ass mbly f sm ller components
into larger and more complex systems is an ubiquitous process
that occurs at all levels: from the extremely large, such as
galaxies, to the extremely small entities, such as molecules.62
In general, self-assembly strongly engages with thermo-
dynamics, and this allows the distinction between equilibrium
and dissipative processes.63–65 Even though the concept of self-
assembly has been historically linked to biology, and in parti-
cular to biological structures such as cellular membranes and
DNA, it has recently turned out to be a powerful and strategic
tool in nanoscience.66–68
In such respect, life, in its deepest biochemical means,
represents the ultimate, most complex and beautiful self-
assembly process. The capability that indeed bio-mol cules
and bio-structures have to interact, recognize and self-replicate
with incredibly high synchrony and low robability of error plays
a central role in life.
Nowadays, the possibility to design and che ically control
long-range ordered nano- and micro-meter scale architectures,
based on either organic or organo-metallic species, still repre-
sents a challenging research topic from both fundamental and
applicative points of view.67–69 Indeed, self-assembly through
weak and noncovalent interactions has been shown to provide a
way to organize molecules in supramolecular structures with
properties superior to common bulk materials.
Several papers have already reported on the self-a sembly in
a competitive environment like water, while such a supra-
molecular process is even more challenging in cellulo and
in vivo. To date, inspiring examples of interaction between
artificial structures and living systems were reported on the
use of self-assembly of synthetic materials70 such as scaﬀolds
for directing cell behavior,71 tissue regeneration72 and blood
vessel formation,73 to cite some. On the other hand, beautiful
examples of preparation of metallic and inorganic nanoparticles
by using bi -templated and/or bio-directed self-assembly have
been reported forming bio-hybrid materials.74–77 Such very pro-
mising and fascinati g examples have paved the way to self-
assembly of molecular components by means of weaker and
non-covalent interactions in living cells.
To the best of our knowledge, only a few examples are so far
reported in which self-assembly of exogenous molecular (i.e.,
organic and/or organometallic) components has been achieved
in or triggered by a very complicated environment such as
living cells. In particular Rao and coworkers78 have reported on
the possibility to carry out a catalyzed condensation reaction
under enzymatic control in living human cervical cancer cells,
HeLa. The reported condensation process has been successfully
visualized by means of fluorescence confocal imaging using a
labeled biotin–streptavidin bio-conjugate. Moreover, Smith and
coworkers79 have nicely shown the possibility to form a host–
guest system based on NIR-emitting squaraine–tetralactam
macrocycle inclusion complexes with very high association
constant. The complexation process has been easily followed
by the increase of the NIR emission at ca. 700 nm even in a
highly competitive biological environment such as bilayer
membranes and in organelles with vesicle-like structures inside
live Chinese hamster ovary (CHO) cells.
2.2.2 Self-assembly properties of luminescent platinum
complexes. The possibility to prepare self-assembled nanostructures
based on TMCs by means f supramolecular approaches repre-
sents an appealing topic with greatly growing interest.80,81
This is due to the possibility to fabricate functional materials
with emerging properties, compared to the bulk, by means
of bottom-up approaches and it is driven by the potential
advantage of the rich physico-chemical properties that metal
complexes might possess. In particular, square-planar Pt(II)
Fig. 1 (a) Simplified MO diagram for a generic transition metal complex and relative spectroscopic excitation transitions. (b) Simplified MO diagram of
two interacting square-planar platinum(II) complexes, showing the intermolecular dz2 orbital overlap in the ground-state and its influence on the energy
of the MO levels.
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the vacant axial sites are no longer susceptible to interactions with reactive species 
such as singlet oxygen (1O2) and others in the local environment.14 The highly toxic 
oxygen species can be generated through non-radiative deactivation of the T1 state by 
the excitation of ground state dioxygen (3O2).28 This makes them much more stable 
than the monomers, which are capable of forming a transient +4 oxidation state upon 
direct coordination of the reactive oxygen species (ROS).29 It is important to note that 
the formation of dimers occurs most frequently in the solid state. 
When excimers form through metal-metal interactions it causes the destabilisation of 
the occupied dz2 orbitals so, where the transition was characterised by dπ → π* in the 
monomer, the new lower energy transition involves dσ* → π*.30 These new excited 
states involve ligand-to-metal-metal charge transfer (LMMCT) and metal-metal-to-
ligand charge transfer (MMLCT) and, due to the increased energy through 
destabilisation of the highest occupied molecular orbital (HOMO), often show lower 
energy absorption and emission profiles.14 This bathochromic shift in the absorption 
is ideal due to the deeper penetration and less harmful nature of longer wavelength 
light. The occupation of the axial sites also prevents quenching by solvent molecules 
or dissolved oxygen, often leading to the advantageous extension of emissive 
lifetimes and higher quantum yields. 
 
Figure 2.4 Simplified molecular orbital (MO) diagram of interacting square-planar PtII complexes 
showing influence of dz2 interaction on the energy levels of the MOs. 
Although these advantageous properties are appealing, the intermolecular interactions 
can also have a detrimental impact, both physically and photophysically. The 
lifetimes can suffer as a result of induced quenching through triplet-triplet 
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annihilation.31 They can also aggregate, reducing the solubility, resulting in their 
precipitation.14  
Most of the literature regarding luminescent d8 complexes focuses on PtII complexes, 
although there are a plethora of luminescent PdII compounds reported. Despite having 
similar properties to those of their platinum counterparts, the higher ionisation 
potential for the 4d orbital of palladium compared to that of the 5d orbital for 
platinum results in blue-shifted absorption and emission profiles from around 430 nm 
for platinum to 390 nm for the coordinatively identical palladium complex.30, 32  
2.1.3. Ancillary ligands for cyclometallated platinum (II) complexes 
Ancillary ligands can be incorporated to help tune a number of properties. They are 
frequently employed to alter the photophysical properties of a complex but can also 
be used to aid solubility and affect the physical attributes, such as charge.33 
Cyclometallated µ-dichloro-bridged dimers of PtII complexes, such as [Pt(ppy)(µ-
Cl)]2, like analogous IrIII precursor complexes, can be split using ancillary ligands to 
produce the monometallic target compound, which can possess much greater 
solubility. Whilst literature on IrIII complexes is dominated by diimines such as 2,2′-
bipyridine and 1,10-phenanthroline, PtII complexes predominantly incorporate β-
diketones such as 2,4-pentanedione (acac), dipivaloylmethane (hmacac) and 
dibenzoylmethane (dbacac).27  
 
Figure 2.5 A selection of anicillary ligands found on cyclometallated PtII complexes. 
Coordinated β-diketonates offer a great deal of diversity and allow tuning of the 
photophysical properties by introduction of aromatic functionalisation in the 1- and 5-
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found to have dramatic influences on the photophysical properties of the complex. 
Replacement of the –CH3 groups on acac with –CF3 moieties has been reported to 
result in a loss of emission from cyclometallated complexes.34 DFT measurements 
revealed that the lowest unoccupied molecular orbital (LUMO) for the 
hexafluoroacetylacetonate (hfacac) complexes showed electron density predominantly 
on the ancillary ligand (seen in the LUMO+2 for the acac complexes). This was 
proposed as being a result of the electron withdrawing CF3 groups stabilising the π* 
orbitals to such a degree that the LUMO shifts from lying on the cyclometallating 
ligand. This suggests that the lack of emission is most probably a result of the poor 
overlap of orbitals involved in excitation as the frontier orbitals are localised on 
different parts of the molecule.35  
Hydroxyquinoline (8-HQ), and its analogues, have also been used as ancillary ligands 
on cyclometallated PtII complexes and show promise as highly efficient singlet 
oxygen generators as well as having desirable photophysical properties.36 These 
compounds have absorption profiles well into the visible region with λmax close to 500 
nm and emit well beyond 700 nm with lifetimes of more than 5 µs.  
Esmaeilbeig et al. utilised the labile PtII coordinated solvent molecule, namely 
DMSO, to undergo ligand exchange with a monodentate, N-aromatic ligand, such as 
imidazole and pyridine (py). 37 They found that complexes of the type [Pt(ppy)(N)Cl], 
where N is the monodentate N-aromatic ligand, display antitumor properties and were 
assessed for their viability for such applications. It was found that the size of the N-
aromatic ligand plays a key role in the biological activity of the complexes. The 
reactions all proceeded to completion in acetone without the need for external heat 
sources, which opens up the possibility of utilising this easy reactivity to appending 
greater functionalisation to the PtII complexes through this readily formed Pt-N bond.    
Kvam et al. originally investigated the photophysical properties of mixed C^N N^N 
PtII complexes in 1995, where N^N is 2,2′-bipyridine (bpy) or a functionalised 
analogue.38 This investigation was later repeated by Jenkins et al. who found that, 
whilst most of Kvam’s conclusions were correct, the reduction of the ligands in the 
two reversible reductions in dimethylformamide (DMF) are attributed to the π* 
orbitals of the diimine ligand with a small contribution from the π* character of the 
cyclometallated ligand. They again concluded that, unlike most d-block diimine 
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complexes, the emission observed is not 3MLCT in character but, instead, 3LC with 
significant metal character perturbed by a low-lying 1MLCT state.39 
2.1.4. Imaging and bioimaging applications of platinum (II) complexes  
There has been a vast array of research on luminescent transition metal complexes, 
resulting in an equally expansive set of applications including optoelectronics,40, 41 
photo-catalysis,42, 43 components for electron transfer systems,44 bio-sensing and bio-
imaging,45, 46 dye-sensitized solar cells (DSSCs) and organic light emitting diodes 
(OLEDs).47, 48 Despite their attractive physical and photophysical properties, 
relatively few systems incorporating PtII have been documented in comparison to the 
heavily investigated systems utilising d6 transition metals and lanthanides. 
 
 Figure 2.6 Range of cyclometallated PtII complexes where the cationic species localise in nuclei (top) 
and neutral compounds exhibit cytoplasmic localisation (bottom). 
 
Their utility as cellular imaging agents is amongst one of the most prevalent areas of 
interest for luminescent PtII complexes. These range from neutral complexes, which 
have been shown to localise in the cytoplasm, to cationic structures localising in 
organelles such as the endoplasmic reticulum and nucleus.14 Cyclometallated, or 
orthometalated, bidentate complexes show high stability and impressive emissive 
properties and, despite the abundance of cyclometallated PtII complexes in the 
literature, very few are suitable for imaging due to their lack of hydrophilicity. 
Examples do exist, however, including compounds by Lai et al., which exhibit higher 
cytotoxicity upon irradiation than in dark studies, suggestive of a high efficacy for 1O2 
generation.49 Mou et al. found that cyclometallated compounds with ancillary β-
diketonate ligands also show promise in cellular imaging with exclusive cytoplasmic 
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tuned through adaptation of the β-diketonate by lowering the triplet-state energy of 
the ancillary ligand.25 
 
Botchway et al. expanded on the development of cellular imaging agents in the 
synthesis of a series of PtII compounds (Figure 2.7) with tridentate ligands that 
expressed remarkably high quantum yields (up to 70 %) and emissive lifetimes (µs 
timeframe) that localise intracellularly with low cytotoxicity.50 They also found that 
the photostability of the compounds was sufficient to allow for two-photon excitation 
(TPE), a tissue-friendly method where a high flux of low energy photons provide two 
photons of low energy simultaneously for one excitation, resulting in an emissive 
wavelength that is lower than that of each photon absorbed. The long lifetimes and 
highly emissive states also made it possible to use the compounds for time-resolved 
emission imaging microscopy (TREM), which allows discrimination between changes 
in lifetime and the time-gated removal of short-lived autofluorescence.51  
 
Figure 2.7 Complexes synthesised by Botchway et al. for cellular imaging using TPE and TREM. 
 
2.1.5. 195Pt NMR spectroscopy 
195Pt is the only spin active isotope of platinum. It is has a good natural abundance 
resulting in a relative sensitivity of 0.01 (where 1 is 1H) and a spin quantum number, 
I, of ½.52 This makes it extremely useful as a means of probing the electronic 
environment of the metal centre. Importantly, studies have revealed the sensitivity of 
the chemical shift (δ) to changes in oxidation state, ligand substitution and 
stereochemistry.53, 54 As the chemical shift of 195Pt spans ±7000 ppm, subtle changes 
such as ligand substitution can often result in shifts of over 100 ppm.55 The technique 
has been used in a wide range of applications, including structural determination of 
the binding and interaction of platinum to drugs and biological components such as 
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Despite the marked advantages of this technique, the sensitivity of δ for 195Pt makes 
comparable data hard to come by as many factors can affect the shift; changes in 
temperature (as much as 1 ppm K-1), solvent, isotopomers and the internal reference 
have all been reported as contributing to difficulties in referencing 195Pt NMR spectra 
reliably.58, 59 
2.1.6. Functionalised phenylquinolines  
Phenylquinoline (pqH) derivatives have been used for over a hundred years in 
medicine: cinchophen (2-phenyl-4-quinolinecarboxylic acid) was used from 1910 as 
an analgesic to treat gout for over twenty years before it was found to cause severe 
liver damage.60 Since then, many derivatives have been synthesised for a range of 
applications. The most researched are compounds based on 2-phenyl-4-
quinolinecarboxamides (Figure 2.8) as they are known to be antagonists for 
tachykinin receptors, giving potential for therapeutics relating to neurological 
diseases, including schizophrenia.61-63 
 
Figure 2.8 Structures of a range of phenylquinoline compounds with biological activity. Of note are 
cinchophen (bottom left) and Talnetant (top right), which have undergone clinical trials. 
 
Phenylquinolines also show frequent use in coordination chemistry due to their 
potential bidentate, N^C coordination mode. They show advantageous photophysical 
properties compared to phenylpyridine (ppyH) owing to the extended π-conjugation 
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bathochromically shifted 1MLCT absorption and 3MLCT emission. For this reason, 
there are an array of IrIII complexes (Figure 2.9) that incorporate functionalised 
cyclometallated phenylquinoline complexes in the literature with applications ranging 
from OLEDs to biotin-tagged imaging agents.64-74 There are also reports of 
cyclometallated PtII complexes with phenylquinoline moieties (Figure 2.9) with 
potential utilities in a variety of areas including polymer light emitting devices 
(PLEDs), OLEDs and photosensitisers for singlet oxygen.18, 19, 27, 75-78  
 










































Chapter 2 discusses the photophysical properties of PtII complexes with functionalised 
cyclometallated phenylquinoline ligands. The functionality of the ligand was altered 
to ascertain how this impacted the luminescent characteristics of the complexes by 
varying the electronic nature of the ligand. The effects of the ancillary ligands on the 
luminescent properties were also investigated by altering the electronic nature of β-
diketonates and also by changing the coordination motif around the PtII atom through 
the introduction of different ligand types. The compounds were characterised, where 
possible, by 195Pt NMR spectroscopy to give a greater understanding of the changes in 
the electronics occurring at the metal centre.  
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2.3. Results and Discussion 
2.3.1. Ligand synthesis 
 
Figure 2.10 Structures of the ligands utilised in Chapter 2. 
The ligands have all been previously reported in the literature and have been 
coordinated to IrIII in a cyclometallated manner.79 LH1 was obtained by a simple 
esterification reaction using a literature methodology.80 LH2 and LH3 were formed 
through the reaction of an acyl chloride and commercially available primary amines 
based on a modified literature methodology.79 Chloroform was used instead of 
acetonitrile as it acted as a better solvent for the acyl chloride, resulting in almost 
instantaneous reactivity upon addition of the amine and EtNiPr2 at room temperature. 
The isolated ligands were analysed by 1H NMR spectroscopy for purity and compared 
with literature values to ensure the reactions were successful. 
2.3.2. Synthesis and characterisation of cyclometallated platinum (II) complexes 
2.3.2.1. [Pt(L)(µ-Cl)]2 complexes 
The cyclometallated PtII µ-dichloro-bridged dimers, [Pt(L)(µ-Cl)]2, were obtained 
from reactions with potassium tetrachloroplatinate (II) and the corresponding ligand, 
LH. Exhaustive attempts at synthesising the complexes were made using a wide range 
of synthetic methodologies before a suitable reaction route was found. Initial trials 
were based on previous experience with the synthesis of analogous cyclometallated 
IrIII chloro-bridged dimers with LH1 utilising 2-methoxyethanol and water (3:1) and 
heating the reaction to 100 °C for 48 h.81 This yielded a grey, insoluble solid, which 
was precipitated with water and filtered. The solid was washed with dichloromethane 
and the filtrate was dried and characterised and was found to be free ligand in almost 
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Figure 2.11 Synthesis of [Pt(L)(µ-Cl)]2 and [Pt(L)(DMSO)Cl] R = OEt (L1), HNt-butyl (L2), HNp-
fluorobenzene (L3), OH (L4). 
Upon further investigation in the literature, it was found that, in the presence of 
alcohol and under elevated temperatures (> 30 °C), the platinate (II) readily reduces to 
Pt0 giving rise to the insoluble black solid found in the previous experimental 
methods.36, 82 The conditions outlined by Shavaleev et al. using [PtCl4](Bu4N)2 in 
ethanol and dichloromethane overcome this issue by reacting at 30 °C for 7 days. 
However, despite the apparent lack of any black solid, the reaction yielded free ligand 
as the major component. 
An experimental procedure was finally selected whereby the ligand was dissolved in 
2-ethoxyethanol and the platinate (II) was added dropwise as an aqueous solution 
with a solvent ratio of 3:1 of 2-ethoxyethanol to water.83 Experience suggested that 
the excessive reduction of Pt0 could be minimised by ensuring that the platinate (II) 
was kept mostly in solution by increasing the volume of solvent accordingly, whilst 
maintaining the 3:1 ratio (typically, using 50 – 100 mg of platinate (II) required 8 mL 
of solvent). The reaction vessel was flushed with nitrogen and wrapped in foil to 
prevent photoreduction.84-86 The mixtures were then heated to 80 °C for 24 – 48 h 
before being cooled to room temperature. The products were precipitated using brine 
to give green/yellow/brown solids upon filtration. Purification was carried out in the 
later steps and the dimers were used as isolated. 
The PtII µ-dichloro-bridged dimers were uncharacterised except for [Pt(L1)Cl]2, for 
which the 195Pt NMR spectrum was obtained for reference. 1H NMR spectra were 
often mixtures of the desired dimer, free ligand and a small trace of ligand-split 
dimer, forming an N2CCl coordination sphere.87 The formation of the 
[Pt(ppy)(ppyH)Cl] complex is noted frequently in the literature and reacts with 
DMSO to form the [Pt(L)(DMSO)Cl] complex in the same way as the µ-dichloro 
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2.3.2.2. [Pt(L)(DMSO)Cl] complexes 
The dimers were split following a preparative method described by Godbert et al. by 
dissolution of the complex with a minimal volume of dimethylsulfoxide,82 followed 
by filtration through cotton wool (to remove any small residues of Pt0). Brine was 
added to precipitate the product before it was washed with plenty of water to remove 
excess dimethylsulfoxide. The adducts were purified in the next step, upon 
coordination of an ancillary ligand, except for [Pt(L1)(DMSO)Cl] which was found to 
be spectroscopically clean from the reaction. Although characterisation by 1H, 13C and 
195Pt NMR spectroscopies all indicated that the product was pure, thin layer 
chromatography (TLC) analysis revealed that there was a dark species with a 
retention factor of zero and a relatively fast moving yellow spot with a 9:1 mixture of 
dichloromethane and ethyl acetate as the mobile phase. Subsequent purification by 
flash column chromatography on silica yielded the product as a dark orange solid. 
The complex could, however, be used without purification as the spectroscopically 
pure brown solid.  
 
 Figure 2.12 1H NMR spectrum for [Pt(L1)(DMSO)Cl]. Highlighted: SO(CH3)2 with 3JHPt coupling. 
1H NMR spectroscopy provided key data confirming the synthesis of the product, 
with a peak at ca. 3.5 ppm with characteristic 195Pt satellites related to 3JHPt coupling 
for the methyl groups on the coordinated DMSO ligand. Given the high level of 
purity, [Pt(L1)(DMSO)Cl] was fully characterised by 1H, 13C and 195Pt NMR 
spectroscopies as well as UV-vis and IR spectroscopies. 1H NMR spectrum of 
[Pt(L1)(DMSO)Cl] revealed the presence of the 3JHPt coupling for the proton on the 
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carbon adjacent to the cyclometallated carbon at 8.4 ppm. 2JCPt coupling was observed 
in the 13C NMR spectrum for the DMSO methyl groups at 46.3 ppm. 
From the [Pt(L)(DMSO)Cl] complex, a variety of other compounds could be obtained 
through different synthetic pathways (Figure 2.13). A number of these were selected 




Figure 2.13 Synthesis of [Pt(L)(py)Cl], [Pt(L)(8-Q)] and [Pt(L)(β-diketonate)]: R = OEt (L1), HNt-
butyl (L2), HNp-fluorobenzene (L3), OH (L4); R′ = CH3 (acac), C(CH3)3 (hmacac), CF3 (hfacac). 
2.3.2.3. [Pt(L)(β-diketonate)] complexes 
Sodium salts of acetylacetone and hexamethylacetylacetone were synthesised based 
on the methodology outlined by Spencer et al. through deprotonation with sodium 
hydride in refluxing petroleum ether to yield the sodium salt as a monohydrate.35 For 
the fluorinated β-diketone, hexafluoroacetylacetone was used without preparation of 
the sodium salt owing to the increased acidity of the α-proton. The [Pt(L)(DMSO)Cl] 
complexes were dissolved in a small volume (ca. 5 mL) of 3-pentanone before the 
sodium salt of the β-diketonate monohydrate (hmacac and acac) or the β-diketone 
(hfacac) was added. Sodium carbonate was added to the reaction with the β-diketone 
to neutralise the change in pH from the formation of HCl. Ten equivalents of both 
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to issues in the separation of excess hmacac from the desired product. The complexes 
were purified by flash column chromatography on silica with dichloromethane and 
were all eluted as the first yellow/orange band.  
[Pt(L4)(acac)] was accessed from [Pt(L1)(acac)] by following a methodology for the 
same ethyl ester deprotection of [Ir(L1)2(bpy)](PF6) by dissolving the complex in 
equal volumes of acetone and 1M NaOH solution.81 
The complexes were all characterised by 1H, 13C and 195Pt NMR spectroscopies as 
well as UV-vis, IR spectroscopies and, in some cases, mass spectrometry although 
obtaining data proved troublesome, possibly due to the species being neutral. 1H 
NMR spectroscopy was used to observe both the α-proton on the β-diketonate at ca. 
5.5 ppm as well as the methyl groups as two very close singlets at ca. 2 ppm. 3JHPt 
satellites can, again, just be made out at 7.8 ppm for the adjacent proton to the 
cyclometallated carbon.  
 
Figure 2.14 1H NMR spectrum for [Pt(L1)(acac)]. Highlighted: CH3C=OCHC=OCH3 (middle), 
CH3C=OCHC=OCH3 (right). 
2.3.2.4. [Pt(L1)(8-Q)] complex 
After attempts following a similar synthetic methodology to the preparation of the β-
diketonate complexes failed using the sodium salt of 8-hydroxyquinoline (prepared in 
a similar manner), a methodology used by Shavaleev et al. was adopted.36 Sodium 
carbonate, 8-hydroxyquinoline and [Pt(L)(DMSO)Cl] were dissolved in 2-
methoxymethanol before being heated to 100 °C under dinitrogen. The cooled 
solution was dried in vacuo before being dissolved in dichloromethane and washed 
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with water to remove inorganic salts. The organic phase was then purified either 
through precipitation with diethyl ether followed by washing with a small volume of 
cold methanol or, if precipitation was unsuccessful, by column chromatography on 
silica in dichloromethane. They were then eluted as the first orange/dark red band, 
closely preceded by the cream coloured band of 8-hydroquinoline. Characterisation of 
the complex using 1H NMR spectroscopy was more difficult due to the number of 
aromatic protons increasing the complexity in the 7-10 ppm range. Despite this, 
comparison to the [Pt(L1)(DMSO)Cl] spectra revealed a wider range in the aromatic 
protons with downfield shifts close to 9.9 ppm and upfield shifts to 6.8 ppm. The 
presence of a second set of satellites at 9.2 ppm relating to 3JHPt coupling for the 
proton in the 2-position of the 8-Q was also used to confirm the presence of a 
coordinated 8-Q species.  
 
Figure 2.15 1H NMR spectrum of [Pt(L1)(8-Q)]. Highlighted: NC2H of 8-quinolinato with 3JHPt 
coupling. 
2.3.2.5. [Pt(L1)(py)Cl] complex 
[Pt(L1)(DMSO)Cl] was dissolved in acetone (ca. 5 mL) before pyridine was added in 
slight excess.37 The mixture was stirred for 16 h and then the solvent was reduced to a 
minimal volume and diethyl ether was added to precipitate the product. The solid was 
then washed with a small volume of diethyl ether to remove any excess pyridine 
before being characterised fully. The 1H NMR spectrum revealed two equivalent 
protons with 195Pt satellites at 9.0 ppm corresponding to the two protons in the 2- and 
6-position of the pyridyl ligand, with 3JHPt coupling. Interestingly, the proton adjacent 
to the cyclometallating carbon shifts substantially upfield compared to any of the 
other observed species at 6.3 ppm. 









Figure 2.16 1H NMR spectrum for [Pt(L1)(py)Cl]. Highlighted: NC2H of pyridine (left), PtCCH of L1 
(right) showing 3JHPt coupling. 
2.3.2.6. Cationic platinum (II) complexes 
Given the uptake of cationic PtII complexes by organelles such as the nucleus, it was 
of interest to try to synthesise a cationic analogue of the complexes.14 This was 
attempted through modulation of the ligand, to afford a locally cationic quaternary 
nitrogen, and through coordination of a neutral diimine to create a universally cationic 
complex.  
The first route involved synthesis of an imidazolium moiety through reaction of a 
halide with methylimidazole in refluxing toluene (Figure 2.17).89 This was done, 
firstly, on the free ligand to assess the viability and then on a complex incorporating 
an alkyl chain with a pendant halide for reactivity at the later stages. Unfortunately 
this route did not yield any meaningful results, which was most likely down to the 
harsh reaction conditions and the presence of an imidazole, which could form 
coordinative bonds with the complex, preventing reactivity in the desired fashion.  
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The second route (Figure 2.18) involved the reaction of a [Pt(L)(DMSO)Cl] complex 
with 2,2′-bipyridine (bpy) in order to synthesise [Pt(L)(bpy)]+. This reaction was 
carried out based upon a similar methodology by Jenkins et al. using DMF as the 
solvent and heating overnight to 65 °C.39  
 
Figure 2.18 Schematic of the successful synthetic route to [Pt(L)(bpy)]+. 
Whilst the product, [Pt(L1)(bpy)]+, was observed by mass spectrometry, initial 
attempts to characterise using 1H NMR spectroscopy yielded very broad, poorly 
defined signals. Eventually, after extending the reacting time from the reported 18 h 
to 48 – 72 h, it was found that, after precipitation with diethyl ether, the complex 
could be partially dissolved in acetonitrile before the counterion was exchanged for 
hexafluorophosphate to aid solubility by addition of a saturated solution of the 
potassium salt. Purification by extraction and precipitation resulted in the desired 
complex being formed. 
2.3.3. 195Pt NMR spectroscopy analysis  
The 195Pt NMR sprectrum of [Pt(L1)(µ-Cl)]2 revealed two distinct 195Pt environments 
with chemical shifts of -3186 and -3219 ppm, most likely corresponding to 
[Pt(L1)(LH1)Cl] and [Pt(L1)(µ-Cl)]2, respectively. Both Pazderski et al. and Ghavale 
et al. have observed the δPt for [Pt(ppy)(ppyH)Cl] at -3212 and -3201 ppm, whilst 
data for [Pt(ppy)(µ-Cl)]2 were reported to be unobtainable due to a lack of 
solubility.33, 90 These values compare to the δPt of -3186 ppm observed for 
[Pt(L1)(LH1)Cl], formed in the synthesis of [Pt(L1)(µ-Cl)]2. The data suggest that 
the PtII is slightly more deshielded in [Pt(L1)(LH1)Cl] than in [Pt(ppy)(ppyH)Cl] 
hence the upfield shift of approximately 15 ppm. 
Whilst Pazderski and Ghavale quote near identical shifts, within error, for the 
[Pt(ppy)(ppyH)Cl] complex, the literature seems to dispute the chemical shift for the  
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unclear, synthesis of [Pt(ppy)(DMSO)Cl] following the standard methodology 
resulted in a δPt of -3815 ppm which is consistent with the shift observed of -3807 
ppm by Ghavale, suggesting that Pazderski’s data are incorrect.  
There appears to be very little influence upon the chemical shift of the 195Pt when the 
functionality at the 4-position is varied: values range from -2765 to -2779 ppm for the 
acac complexes of L1 – L3 (it is not possible to include the data for [Pt(L4)(acac)] 
due to the change in solvent and the fact that solvent can affect the observed shift in 
195Pt NMR spectroscopy).52  
However, altering the ancillary ligand induced a much greater change. Within the β-
diketonates, a shift of almost 100 ppm was observed between acac and hfacac, which 
can be explained by the extremely powerful electron withdrawing influence of the 
fluorine atoms, resulting in reduced electron density on the PtII. Interestingly, the 
electron donating hmacac does not follow the same trend and, instead, also results in a 
more deshielded metal. This is unexpected and could be due to the more bulky t-butyl 
groups influencing the shift, either through a change in the solvation or intramolecular 
interactions with the PtII.  
Changing the coordination mode via the ancillary ligand induced an even greater 
rabge of chemical shifts. [Pt(L1)(DMSO)Cl] has a shift of -3662 ppm, the most 
upfield shift observed throughout the complexes, whilst the β-diketonate complexes 
gave rise to the most deshielded metal centres and lie around -2770 ppm. [Pt(L1)(8-
Q)] and [Pt(L1)(py)Cl] lie in the middle with somewhat similar chemical shifts for the 
metal of -2922 and -3158 ppm, respectively. This could be explained by the fact that 
the coordination modes are relatively alike, which is also the case for 
[Pt(L1)(LH1)Cl] which, too, has a similar shift of -3186 ppm. The only difference 
between the 8-Q and py complexes is the coordination of an O donor compared to a 
Cl donor, and both are strongly electronegative, hard bases. 
195Pt NMR spectroscopic studies of the cationic [Pt(L1)(bpy)](PF6) complex revealed 
a shift of -3097 ppm, in CD3CN. Due to the solubility of the complex, direct 
comparison between this and the other compounds is not possible however, despite 
the change in solvent, the shift is still small relative to the possible range of values 
found in 195Pt NMR spectroscopy. 
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Compound δPt Related compound δPt 
[Pt(L1)(µ-Cl)]2 -3219 [Pt(ppy)(µ-Cl)]2 a 
[Pt(L1)(LH1)Cl] -3186 [Pt(ppy)(ppyH)Cl] -3212,90 -3201,33 -3203b 
[Pt(L1)(DMSO)Cl] -3662 [Pt(ppy)(DMSO)Cl] -3351,90 -3807,33 -3815b 
[Pt(L1)(acac)] -2765  
[Pt(ppy)(acac)] 
 
-2868b [Pt(L2)(acac)] -2779 [Pt(L3)(acac)] -2769 
[Pt(L4)(acac)] c -2781   
[Pt(L1)(hmacac)] -2733   
[Pt(L1)(hfacac)] -2693   
[Pt(L1)(8-Q)] -2922 [Pt(ppy)(8-Q)] d 
[Pt(L1)(py)Cl] -3158 [Pt(ppy)(py)Cl] -1632e 
[Pt(L1)(bpy)](PF6) f -3097   
a too insoluble to observe. b prepared for reference according to literature33, 90. c recorded in CD3OD. d no 
comparable data available. e recorded in d6-acetone. f recorded in CD3CN. 
Table 2.1 195Pt NMR spectroscopy chemical shifts for all complexes in Chapter 2 (left) along with 
related shifts for analogous ppy complexes (right). 
The data suggest that, throughout the series, coordination of L1 results in less electron 
density on the PtII than is observed in the analogous ppy complexes. This could be 
due, in part, to the electron withdrawing nature of esters and amides. Another 
possibility is apparent distortion in the square planar configuration due to the added 
bulk of the quinoline ring system in the ligand. The proton in the 8-position appears to 
be situated in very close proximity to the ancillary ligands and, as a result, distorts the 
planar aromatic system, and hence the square planar configuration, in order to avoid 
unfavourable interactions. 
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2.3.4. X-ray crystal structures 
The crystal structure of [Pt(L1)(DMSO)Cl] revealed a very distorted arrangement 
around the central Pt atom, with only a 160.43(7)° C-Pt-Cl angle. The bond lengths of 
2.010(2), 2.0788(19), 2.4070(5) and 2.2184(6) Å for the Pt-C, Pt-N, Pt-Cl and Pt-S 
bonds, respectively, are all within error of the values found for [Pt(ppy)(DMSO)Cl] 
by Godbert et al.82 This suggests that the most stable coordination geometry is 
sacrificed in order to maintain the coordinative bond strengths. The resultant strain 
induces a twist in the molecule whereby the S-Pt-Cl plane is at a 48° angle to the 
quinoline ring in order to reduce the Cl-H interactions. This strain means that there 
are no Pt-Pt interactions within the crystal packing; the head-to-tail motif still exists 
but, in this example, the cyclometallated ligand of one molecule sits over the 
cyclometallated ligand of another resulting in π-π interactions but no metallophilic 
contacts. This is also observed in Godbert’s structure suggesting that the lack of Pt-Pt 
interactions is most likely due to the out of plane orientation of the methyl groups of 
the DMSO ligand. 
The bond lengths in the inner-coodination sphere of [Pt(L1)(acac)] were found to be 
1.960(4) and 2.045(3) Å for Pt-C and Pt-N, respectively. These compare to 1.948(8) 
and 1.979(6) Å for the Pt-C and Pt-N bond lengths of [Pt(ppy)(acac)].26 The Pt-O 
bond lengths were found to be 1.999(3) and 2.101(3) Å, with the shorter bond length 
being in the trans position to the coordinated N atom. These compare to the results 
outlined by Bossi et al. of 2.007(5) and 2.065(6) Å, respectively. These values 
suggest that the bond lengths around the coordination sphere are very similar, within 
error, and that altering the phenylpyridine for a phenylquinoline-like moiety does not 
change the strength of the cyclometallating bonds. Unlike the planar structure 
observed by Bossi et al. for the ppy complex, the crystal structure of [Pt(L1)(acac)] 
revealed a departure from planarity, most prominently from the extra benzene ring 
within the quinolyl moiety. This is most likely a result of the unfavourable interaction 
of the proton in the 8-position of the quinoline ring with the ancillary ligand. The 
distances between the protons in the 8-position of the quinolyl moiety and the 3-
position of the phenyl group are approximately 2.5 Å from the oxygen atoms of the 
ancillary ligand in Bossi’s crystal structure. The distance on the phenyl side of 
[Pt(L1)(acac)] is very similar, at around 2.5 Å, whilst the proton in the 8-position of 
the quinoline ring is approximately 2.0 Å from the ancillary ligand, despite more than 
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20° of torsion. There appear to be metallophilic interactions within the solid state, 
with Pt-Pt distances of approximately 3.3 Å compared to around 3.7 Å in 
[Pt(ppy)(acac)]. The reduced bond length could be due to the increased conjugation 
around the cyclometallated ring system leading to greater π-π interactions. Both 
structures pack in a similar manner with a head-to-tail arrangement whereby the 
cyclometallated ligand of one molecule lies above or below the ancillary ligand of 
another.  
The X-ray crystal structure of [Pt(L1)(bpy)](PF6), as with the DMSO complex, 
displays a high degree of distortion in the square planar geometry with an angle 
between the plane of the bpy and the plane of the cyclometallated ligand of 42° due to 
unfavourable H-H interactions between the two ligands. The bond lengths within the 
inner-sphere coordination are 2.012(6) and 2.046(5) Å for the Pt-C and Pt-N of the 
phenylquinoline ligand and 2.145(5) and 2.022(5) Å for the Pt-N bonds of the bpy, 
where the shorter bond is trans to the coordinated quinolyl moiety. The closest 
comparable crystal structure, obtained by Sooksawat et al., contains a 2,6-
diphenylpyridine with a C^N coordination mode and a N^N coordinated 4,4′-
bimethyl-2,2′-bipyridine.91 This compound was found to have bond lengths of 
1.997(7), 2.063(7), 2.137(6) and 2.027(7) Å for the Pt-C, Pt-N, Pt-N (trans to C) and 
Pt-N (trans to N) bond distances, respectively. The cyclometallating ligand’s Pt bond 
lengths are very similar to those of the acac and DMSO complexes detailed above. 
This suggests that, once again the bond strength is maintained at the expense of the 
planarity of the two ligands, which are highly distorted. Despite this, unlike the 
DMSO complex, a Pt-Pt interaction is visible although it is much longer than the acac 
complex and, at around 4.3 Å, is at the limits of interactivity based on the van der 
Waal’s radius calculated by Alvarez for Pt.92 
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2.3.5. X-ray crystal structure of [Pt(L1)(DMSO)Cl]  
 
Figure 2.19 Ball and stick X-ray crystal structure of [Pt(L1)(DMSO)Cl] (top) and the unit cell packing 
(bottom). 
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2.3.6. X-ray crystal structure of [Pt(L1)(acac)] 
 
Figure 2.20  Ball and stick X-ray crystal structure of [Pt(L1)(acac)] (top), the Pt-Pt interaction (middle) 
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2.3.7. X-ray crystal structure of [Pt(L1)(bpy)](PF6) 
  
Figure 2.21 Ball and stick X-ray crystal structure of [Pt(L1)(bpy)](PF6) (top), Pt-Pt interactions 
(middle) and the unit cell packing (bottom).  
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2.3.9. Electronic absorption spectroscopy and DFT calculations 
The absorption properties of the complexes were measured in chloroform except for 
[Pt(L4)(acac)], which was measured in methanol, and [Pt(L1)(bpy)](PF6), which was 
measured in acetonitrile. They were all pale yellow solutions and absorbed below 550 
nm. 
Compound λmax / nm 
[Pt(L1)(acac)] 253, 292, 300, 363, 427 
[Pt(L2)(acac)] 258, 297, 343, 360, 415 
[Pt(L3)(acac)] 300, 342, 363, 442 
[Pt(L4)(acac)]a 282, 334, 348, 382 
[Pt(L1)(hmacac)] 253, 291, 301, 357, 437 
[Pt(L1)(hfacac)] 253, 293, 370, 400, 442 
[Pt(L1)(DMSO)Cl] 257, 293, 366, 420 
[Pt(L1)(py)Cl] 255, 285, 367, 450 
[Pt(L1)(8-Q)] 257, 284, 370, 455 
[Pt(L1)(bpy)](PF6)b 281, 318, 355, 368, 395, 448 
a recorded in methanol. b recorded in acetonitrile. 
Table 2.3 Absorption maxima (λmax) for complexes in Chapter 2. 
The spectra all reveal strong absorption between 250 and 350 nm corresponding to 
intraligand 1IL(π → π*) transitions. Lower energy transitions from around 350 nm, 
tailing off beyond 500 nm, can be classified as a combination of metal-to-ligand 
charge transfer (1MLCT) and ligand-to-ligand charge transfer (1LLCT). The observed 
ML or LL transitions are red-shifted compared to UV-vis data in the literature for 
[Pt(ppy)(acac)] and [Pt(ppy)(hfacac)] where the lowest energy absorption maxima lie 
around 350 to 370 nm.34, 93 UV-vis data for [Pt(pq)(acac)] and 
[Pt(isoquinoline)(acac)], as expected, match the data recorded far more closely with 
low energy transitions at 400 to 420 nm.27, 93 This red-shift was a result of the lower 
lying π* orbitals on the cyclometallated ligand owing to the extended conjugation 
around the aromatic system. 
 




a recorded in methanol. b recorded in acetonitrile.  
Figure 2.22 Absorption profiles (normalised) for complexes in chloroform. 
The change in functionalisation from ester to amide appears to invoke a minor change 
in the absorption profile, especially around 340 – 400 nm, whilst altering the nature of 
the amide appears to have very little influence at all. Interestingly, the absorption is 
much greater affected by the nature of the ancillary ligand: between the β-diketonates, 
there is a subtle shift in absorption maxima ca. 430 – 440 nm. The intensities of the 
1MLCT band are also dramatically affected by the class of ancillary ligand 
incorporated: whilst the acac and hmacac ligands show a pronounced peak maxima, 
the pyridine, bipyridine and hydroxyquinoline ligands render the absorptions beyond 
430 nm as nothing more than a shoulder of the higher energy absorption maxima ca. 
380 nm.  
Given the interest in tuning the photophysical properties and, therefore, the electronic 
properties of the cyclometallated PtII complexes, it was thought useful to carry out 
density functional theory (DFT) calculations in order to ascertain how the different 
ancillary ligands were influencing the electronics and, in particular, which transitions 
might be occurring in the lower energy absorptions and whether any possible 
explanations could be found for the changes in absorption profile. Time dependent 
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Table 2.4 Calculated representations for the HOMO-1s (and HOMO-2s) (left), HOMOs (and HOMO-
1s) (middle) and LUMOs (right) of a series of PtII complexes along with the band gaps. 
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Theoretical calculations revealed that most low energy transitions occurred from the 
HOMO-1 and HOMO to the LUMO although, for [Pt(L1)(py)Cl] and [Pt(L1)(8-Q)], 
the transitions predicted at 510 and 610 nm respectively are not found experimentally 
and so the next lowest possible transition was visualised. The second excited state for  
[Pt(L1)(8-Q)] involved only HOMO → LUMO transitions as did the first excited 
state predicted for [Pt(L1)(DMSO)Cl]. The LUMOs for all complexes, regardless of 
ancillary ligand, appear through DFT to be very similar and it is the HOMO and 
HOMO-1 (and HOMO-2 for the pyridine analogue) that affects the absorption.  
In all cases, the majority of the electron density in the HOMO lies across both the 
ancillary ligand and the phenyl moiety of the cyclometallated ligand as well as the d-
orbitals of the platinum. The percentage contribution to the energy levels for the PtII’s 
d-orbitals were calculated from the theoretical data and allowed the relative 
contribution of LLCT and MLCT to be investigated for each class of compound.  
 % d-orbital character 
Compound HOMO -2 HOMO-1 HOMO LUMO 
[Pt(L1)(acac)] 41.81% 35.51% 40.29% 2.00% 
[Pt(L1)(hfacac)] 37.52% 19.01% 24.83% 0.96% 
[Pt(L1)(DMSO)Cl] 11.54% 16.38% 23.29% 0.32% 
[Pt(L1)(py)Cl] 7.10% 11.25% 26.48% 1.00% 
[Pt(L1)(8-Q)] 31.13% 14.12% 4.25% 0.47% 
[Pt(L1)(bpy)](PF6) 15.54% 24.88% 6.47% 0.25% 
Table 2.5 Percentage d-orbital character predicted for the HOMO-2, HOMO-1, HOMO and LUMO, 
where the orbitals involved in observable transitions in the UV-vis spectra are highlighted in bold.  
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2.3.9.1. Luminescence spectroscopy  
Steady state luminescence and lifetime data were acquired for all complexes and were 
obtained in chloroform, except for [Pt(L4)(acac)] and [Pt(L1)(bpy)](PF6), which were 
carried out in methanol and acetonitrile, respectively. Shoulders ca. 660 nm are a 
result of an artefact associated with the spectrometer and should be disregarded. 
Compound λema / nm τa / ns Φa 
[Pt(L1)(acac)] 639 331b 0.2% 
[Pt(L2)(acac)] 615 427b  







[Pt(L1)(hmacac)] 641 318b  
[Pt(L1)(hfacac)] 616 262b  
[Pt(L1)(DMSO)Cl] 610 113c 0.1% 
[Pt(L1)(py)Cl] 626 365c 0.4% 
[Pt(L1)(8-Q)] 620 59b  
[Pt(L1)(bpy)](PF6) 630 155c  
a in chloroform unless stated otherwise. b excited at 295 nm. c excited at 372 nm. d in H2O. e in methanol.  
Table 2.6 Photophysical properties of the complexes synthesised in Chapter 2. 
 
The data show that by altering the ancillary ligand and nature of the cyclometallated 
ligand, it is possible to tune the lifetime, excitation profile and emission maxima of 
cyclometallated PtII complexes. Even excluding the emission of the water-soluble 
complex at 605 nm, so as to rule out any influence of solvatochromism, the emission 
maxima span a range of over 30 nm. The effect on the lifetime is even more 
pronounced with lifetimes of some species almost an order of magnitude greater than 
others.  
The excitation spectra for the complexes’ emission between 600 and 640 nm vary 
dramatically. Whilst they all exhibit strong emission when excited between 250 and 
300 nm, the relative intensity of emission from excitation of lower energy, 400 to 450 
nm, varies between the complexes.  
The emission profiles show subtle shifts in maxima with the highest energy emission 
for  [Pt(L4)(acac)] and the lowest energy maximum for [Pt(L1)(acac)]. As 
[Pt(L4)(acac)] was carried out in a much more polar solvent, it is possible that the 
higher energy emission is a result of positive solvatochromism whereby either the 
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ground state is stabilised by the solvent, or the excited state destabilised. Interestingly, 
no compounds displayed any effective solvatochromic shifts when assessed, with 
shifts of no more than a few nanometres, which is within error.  
 
a recorded in water. 
Figure 2.24 Normalised emission profiles of a selection of complexes from Chapter 2. 
Given the extent to which the functionalisation of the cyclometallated ligand can 
influence the emission, it is possible that changing the solvent is not inducing the 
largest effect on the energy of the emission. Switching from an ester and an amide, 
and even altering the functionality of the amide, appears to have a strong influence on 
the emission, so it seems likely that deprotection of the ester to a carboxylic acid 
would play more of a role in influencing the emission than the solvent. 
Altering the functionality of the β-diketonate also appears capable of influencing both 
the lifetime and emission maxima. Whilst there is very little difference between the 
acac and hmacac complexes, the hfacac complex shows both a reduction in lifetime 
by almost 20% and a blueshift in the emission by more than 20 nm, displaying a 
contradictory trend to the Energy Gap Law. Interestingly, in contrast to results 
published by both Ghedini et al. and Spencer et al., the presence of the hfacac does 
not result in the quenching of emission.34, 35 The DFT calculations for this complex 
reveal that the electron density lies across the ancillary ligand only in the LUMO+1. 
This is most likely due to the fact that the added aromaticity in the cyclometallating 
ligand has lowered energy of the π* orbitals on the phenylquinoline more than the 
affect of the CF3 moieties have had on lowering the π* orbitals on the ancillary ligand. 









[Pt(L1)(acac)] Pt(L2)(acac)] [Pt(L3)(acac)] [Pt(L4)(acac)] a
[Pt(L1)(hmacac)] [Pt(L1)(hfacac)] [Pt(L1)(DMSO)Cl] [Pt(L1)(py)Cl]




a measured in water. 
Figure 2.25 Normalised lifetime decay profiles. 
The lifetimes are similar with all but [Pt(L1)(DMSO)Cl], [Pt(L1)(8-Q)], 
[Pt(L1)(hfacac)] and [Pt(L1)(bpy)](PF6) lying between 427 and 318 ns in aerated 
solvent. The presence of the CF3 groups again influence the photophysical properties 
and results in a quenching effect on the lifetime, reducing it from 331 to 262 ns. More 
interesting, however, is the difference of ca. 60 ns between the t-butyl and p-
fluorobenzene functionalised amides. It appears that altering the functionalisation of 
the cyclometallated ligand has a profound influence on the lifetime and opens up the 
possibility to tune the lifetime, and emission, through simple alteration of 
substituents.  
Also of interest is the apparent quenching of the emission at 610 nm in 
[Pt(L1)(DMSO)Cl]. The effect is such that fluorescent emission from the ligand at 
400 nm, which is usually no more than a small indent in the baseline, appears equally 































This chapter summarises the synthetic routes to a series of cyclometallated PtII 
complexes via µ-dichloro-bridged dimer intermediates. Despite initial failings in the 
synthesis, a methodology was adopted which led to the successful formation of the µ-
dichloro-bridged dimers from tetrachloroplatinate (II). The dimers were split using 
DMSO to give [Pt(L)(DMSO)Cl] complexes, which could be purified for use as a 
final product or further reacted with ancillary ligands. These included several β-
diketonates or β-diketones, 8-hydroxyquinoline, pyridine and 2,2′-bipyridine in order 
to give a breadth of spectral variation and to alter the physical properties of the 
complexes. Altering the functionality of the cyclometallated phenylquinoline ligand 
and the type of ancillary ligand were both found to perturb the emissive wavelength 
and lifetime of the complexes in aerated solvents at room temperature. Crystal 
structures of [Pt(L1)(acac)] and [Pt(L1)(bpy)](PF6) reveal Pt-Pt interactions, albeit 
weak interactions for the bpy complex, whilst [Pt(L1)(DMSO)Cl] shows a very 
distorted square planar geometry resulting in no Pt-Pt interactions in the solid state.  
  




2.5.1. General physical measurements 
1H NMR spectra were recorded on a Bruker Avance dpx 400 or 250 MHz 
spectrometer, 13C{1H} NMR spectra on a Joel Eclipse 300 MHz or Bruker Avance 
dpx 500 MHz spectrometer and 195Pt NMR spectra on Bruker Avance dpx 500 MHz 
spectrometer, and were recorded in CDCl3, D2O, CD3OD or d6-DMSO solutions. 1H, 
13C{1H} and 195Pt NMR spectroscopies’ chemical shifts (δ) were determined relative 
to internal tetramethylsilane, Si(CH3)4 and are given in ppm. Low-resolution mass 
spectra were obtained by the staff at Cardiff University. High-resolution mass spectra 
were carried out by the staff at Cardiff University and the EPSRC National Mass 
Spectrometry Service at Swansea University, UK. All photophysical data were 
obtained on a JobinYvon-Horiba Fluorolog-3 spectrometer fitted with a JY TBX 
picosecond photodetection module in CHCl3, MeOH or H2O solutions. Emission 
spectra were uncorrected and excitation spectra were instrument corrected. The pulsed 
source was a Nano-LED configured for 295, 372 or 459 nm output operating at 500 
kHz or 1 MHz. Luminescence lifetime profiles were obtained using the JobinYvon–
Horiba FluoroHub single photon counting module and the data fits yielded the 
lifetime values using the provided DAS6 deconvolution software. IR spectra were 
recorded on an ATR equipped Shimadzu IRAffinity-1 spectrophotometer. UV-vis 
data were recorded in solution on a Perkin Elmer Lamda20 spectrophotometer.  
2.5.2. Density functional theory 
Scalar relativistic DFT calculations were carried out using GAUSSIAN09,94 with 
relativistic effects incorporated via use of appropriate effective core potentials 
(ECPs). Geometry optimisations of both singlet ground and triplet excited states were 
performed at the B3LYP level,95, 96 with a basis set consisting of Stuttgart–Dresden 
basis set plus ECP on Pt and 6-31+G(d,p) on all remaining atoms.97-100 Time-
dependent DFT (TD-DFT) calculations also employed B3LYP. As shown by Vlček et 
al.,101 solvent effects can be crucial for obtaining satisfactory agreement between 
experiment and TD-DFT. Solvent was therefore modeled using the polarisable 
continuum model,102 with the molecular cavity defined by a united atom model that 
incorporates hydrogen into the parent heavy atom, and included in both geometry 
optimisations and TD-DFT calculations. Triplet states were confirmed not to suffer 
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from significant spin contamination via the expectation value of the S2 operator, 
which in all cases were less than 2.01. Thus, effects of spin-contamination on energy 
differences and optimised structures are expected to be negligible. Emission energies 
were predicted at the triplet-optimised geometry using TD-DFT and were calculated 
vertically, i.e. without geometry relaxation. 
2.5.3. X-ray crystallography 
A small sample of pure product was dissolved in chloroform to give a concentrated 
solution. Toluene was added and the solution was left to evaporate slowly to yield 
brightly coloured crystals. X-ray crystallography measurements were carried out by 
Dr Peter Horton at the EPSRC National Crystallography Service at the University of 
Southampton, UK.103 The diffractometer was a Rigaku AFC12 goniometer equipped 
with an enhanced sensitivity (HG) Saturn724+ detector mounted at the window of an 
FR-E+ SuperBright molybdenum rotating anode generator with HF Varimax optics 
(100 µm focus). The cell was determined and defined, the data reduced and the 
absorption corrected using CystalClear-SM Expert 3.1 b27 (Rigaku, 2012). The 
structure was solved using SUPERFLIP and refined using SHELXL-2013.104, 105 The 
graphics were obtained using ORTEP3 for Windows.106 
2.5.4. Ligand synthesis 
Synthesis of LH1: was prepared by literature methodology.80 2-phenyl-4-
quinolinecarboxylic acid (2.000 g) and H2SO4 (1 mL, excess) were heated in ethanol 
(100 mL) at reflux for 16 h under dinitrogen. The solvent was removed in vacuo and 
the residue dissolved in dichloromethane and washed with NaHCO3 (sat. soln, 50 
mL), water (20 mL) and brine (20 mL). The organic phase was dried over MgSO4, 
filtered and dried in vacuo to afford the product as a yellow semi-solid. Yield = 2.180 
g, (98%). 1H NMR (400 MHz, CDCl3): δH 8.75 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 0.8 
Hz), 8.40 (1H, s), 8.34 (1H, d, 3JHH = 8.4 Hz), 8.22 – 8.19 (2H, m), 7.84 – 7.80 (1H, 
m), 7.69 – 7.64 (1H, m), 7.60 – 7.50 (3H, m), 4.56 (2H, q, 3JHH = 7.2 Hz), 1.51 (3H, t, 
3JHH = 7.2 Hz) ppm. 
General procedure for the synthesis of 2-phenyl-4-quinolinecarboxamides: Based 
on a modified literature methodology.79 Thionyl chloride (excess) was added, 
dropwise, to a stirring suspension of 2-phenyl-4-quinolinecarboxylic acid (1.1 eq) in 
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chloroform (10 mL). The reaction was heated at reflux for 16 h under dinitrogen. The 
solvent was removed in vacuo and the yellow solid redissolved in chloroform (10 mL) 
before RR’NH / RRNH / RNH2 (1 eq) was added slowly to the stirring solution. 
EtNiPr2 (excess) was added dropwise and the mixture was stirred for 16 h at room 
temperature under dinitrogen. The solvent was removed in vacuo before being 
redissolved in dichloromethane (20 mL). The crude mixture was washed with 
NaHCO3 (sat. soln, 2 x 20 mL), water (1 x 20 mL) and brine (1 x 20 mL). The organic 
phase was dried over MgSO4 and filtered before the solvent was removed in vacuo. 
Synthesis of LH2: Following the general procedure for the synthesis of 2-phenyl-4-
quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic acid (0.233 g, 0.935 
mmol) and tert-butylamine (0.062 g, 0.850 mmol). Yield = 0.235 g, (91%). 1H NMR 
(400 MHz, CDCl3): δH 8.14 (1H, d, 3JHH = 8.0 Hz), 8.10 – 8.05 (3H, m), 7.75 (1H, s), 
7.74 – 7.70 (1H, m), 7.54 – 7.47 (4H, m), 6.09 (1H, br. s), 1.56 (9H, s) ppm.  
Synthesis of LH3: Following the general procedure for the synthesis of 2-phenyl-4-
quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic acid (0.233 g, 0.935 
mmol) and 4-fluoroaniline (0.094 g, 0.850 mmol). Yield = 0.250 g, (86%). 1H NMR 
(400 MHz, CDCl3): δH 8.18 (1H, d, 3JHH = 8.4 Hz), 8.13 (2H, d, 3JHH = 8.0 Hz), 8.10 
– 8.08 (2H, m), 7.90 (1H, s), 7.78 – 7.72 (3H, m), 7.55 – 7.48 (4H, m), 7.16 – 7.11 
(2H, m) ppm.  
2.5.5. Complex synthesis 
General procedure for the synthesis of platinum dimers: Based on a modified 
literature methodology.82 A solution of potassium tetrachloroplatinate (II) (1 eq) in 
water (2 mL) was added to a stirring solution of LH (1 eq) in 2-ethoxyethanol (6 mL) 
under dinitrogen and heated to 80 °C for 16 h in a foil-wrapped flask. Brine (10 mL) 
was added to the cooled solution and the resultant precipitate was collected on a sinter 
and washed with water (2 x 10 mL) and dried. The solid was used without 
purification. 
Synthesis of [Pt(L1)Cl]2: Following the general procedure for the synthesis of 
platinum dimers using potassium tetrachloroplatinate (II) (0.084 g, 0.201 mmol) and 
LH1 (0.056 g, 0.201 mmol). Yield = 0.049 g, (48%). 195Pt (107.5 MHz, CDCl3): δPt -
3219 ppm. 
Chapter 2: Tuning the photophysical properties of platinum (II) complexes 
 
70 
Synthesis of [Pt(L2)Cl]2: Following the general procedure for the synthesis of 
platinum dimers using potassium tetrachloroplatinate (II) (0.261 g, 0.629 mmol) and 
LH3 (0.191 g, 0.629 mmol). Yield = 0.265 g, (79%). 
Synthesis of [Pt(L3)Cl]2: Following the general procedure for the synthesis of 
platinum dimers using potassium tetrachloroplatinate (II) (0.171 g, 0.412 mmol) and 
LH4 (0.141 g, 0.412 mmol). Yield = 0.151 g, (64%).  
General procedure for splitting platinum dimers: Based on a modified literature 
methodology.107 Crude [Pt(L)Cl]2 was dissolved in a minimum volume of DMSO 
before being precipitated with brine (10 mL), filtered on a sinter and washed with 
water (2 x 20 mL). The solid was dried and purified if necessary.  
Synthesis of [Pt(L1)(DMSO)Cl]: Following the general procedure for splitting 
platinum dimers using [Pt(L1)Cl2] (0.049 g, 0.048 mmol). Obtained as a brown/green 
solid. Yield = 0.053 g, (94%). 1H NMR (400 MHz, CDCl3): δH 9.07 (1H, d, 3JHH = 8.4 
Hz), 8.58 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 1.2 Hz), 8.40 – 8.35 (1H, m), 8.29 (1H, s), 
7.78 – 7.74 (1H, m), 7.71 – 7.68 (1H, m), 7.65 – 7.61 (1H, m), 7.31 – 7.25 (2H, m), 
4.59 (2H, q, 3JHH = 7.2 Hz), 3.67 (6H, s (with satellites 3JHPt = 22 Hz)), 1.53 (3H, t, 
3JHH = 7.2 Hz). 13C{1H} NMR (75.6 MHz, CDCl3): δC 166.5, 165.3, 147.6, 145.7, 
143.0, 139.9, 133.9, 130.9, 129.8, 128.6, 128.3, 126.1, 125.5, 125.2, 125.0, 117.6, 
62.7, 46.3 (satellites 46.7 & 45.9), 14.4 ppm. 195Pt (107.5 MHz, CDCl3): δPt -3662 
ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 257 (28100), 293 (20100), 366 (9050) 
nm. IR (thin film): νmax 3048, 2976, 2918, 1715, 1597, 1578, 1543, 1514, 1466, 1451, 
1397, 1375, 1348, 1292, 1271, 1248, 1233, 1194, 1130, 1018, 758 cm-1. 
Synthesis of [Pt(L2)(DMSO)Cl]: Following the general procedure for splitting the 
platinum dimers using [Pt(L2)Cl]2 (0.265 g, 0.249 mmol). Obtained as a yellow/green 
solid. Yield = 0.283 g, (93%). 195Pt (107.5 MHz, CDCl3): δPt -3675 ppm. 
Synthesis of [Pt(L3)(DMSO)Cl]: Following the general procedure for splitting the 
platinum dimers using [Pt(L4)Cl]2 (0.151 g, 0.132 mmol). Obtained as a brown/green 
solid. Yield = 0.156 g (91%). 195Pt (107.5 MHz, CDCl3): δPt -3673 ppm. 
General procedure for coordinating β-diketonates to platinum complexes: Based 
on a modified literature methodology.108 [Pt(L)(DMSO)Cl] (1 eq) was dissolved in 3-
Chapter 2: Tuning the photophysical properties of platinum (II) complexes 
 
71 
pentanone (5 mL), to which, the β-diketonate (1 – 10 eq) was added. The reaction was 
stirred at room temperature for 16 h under dinitrogen. The solvent was removed in 
vacuo and the crude product dissolved in dichloromethane (10 mL) and filtered to 
remove any insoluble salts. The yellow solution was dried in vacuo. The crude 
products were purified by column chromatography (silica, dichloromethane) and were 
eluted as the first yellow band with dichloromethane and dried in vacuo. 
General procedure for preparing sodium salts of β-diketonates: Based on a 
literature methodology.35 The β-diketonate (1.1 eq) was added slowly to a stirring 
suspension of NaH (1 eq) in petroleum ether (50 mL) under dinitrogen. The 
suspension was stirred at room temperature until the effervescence had subsided and 
was then heated at reflux for 3 h. The suspension was cooled and the product was 
obtained through filtration and washing with copious amounts of petroleum ether. 
Synthesis of sodium acetylacetonate monohydrate: 2,4-pentanedione (1.000 g, 
10.000 mmol), NaH (60% dispersion in mineral oil) (0.400 g, 9.091 mmol). Yield = 
1.235 g, (97%). 
Synthesis of the sodium hexamethylacetylacetonate monohydrate: 2,2,6,6,-
tetramethyl-3,5-heptanedione (1.000 g, 5.435 mmol), NaH (60% dispersion in mineral 
oil) (0.217 g, 4.941 mmol). Yield = 1.051 g, (95%). 
Synthesis of [Pt(L1)(acac)]: Following the general procedure for coordinating β-
diketonates to platinum complexes using [Pt(L1)(DMSO)Cl] (0.053 g, 0.091 mmol) 
and sodium acetylacetonate monohydrate (0.111 g, 0.910 mmol). Obtained as a dark 
orange solid. Yield = 0.042 g, (81%). 1H NMR (400 MHz, CDCl3): δH 9.59 (1H, dd, 
3JHH = 8.0 Hz, 4JHH = 0.4 Hz), 8.69 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 1.2 Hz), 8.24 (1H, 
s), 7.81 – 7.75 (2H, m), 7.65 – 7.60 (2H, m), 7.29 – 7.25 (1H, m), 7.21 – 7.17 (1H, 
m), 5.58 (1H, s), 4.56 (2H, q, 3JHH = 7.2 Hz), 2.06 (3H, s), 2.05 (3H, s), 1.52 (3H, t, 
3JHH = 7.2 Hz) ppm. 13C{1H} NMR (75.6 MHz, CDCl3): δC 185.7, 184.2, 169.4, 
165.7, 149.9, 145.7, 140.3, 137.4, 130.8, 130.0, 129.7, 127.7, 126.9, 125.4, 125.2, 
125.1, 124.0, 118.1, 101.8, 62.3, 28.5, 27.2, 14.4 ppm. 195Pt (107.5 MHz, CDCl3): δPt -
2765 ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 253 (17500), 292 (13900), 300 
(14400), 363 (5570), 427 (3720) nm. IR (thin film): νmax 3115, 3053, 2980, 2920, 
1723, 1580, 1541, 1522, 1452, 1393, 1375, 1298, 1267, 1238, 1196, 1146, 1028, 762 
cm-1. 
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Synthesis of [Pt(L1)(hmacac): Following the general procedure for coordinating β-
diketonates to platinum complexes using [Pt(L1)(DMSO)Cl] (0.023 g, 0.039 mmol) 
and sodium hexamethylacetylacetonate monohydrate (0.009 g, 0.043 mmol). Yield = 
0.024, (93%). 1H NMR (400 MHz, CDCl3): δH 9.70 (1H, d, 3JHH = 9.2 Hz), 8.71 (1H, 
dd, 3JHH = 8.4 Hz, 4JHH = 0.8 Hz), 8.26 (1H, s), 7.88 (1H, dd (with satellites), 3JHH = 
7.6 Hz, 4JHH = 0.8 Hz), 7.81 – 7.77 (1H, m) 7.67 – 7.61 (2H, m), 7.32 – 7.28 (1H, m), 
7.23 – 7.19 (1H, m), 5.94 (1H, s), 4.58 (2H, q, 3JHH = 7.2 Hz), 1.54 (3H, t, 3JHH = 7.2 
Hz), 1.35 (9H, s), 1.30 (9H, s) ppm. 13C{1H} NMR (75.6 MHz, CDCl3): δC 195.7, 
193.9, 169.5, 165.8, 150.0, 145.8, 141.1, 137.4, 131.0, 130.5, 129.7, 127.7, 127.5, 
125.4, 125.1, 125.0, 123.9, 118.1, 92.8, 62.4, 42.3, 41.1, 28.8, 28.6, 14.4 ppm. 195Pt 
(107.5 MHz, CDCl3): δPt -2733 ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 253 
(18700), 291 (12300), 301 (13000), 357 (5220), 437 (3610) nm. IR (thin film): νmax 
3117, 3057, 2961, 2924, 2855, 1724, 1601, 1584, 1559, 1549, 1530, 1497, 1462, 
1452, 1391, 1357, 1360, 1263, 1238, 1225, 1194, 1144, 1026, 791, 760 cm-1. 
Synthesis of [Pt(L1)(hfacac): Following the general procedure for coordinating β-
diketonates to platinum complexes using [Pt(L1)(DMSO)Cl] (0.022 g, 0.057 mmol), 
Na2CO3 (0.007 g, 0.063 mmol) and hexafluoroacetylacetone (0.013 g, 0.063 mmol). 
Obtained as a yellow solid. Yield = 0.036 g, (92%). 1H NMR (400 MHz, CDCl3): δH 
8.97 (1H, dd, 3JHH = 9.2 Hz, 4JHH = 0.8 Hz), 8.75 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 1.2 
Hz), 7.95 (1H, s), 7.64 – 7.60 (1H, m), 7.57 – 7.52 (1H, m), 7.37 – 7.35 (1H, m), 7.24 
– 7.22 (1H, m), 7.10 – 7.08 (2H, m), 6.21 (1H, s), 4.55 (2H, q, 3JHH = 7.2 Hz), 1.53 
(3H, t, 3JHH = 7.2 Hz) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 184.6, 183.1, 
168.4, 163.8, 148.6, 144.5, 142.7, 139.1, 130.1, 128.8, 128.7, 126.3, 125.8, 124.1, 
124.0, 123.3, 122.9, 121.6, 115.0, 114.9, 113.3, 100.9, 27.4, 26.1 ppm. 195Pt (107.5 
MHz, CDCl3): δPt  -2693 ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 253 
(17700), 293 (12500), 370 (5370), 400 (2930) nm. IR (thin film): νmax 2934, 2851, 
1724, 1624, 1603, 1545, 1466, 1456, 1377, 1350, 1260, 1200, 1146, 1109, 1030, 735 
cm-1. 
Synthesis of [Pt(L2)(acac)]: Following the general procedure for coordinating β-
diketonates to platinum complexes using [Pt(L2)(DMSO)Cl] (0.050 g, 0.077 mmol) 
and sodium acetylacetonate monohydrate (0.094 g, 0.770 mmol). Obtained as a dark 
yellow solid. Yield = 0.046, (94%). 1H NMR (400 MHz, CDCl3): δH 9.28 (1H, d, 3JHH 
= 8.8 Hz), 8.95 (1H, s), 7.86 (1H, d, 3JHH = 8.0 Hz), 7.69 – 7.66 (2H, m), 7.49 – 7.45 
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(2H, m), 7.36 – 7.31 (2H, m), 7.11 – 6.98 (4H, m), 6.80 – 6.76 (1H, m), 5.47 (1H, s), 
2.00 (3H, s), 1.81 (3H, s) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 184.5, 183.1, 
168.8, 165.3, 148.6, 144.8, 144.4, 139.2, 130.0, 129.0, 128.6, 126.2, 125.8, 124.0, 
123.9, 123.4, 122.9, 112.9, 100.8, 51.9, 27.9, 27.3, 26.2 ppm. 195Pt (107.5 MHz, 
CDCl3): δPt -2779 ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 258 (28800), 297 
(28300), 343 (9200), 360 (6800), 415 (3130) nm. IR (thin film): νmax 3300, 3057, 
2963, 2924, 2853, 1721, 1647, 1595, 1572, 1549, 1516, 1456, 1393, 1366, 1302, 
1263, 1219, 1161, 1092, 1028, 793, 762, 733, 702 cm-1. 
Synthesis of [Pt(L3)(acac)]: Following the general procedure for coordinating β-
diketonates to platinum complexes using [Pt(L3)(DMSO)Cl] (0.050 g, 0.077 mmol) 
and sodium acetylacetonate monohydrate (0.094 g, 0.770 mmol). Obtained as a dark 
yellow solid. Yield = 0.046, (94%). 1H NMR (400 MHz, CDCl3): δH 9.28 (1H, d, 3JHH 
= 8.8 Hz), 8.95 (1H, s), 7.86 (1H, d, 3JHH = 8.0 Hz), 7.69 – 7.66 (2H, m), 7.49 – 7.45 
(2H, m), 7.36 – 7.31 (2H, m), 7.11 – 6.98 (4H, m), 6.80 – 6.76 (1H, m), 5.47 (1H, s), 
2.00 (3H, s), 1.81 (3H, s) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 184.6, 183.1, 
168.4, 163.8, 148.6, 144.5, 142.7, 139.1, 130.1, 128.8, 128.7, 126.3, 125.8, 124.1, 
124.0, 123.3, 122.9, 121.6, 121.5, 115.0, 114.9, 113.3, 100.8, 27.4, 26.1 ppm. 195Pt 
(107.5 MHz, CDCl3): δPt -2769 ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 300 
(14860), 342 (9840), 363 (4650), 442 (2170) nm. IR (thin film): νmax 3262, 3063, 
2963, 2924, 2853, 1672, 1655, 1582, 1547, 1522, 1508, 1456, 1404, 1373, 1308, 
1260, 1211, 1157, 1090, 1015, 939, 864, 833, 800, 760, 729, 698 cm-1. 
Synthesis of [Pt(L4)(acac)]: The deprotection of the ethyl ester was carried out based 
on a similar literature methodology.81 [Pt(L1)(acac)] (0.029 g, 0.051 mmol) was 
dissolved in acetone (5 mL) and potassium hydroxide (1 M soln, 5 mL) and stirred for 
16 h at room temperature under dinitrogen. The acetone was removed in vacuo and 
the solution neutralised with hydrochloric acid (1 M soln). The water was removed in 
vacuo and the solid dissolved in methanol (5 mL) and filtered to remove inorganic 
salts. Yield = 0.024 g, (87%). 1H NMR (400 MHz, CD3OD): δH 9.58 (1H, d, 3JHH = 
9.2 Hz), 8.30 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 1.6 Hz), 7.93 (1H, s), 7.73 – 7.69 (1H, 
m), 7.65 – 7.62 (1H, m), 7.58 – 7.53 (2H, m), 7.13 – 7.07 (2H, m), 5.48 (1H, s), 2.86 
(3H, s), 1.81 (3H, s) ppm. 13C{1H} NMR (125.8 MHz, CD3OD): δC 185.7, 183.9, 
172.8, 169.9, 150.2, 149.6, 146.5, 139.1, 130.1, 129.5, 128.5, 127.4, 126.3, 126.0, 
124.7, 124.4, 123.4, 113.2, 101.0, 26.9, 25.7 ppm. 195Pt (107.5 MHz, CD3OD): δPt -
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2781 ppm. MS(ES) found m/z = 541.06 for [M – H]-. UV-vis (MeOH): λmax (ε / dm
3 
mol-1 cm-1) 282 (4990), 334 (1850), 348 (1940), 382 (1360) nm. IR (thin film): νmax 
3379, 2963, 2918, 2849, 1659, 1576, 1539, 1520, 1454, 1393, 1360, 1337, 1277, 
1024, 764 cm-1. 
General procedure for coordinating 8-hydroxyquinoline to platinum complexes: 
Based on a modified literature methodology.36 [Pt(L)(DMSO)Cl] (1 eq), Na2CO3 (1.1 
eq) and 8-hydroxyquinoline (1.1 eq) were heated to 100 °C, with stirring under 
dinitrogen, in 2-methoxyethanol (5 mL) for 24 h. The solvent was removed in vacuo 
and the crude product purified by precipitation or column chromatography. 
Synthesis of [Pt(L1)(8-Q)]: Following the general procedure for coordinating 8-
hydroxyquinoline to platinum complexes using [Pt(L1)(DMSO)Cl] (0.038 g, 0.065 
mmol), Na2CO3 (0.008 g, 0.072 mmol) and 8-hydroxyquinoline (0.010 g, 0.072 
mmol). The product was purified by column chromatography (silica, 
dichloromethane). The product was eluted as the first red band with dichloromethane 
and dried to yield a dark red solid. Yield = 0.035 g, (88%). 1H NMR (400 MHz, 
CDCl3): δH 9.93 (1H, d, 3JHH = 8.8 Hz), 9.18 (1H, d (with satellites 3JHPt = 44 Hz), 
3JHH = 5.2 Hz), 8.66 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 0.8 Hz), 8.28 (1H, dd, 3JHH = 8.0 
Hz, 4JHH = 0.8 Hz), 8.23 (1H, s), 7.94 – 7.91 (1H, m), 7.67 – 7.63 (2H, m), 7.56 – 7.49 
(2H, m), 7.40 – 7.36 (1H, m), 7.28 – 7.25 (1H, m), 7.22 – 7.18 (1H, m), 7.15 (1H, dd, 
3JHH = 8.0 Hz, 4JHH = 0.8 Hz), 6.92 (1H, dd, 3JHH = 8.0 Hz, 4JHH = 0.8 Hz), 4.57 (2H, 
q, 3JHH = 7.2 Hz), 1.53 (3H, t, 3JHH = 7.2 Hz) ppm. 13C{1H} NMR (75.6 MHz, 
CDCl3): δC 168.3, 167.4, 165.7, 149.7, 148.1, 147.6, 145.25, 144.66, 138.78, 137.91, 
132.90, 131.65, 131.02, 130.83, 129.80, 128.48, 128.0, 125.9, 125.2, 124.7, 123.6, 
121.0, 117.9, 116.1, 111.5, 62.4, 14.4 ppm. 195Pt (107.5 MHz, CDCl3): δPt -2922 ppm. 
UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 257 (16700), 284 (15900), 370 (12400) nm. 
IR (thin film): νmax 3063, 2965, 2934, 2864, 1721, 1653, 1645, 1599, 1580, 1541, 
1501, 1452, 1375, 1352, 1294, 1262, 1240, 1196, 1144, 1092, 1084, 1022, 795, 762, 
733 cm-1. 
General procedure for coordinating a monodentate N-heterocycle to platinum 
complexes: Prepared by a modified literature methodology.37 The N-heterocycle (1 – 
1.1 eq) was added to [Pt(L)(DMSO)Cl] (1 eq) in acetone (5 mL) and stirred for 16 h 
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under dinitrogen at room temperature. The solvent was removed in vacuo and the 
product purified according to the compound.  
Synthesis of [Pt(L1)(py)Cl]: Following the general procedure for coordinating a 
monodentate N-heterocycle to platinum complexes using pyridine (0.007 g, 0.094 
mmol) and [Pt(L1)(DMSO)Cl] (0.050 g, 0.086 mmol). The solvent was reduced in 
volume and diethyl ether (5 mL) was added to precipitate the desired product, which 
was filtered and washed with cold diethyl ether (2 x 5 mL). Yield = 0.043 g, (86%). 
1H NMR (400 MHz, CDCl3): δH 9.80 (1H, dd, 3JHH = 8.8 Hz, 4JHH = 0.8 Hz), 9.01 
(2H, d (with satellites 3JHPt = 48.0 Hz) ), 8.59 (1H, d, 3JHH = 8.4 Hz), 8.23 (1H, s), 
7.93 – 7.89 (1H, m), 7.83 – 7.79 (1H, m), 7.67 – 6.60 (2H, m), 7.47 – 7.44 (2H, m), 
7.19 – 7.16 (1H, m), 7.03 – 6.98 (1H, m), 6.29 (1H, dd (with satellites 3JHPt = 42.4 
Hz), 3JHH = 8.0 Hz, 4JHH = 0.8 Hz), 4.57 (2H, q, 3JHH = 7.2 Hz), 1.52 (3H, t, 3JHH = 7.2 
Hz) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 168.1, 165.6, 154.1, 149.3, 146.0, 
143.7, 138.5, 138.0, 131.0. 130.6, 130.3, 129.5, 128.1, 126.1, 125.7, 124.9, 124.7, 
123.9, 117.6, 62.4, 14.3 ppm. 195Pt (107.5 MHz, CDCl3): δPt -3158 ppm. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 255 (31800), 285 (26000), 367 (12800), 450 (1990) 
nm. IR (thin film): νmax 3096, 3053, 2980, 2924, 2224, 1723, 1717, 1580, 1541, 1451, 
1373, 1292, 1267, 1240, 1196, 1144, 1024, 907, 864, 760, 727, 689 cm-1. 
General procedure for coordinating 2,2′-bipyridine to platinum complexes: 
Prepared by a modified literature methodology.39 2,2’-bipyridine (1.1 eq) was added 
to [Pt(L)(DMSO)Cl] (1 eq) in DMF (5 mL) and stirred for 48 h under dinitrogen at 65 
°C. Diethyl ether was added to precipitate the complex, which was filtered and 
washed with plenty of diethyl ether. The yellow solid was dissolved in acetonitrile 
before a saturated aqueous solution of potassium hexafluorophosphate was added 
drop wise to exchange the chloride counter-ion. The precipitate was dissolved in 
dichloromethane before being washed with water (2 x 50 mL) and dried over MgSO4, 
filtered and the solvent was reduced in volume. Diethyl ether was added to precipitate 
and the solid was collected by filtration, washed with diethyl ether and dried to yield a 
dark yellow solid. 
Synthesis of [Pt(L1)(bpy)Cl]: Following the general procedure for coordinating a 
bipyridine to platinum complexes using 2,2’-bipyridine (0.031 g, 0.200 mmol) and 
[Pt(L1)(DMSO)Cl] (0.070 g, 0.182 mmol). Yield = 0.057 g, (73%). 1H NMR (400 
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MHz, CDCl3): δH 9.40 (1H, d (with satellites 3JHPt = 40.8 Hz), 3JHH = 6.0 Hz), 8.66 – 
8.61 (2H, m), 8.39 – 8.34 (1H, m), 8.32 – 8.28 (3H, m), 8.17 – 8.13 (1H, m), 8.09 – 
8.07 (1H, m), 7.81 – 7.73 (3H, m), 7.64 – 7.61 (1H, m), 7.43 – 7.36 (2H, m), 7.29 – 
7.22 (2H, m), 4.60 (2H, m q, 3JHH = 7.2 Hz), 1.53 (3H, t, 3JHH = 7.2 Hz) ppm. 13C{1H} 
NMR (125.8 MHz, CD3CN): δC 167.6, 164.9, 157.3, 155.0, 152.8, 150.9, 146.5, 
146.1, 142.3, 140.5, 140.1, 140.0, 132.0, 131.3, 130.3, 128.6, 128.2, 127.0, 126.5, 
126.3, 125.2, 124.9, 124.6, 124.0, 123.3, 118.1, 62.6, 13.3 ppm. 195Pt (107.5 MHz, 
CD3CN): δPt -3097 ppm. UV-vis (CH3CN): λmax (ε / dm
3 mol-1 cm-1) 281 (28600), 318 
(12900), 355 (10900), 368 (11500), 395 (8200), 448 (2460) nm. IR (thin film): νmax 
3086, 3055, 2984, 2932, 1723, 1669, 1599, 1582, 1545, 1472, 1449, 1377, 1267, 
1246, 1200, 1157, 1146, 1024, 839, 762, 731, 700 cm-1.  
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Chapter 3 aims to adapt the functionalisation of 2-phenylquinoline ligand 
architectures to increase the hydrophilicity of the subsequent complexes towards 
biologically relevant studies. Recent literature, outlined below, discusses the 
application of a class of cyclometallated PtII complexes in the fight against 
Alzheimer’s disease. This chapter also aims to develop a macrocylic ligand system 
capable of exploiting a coordination technique, utilised in Chapter 2, in order to form 
a dimetallic (PtII / GdIII) bimodal imaging agent with potential application as a 
contrast agent in magnetic resonance imaging. Chapter 3 will also examine the 
photophysical properties of the dimetallic species to ascertain some of the physical 
attributes of the species by incorporating YbIII. 
3.1.1. Amyloid-β  peptide and Alzheimer’s disease – The amyloid hypothesis 
Given that this chapter aims to develop compounds towards the potential detection 
and/or treatment of Alzheimer’s, it is crucial that the disease be explained in some 
detail. Alzheimer’s disease is one of the major causes of death in the developed 
world, after heart disease, cancer and strokes. It affects between 1 and 6% of those 
over the age of 65 and is an increasing problem with larger numbers of elderly people 
living for longer. The disease initially causes memory loss before worsening to leave 
patients bedridden, incontinent and with a personality completely unrecognisable to 
friends and family.1  
 
Figure 3.1 Structure of amyloid-β peptide in water determined by NMR spectroscopy (left)2 and 
amyloid cascade process (right).3 
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Scheme 1. Schematic representation of the APP695 with numbering of the residues
in the CuBD and TMD  (transmembrane domain). Left: Sequence of the CuBD encom-
passing the three-disulfide bonds is shown. Residues in red and italic are involved
in  Cu(II) binding. Right: Sequence of the A!42 peptide issued from cleavage of the
APP. Residues underlined at positions 16 and 28 represent the C-term of the A!1–16
and A!1–28 truncated models usually used for the study of metal ions coordination.
Familial mutations (A21G, E22Q, E22G, E22K and D23N) and deletion (!E22) outside
the metal ions binding domain are lso shown.
As previously described, metal ions binding to A! may  strongly
impact the etiology of AD. The focus of the present review is to
delineate the coordination of Cu(II), Cu(I) and Fe(II) ions to A!,
binding of Zn(II) ion being the subject of other reviews [50–52],
including one in this special issue [43]. Also Cu binding to the APP
protein will be briefly described. Affinity of metal ions for A! and
APP is crucial for estimating the biological relevance of the metal
ions – peptide/proteins interactions and will be briefly commented
on. Recent reviews on this subject include Refs. [51,53,54] and Ref.
[55] in this special issue.
2. Copper and amyloid precusor protein
2.1. The amyloid precursor protein (APP)
APP is a type-I trans-membrane protein expressed in many
mammalian cells that plays a central role in AD. In neuronal cells,
APP is mainly expressed as a 695-residue protein with several sub-
domains [56–58] including the Cu Binding Domain (CuBD) [59–62],
a trans-membrane domain (Scheme 1) and the E2 domain which
contains a coiled coil dimerization motif. APP can be cleaved either
in the amyloidogenic pathway by the ! and "-secretases leading to
the formation of the A! peptide or in the non-amyloidogenic path-
way  first by the #-secretase and then by the "-secretase leading
to A!17–40 and A!17–42 fragments, known as p3 peptides [56–58].
Cleavage by both #- and !-secretases leads to the formation of
the A!1–16 peptide [63]. !-Secretase can also cleave APP at a sec-
ondary site leading to A!11–40 and A!11–42 peptides [57] (see also,
Scheme 2 in Section 3.2).
2.2. Functions of APP
Exact functions of APP remain elusive [57]. In a mouse model
study, APP possesses a ferroxidase activity similar to ceruloplasmin,
facilitating iron export through interaction with ferroportin [64].
Other possibilities include neuronal growth [65], signaling [66] and
Cu metabolism attributed to the presence of the CuBD. Regarding
Scheme 2. A schematic view of the amyloid cascade. Left side: in the non-amyloidogenic pathway, APP is first cleaved by the #-secretase between A! positions 16 and 17
and  then by the "-secretase leading to formation of A!17–40/42 (p3) peptides, or by the !-secretase leading to A!1–16. Right side: in the amyloidogenic pathway, APP is cleaved
by  the !- and "-secretases leading to the formation of the A!1–40/42 peptides. Aggregation process is modulated by coordination of metal ions and toxic oligomers are formed.
They  will be further transformed in fibrils found in the amyloid plaques observed in AD brains. Degradation pathway of the A! monomers can also be perturbed in AD with
a  decreased of the intracellular Cu content linked to a reduced degradation process [97].
of residue F4 show NOE cross-peaks with V18 Hc as well as many
medium to weak NOEs to the side-chains of A21, E22, and V24. To-
gether these NOEs constrain the N-terminus in a hairpin conforma-
tion with the central helix. The packing of the hydrophobic phenyl
ring of F4 against the hydrophobic side chains of V18 and A21in the
central helix is likely to be responsible for this constraint. Hydro-
gen bonds from the side-chain of Q15 on the central helix to ex-
posed carbonyls in the N-terminal coil that are observed in many
of the structures also likely contribute to the packing of the N-ter-
minus against the helix. In the C-terminus, the hairpin conforma-
tion is constrained to lie against the other side of the helix by
long-range NOEs between the aromatic ring protons of F19 to Ha
of G38. Similar NOEs from the C-terminus to central hydrophobic
cor of Ab1–40 have been det cted in other NMR studies [13] and
MD si ulations [25,26]. NOEs in the interior of the hairpin, in par-
ti ul fr m Hd of N27 to the side-chain of V36 further confirms a
hairpin conformation. Like the N-terminus, hydrophobic clustering
appears to be responsible for this interaction. In this case, it is the
clustering of F19 with the hydrophobic residues at the C-terminus
that appears to be responsible for the collapse of the C-terminus
against the central helix. The interaction of the C-terminus with
the central hydrophobic core would presumably be stronger in
Ab1–42, which possesses two additional hydrophobic residues at
the C-terminus (IA), in agreement with fluorescence measure-
ments [27].
Although both the N- and C-termini lack stable secondary struc-
ture, they are not completely unstructured, as both contain many
twists and turns caused by local interactions between side-chains
after the end of helical secondary structure. The chemical shift in-
dex plot shows substantial negative deviations from random coil
values from D1 to G29, as well as negative deviations in the
Fig. 2. (A) NOE connectivity plot showing the formation of a 310 helix for residues
H13 to D23 of Ab1–40. The strengths of sequential NOEs are indicated by the height
of the bars, graded into categories of strong, medium, or weak. (B) Deviations from
Ha random coil chemical shift values showing the propensity of Ab1–40 to form a
helix.
Fig. 3. (A) High-resolution NMR structures of Ab1–40 at 15 !C at pH 7.3 in 50 mM
NaCl. (B) A cartoon plot showing the long-range NOEs stabilizing the formation of
the hairpin structure and the bends in the N- and C-termini (red lines). (For
interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
Fig. 4. The aromatic region of a 2D-NOESY spectrum showing crosspeaks between
F19 and F20 and the C-terminus and F4 and the central helix.
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The disease is thought to be linked to amyloid-β peptide (Aβ) (Figure 3.1).4 The 
peptide is a 38, 40 or 42 amino acid sequence in the amyloid precursor protein (APP), 
which is an integral membrane protein found in many structures, but especially in the 
neuronal synapses.5 The peptide is spliced from the protein by two enzymes (α- and 
γ-secretase).6 A possible defect in the splicing of the protein by the γ-secretase, or a 
mutation in the amino acid sequencing, has been found to result in an increase in the 
‘sticky’ Aβ42, which is thought to form fibrils which aggregate to form amyloid 
plaques.7 These plaques were thought to be toxic and cause damage to neurons, which 
leads to a repair mechanism causing an inflammatory response. The plaques were also 
thought to cause the formation of tau protein fibrils, which further the damage to the 
brain through cellular damage, leading to dementia however more recent evidence 
suggests that the plaques are a response to the formation of toxic soluble oligomers 
precipitating.4, 8 
More recently, interaction of CuII and ZnII with Aβ peptide have been linked to 
Alzheimer’s disease through their involvement in the amyloid cascade process.3, 9 
Redox-active metals such as ZnII are capable of forming reactive oxygen species 
(ROS), which are highly toxic and thought to be a key part of the pathology, along 
with the metals’ ability to induce amyloidogenic peptide aggregation.10 
3.1.2. Peptide binding 
Based on the knowledge that Alzheimer’s disease is intimately associated with Aβ 
peptide, it is important to give some background information on peptide binding and, 
in particular, the binding of PtII complexes to Aβ peptide and how this shows promise 
in the battle against Alzheimer’s disease.  
There are many reports of metal interactions with peptides. Of great interest is the 
interaction of metal ions and complexes with Aβ peptide because of its link to 
Alzeihmer’s disease. Bathocuproine (Figure 3.2) had been shown to interact with Aβ 
through NMR spectroscopy and,11 in 2008, Barnham et al. found that an L-PtCl2 
complex (where L = 1,10-phenanthroline-type diimine, such as bathocuproine) 
coordinated to Aβ, inhibiting aggregation and neutralising the resultant toxicity. They 
found that cisplatin did not show any affect on the effects of Aβ, suggesting that the 
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planar aromatic nature of the ligand, L, is a key component in preventing aggregation 




Figure 3.2 Structures (left to right) of bathocuproine, bathocuproine sulfonic acid and the three L-PtCl2 
complexes investigated by Barnham et al.12 
The results found by Barnham et al. were further investigated to uncover the 
complex-peptide interactions. Using an Aβ1-16 oligomer, Ma et al. found that initial 
non-covalent interactions between the planar aromatic ligand and the peptide resulted 
in rapid platination of Aβ with multiple coordination modes (Figure 3.3). His6/His14 
chelation was the major product but coordination was also found at Asp7, His13 and 
Lys16.13  
 
Figure 3.3 Interaction of [Pt(Cl)2(phen)] with Aβ1-16.13 
 
In 2013, Collin et al. investigated the potential of five complexes to inhibit the 
coordination of copper and zinc to Aβ and thus prevent aggregation and the formation 
of ROS.14 Their research (Figure 3.4) revealed that, although the Cu(Aβ) could not be 
prevented by the coordination of the PtII complexes, Zn binding was completely 
precluded, which is important given the aggregation of Zn(Aβ), the high zinc 
concentrations around glutamatergic neurons and the preferential formation of the 
amyloid plaques at these sites.15-17 
ing in inactivity against inhibiting peptide aggregation. This
hypothesis suggests that the binding modes of various plati-
num complexes to peptide could be crucial in the inhibition
of Ab aggregation.
The N-terminal peptide 1–16 (Ab1–16) has been widely em-
ployed for studying the metal-binding properties of Ab be-
cause this metal-binding domain covers all coordination resi-
dues for most common transition-metal ions. The interac-
tions of Ab1–16 with metal ions have been studied by differ-
ent techniques, including NMR, extended X-ray absorption
fine structure (EXAFS), and EPR spectroscopy and ESI-
MS.[3b,9] Tandem MS is capable of providing structural infor-
mation by the fragmentation of selected ions. This informa-
tion can be pieced together to obtain structural information
on the integral molecule.[10] For example, the binding sites
and redox properties of Cu2+ to Ab have been identified by
tandem MS and showed that His13 and His14 had more oxi-
dation tendency than that of His6.[11]
Herein, we have carried out the detailed investigation on
the reactions of Ab1–16 with platinum complexes. The reac-
tions were monitored by HPLC and the products were sepa-
rated for ESI-MS analyses. The binding preference of
[PtCl2ACHTUNGTRENNUNG(phen)] in the peptide were identified by using
tandem MS. Furthermore, the noncovalent interaction be-
tween phenanthroline of platinum complexes and Ab pep-
tide was characterized by NMR spectroscopy and fluores-
cence measurements. This noncovalent interaction signifi-
cantly promoted the coordination of platinum complexes to
Ab peptide. The platinum(II) atom and phen ligand play
synergistic roles in the inhibition of Ab aggregation
(Scheme 1).
Results
The solvolysis of [PtCl2 ACHTUNGTRENNUNG(phen)] in DMSO/H2O : Similar to
the literature,[7a] the reaction of Ab1!16 with [PtCl2ACHTUNGTRENNUNG(phen)]
was performed in DMSO/H2O mixture because [PtCl2-ACHTUNGTRENNUNG(phen)] was insoluble in aqueous solution. Thus, it was nec-
essary to v rify the identity of th platinum compound in so-
lution because the solvolysis of platinum complexes in
DMSO has been reported.[12] It was found that the 2, 9-di-
m thyl-1,10-phenanthroline (dmphen) complex [PtCl2-ACHTUNGTRENNUNG(dmphen)] readily reacted with DMSO to form [PtCl2-ACHTUNGTRENNUNG(dmphen)ACHTUNGTRENNUNG(dmso)], whereas [PtCl2ACHTUNGTRENNUNG(phen)] was very stable in
DMSO.[12] In this work, we observed that [PtCl2ACHTUNGTRENNUNG(phen)] sol-
volyzed rapidly in DMSO/H2O (v/v 2:1) at 25 8C to produce
[PtCl ACHTUNGTRENNUNG(dmso)ACHTUNGTRENNUNG(phen)]Cl.
The solvolysis of [PtCl2ACHTUNGTRENNUNG(phen)] in mixed DMSO/H2O sol-
vents was investigated by NMR spectroscopy, HPLC, and
ESI-MS. The NMR signals of [PtCl2 ACHTUNGTRENNUNG(phen)] in pure
[D6]DMSO remained unchanged over two weeks at room
temperature, which was consistent with previous reports.[12a]
However, once D2O was added to the solution in
[D6]DMSO, a new set of signals appeared quickly, which
were shifted downfield relative to [PtCl2 ACHTUNGTRENNUNG(phen)] (Fig-
ure 1A). This result indicates that water molecules promote
the solvolysis of [PtCl2ACHTUNGTRENNUNG(phen)] in DMSO. HPLC analysis
showed that the conversion of [PtCl2ACHTUNGTRENNUNG(phen)] was fast and
70% of [PtCl2 ACHTUNGTRENNUNG(phen)] reacted in 10 min (Figure 1B). The
product was isolated and analyzed by ESI-MS, which
showed the composition of
[PtCl ACHTUNGTRENNUNG(dmso)ACHTUNGTRENNUNG(phen)]+ (m/z
calcd: 488.02; found: 488.88;
Figure S1 in the Supporting In-
formation). This result indicat-
ed that a chloro ligand was sub-
stituted by DMSO in the mixed
solvent, in which water mole-
cules played the role of catalyst.
No other peak was observed in
the HPLC profiles with longer
Scheme 1. The interaction of [PtCl2 ACHTUNGTRENNUNG(phen)] with Ab1–16 and the proposed binding model of the Ab platination
adduct.
Figure 1. A) NMR spectra of [PtCl2ACHTUNGTRENNUNG(phen)] in pure [D6]DMSO (i) and in
the mixed solvent of [D6]DMSO/D2O (ii). B) HPLC profiles of [PtCl2-ACHTUNGTRENNUNG(phen)] dissolved in DMSO/H2O (v/v 2:1) at 25 8C for different times.
Peaks m and n were assigned to [PtCl2 ACHTUNGTRENNUNG(phen)] and [PtCl ACHTUNGTRENNUNG(dmso)ACHTUNGTRENNUNG(phen)]Cl,
respectively. A gradient of 20–80% B (CH3CN/H2O (90:10)) in 20 min
was used.



























Figure 3.4 Binding of a cyclometallated PtII complex with Aβ1-16.14 
3.1.3. Magnetic resonance imaging 
As mentioned in the opening remarks of this chapter, one of the reasons for increasing 
the hydrophilicity of the phosphorescent cyclometallated PtII moiety was to be able to 
append a GdIII-containing architecture so that the subsequent relaxivity studies could 
be carried out. In order to develop a compound for these measurements, it is 
important that the basic principles behind magnetic resonance imaging and relaxivity 
are explained so that an appreciation for the parameters determining a compound’s 
utility as a contrast agent are understood.  
Magnetic resonance imaging (MRI) has become one of the most useful diagnostic 
techniques in modern medicine. It is a non-invasive tool that allows whole-body 
imaging with deep tissue penetration without the use of harmful ionising radiation 
like X-rays.18, 19 It can provide high definition three-dimensional images of soft tissue 
with millimetre accuracy by probing the environment of in vivo water protons via 
their relaxation rates.20, 21 The sensitivity can be enhanced through the introduction of 
a contrast agent, which are typically paramagnetic, superparamagnetic or 
ferromagnetic compounds capable of catalytically reducing the relaxation rate of 
proximal water molecules. The seven unpaired electrons on GdIII result in a high 
magnetic moment and long electron spin relaxation time, making it an ideal candidate 
for use in contrast agents, which is the reason why it is the most widely used metal for 
increasing the contrast in MRI.22 Despite this, free GdIII is highly toxic (LD50 of 0.2 
mmol kg-1 in mice) and must be administered in the form of a stable chelate to 
prevent leaching of the metal ion in vivo.23 Given the toxic nature of the GdIII ion, the 
contrast agent is administered at a much lower concentration than that of water within 
the body so it is important that Gd-based contrast agents are able to coordinate and 
dissociate multiple water molecules in quick succession in order to increase the 
contrast effectively.24  
2132 Chem. Commun., 2013, 49, 2130--2132 This journal is c The Royal Society of Chemistry 2013
strong trans eﬀect, leading to an easy chloride departure
followed by replacement by a ide-chain of one of the three
His.15 Here, His13 was identified as the main His involved in Pt
binding in !1. Side-chain Glu11 completes the coordination
sphere of the Pt according to Scheme 2.
(ii) Impact on Cu and Zn-associated Ab toxicity: Interference
of Pt with both Cu(II) and Zn c ordination t Ab28 is in line
with the yields of Pt compounds coordination to Ab28 observed
by HPLC/MS analysis (i.e., 93%, 90%, 54%, 35% and 34% for !2,
!1, !3, !4 and !5, respectively) and by NMR (Fig. S6 and S7, ESI†).
Indeed complexes !1 and !2 eﬃciently preclude Zn induced Ab28
aggregation and modify significantly the Cu(Ab28) EPR signa-
ture. Complex !3 has a lesser impact and complexes !4 and !5 have
almost no eﬀect on both features. Although a strong eﬀect is
detected for complexes !1 and !2 upon reshuﬄing of the Cu(II)
c ordi ation sphere in Ab28, this modification is not enough to
perturb significantly the Cu(Ab) induced ROS production. In
contrast to Cu(II), His13 and Glu11 may be essential residues
for Zn binding and induced Ab28 aggregation (reviewed in
ref. 13 and 17). Hence, Pt preferential coordination to those
two residues precludes Zn binding in its natural site and clearly
aﬀects the associated Ab28 aggregation.
(iii) Biological relevance: Pt-compound !1 could be interest-
ing as it has a specific eﬀect, in terms of activity, i.e. it stops Zn-
induced aggregation but not Cu(Ab) redox reactivity. A priori,
co !2 is also very potent to specifically inhibit the Zn
associated process but its hydro-solubility hampers its use
in vivo. For therapeutic approaches, chelators are another
strategy often studied for AD.18 Chelators are often selective
but not specific, i.e. they can bind to both Zn and Cu but with
diﬀerent aﬃnity according to the Irving Williams series. Here,
with Pt complexes, it is possible to address eﬀects (ROS
production or Ab aggregation) linked to a specific metal
ion. Such a strategy relying on specific interference of Pt
compounds (with either ROS production or aggregation) is thus
a very appealing therapeutic approach.
We thank Sara Ruiz for the measurements of the Ascorbate
consumption by Cu(Ab28) in the presence of Pt compounds and
C. Bijani for NMR measurements.
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Fig. 2 (A) Trace chromatogram (left) and corresponding mass spectrum (right) of Ab28 (top, tr = 14.14 min) and the Ab28/Pt(f-MePy) complex (bottom, tr =
15.64 min). (B) Fragmentation scheme of the Ab28–Pt(f-MePy) complex deduced from top-down tandem mass spectra (see ESI,† Fig. S10 and S11) of the triply-

















































MRI works by measuring the difference in the nuclear magnetic resonance properties 
of water protons imposed by the local environment. The nuclear spins of the protons 
are exposed to an external magnetic field, B0, which results in their alignment with 
the field. The nuclear spins are then realigned with the transverse plane by pulsed 
radio waves at 90° to B0. After the pulse sequence, the nuclei are allowed to relax 
back in line with B0. 
Relaxation occurs through T1 and T2 processes, where T1 is the spin-lattice 
(longitudinal) relaxation time and T2 is the spin-spin (transverse) relaxation time.19 
Contrast agents can reduce T1 and T2 to increase the number of relaxations in a given 
time frame, which allows for a greater contrast to be achieved in an MR image. How 
useful a compound is as a contrast agent is determined by the relaxivity, which can be 
defined as the relative increase in relaxation of bulk water protons by the agent at a 
given concentration. This can be observed through r1 and r2, which are related to T1 
and T2, respectively. The effect of most interest in MRI is the longitudinal relaxation 
rate due to the slower rate of relaxation by the T1 component.25 Relaxivity, r1, is 
described in equation (18) where (1/T1)obs is the inverse of the observed T1, [Gd] is the 
concentration of Gd ions and (1/T1)d is the diamagnetic contribution, which is the 











The paramagnetic relaxation enhancement (Figure 3.5) of water molecules by 
gadolinium, and other paramagnetic species, is made up of two components: inner-
sphere and outer-sphere.23 Inner sphere relaxation relates to the enhanced relaxation 
of water molecules directly coordinated to the paramagnetic species (usually GdIII 
ions), whilst outer-sphere relaxation is the relaxation enhancement of solvent 
molecules in the second coordination sphere and the bulk solvent. Inner-sphere and 
second-sphere water molecules are relaxed before exchanging rapidly with the bulk 
water, meaning that relaxation is dependent upon the number of coordination sites for 
water within the inner and second-sphere, their distances to the metal ion and the rate 
of exchange with the bulk solvent.20  
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The inner-sphere contribution consists of q coordinated water molecules with a Gd-H 
distance r and a residency time of coordination τM, whilst second-sphere has q′ water 
molecules with a Gd-H distance of r′ and a residency time within the second-sphere 
of τM′. Relaxivity is also affected by the rotational motion of the contrast agent 
through the bulk solution, which gives a rotational correlation time, τR. The motion of 
bulk water is also a factor and is described by a translational diffusion correlation 
time, τD, which changes with factors such as viscosity.23  
 
Figure 3.5 Graphical depiction of the factors influencing r1 relaxation rates.26 
Appreciation of these components is critical in understanding how relaxation occurs 
and how contrast agents can be developed in order to provide greater image contrast 
by increasing water exchange rates, reducing tumbling by enhancing the molecular 
size and weight and increasing inner-sphere coordination.  
3.1.5. Contrast agents 
Contrast agents are administered intravenously and, as such, must be kinetically inert 
to prevent leaching of toxic GdIII ions into the body, capable of rapid excretion from 
the body so as to only be prevalent for the time taken to perform the MRI scan and 
have good aqueous solubility to stay in solution under physiological conditions. For 
this reason, most commercial GdIII-based contrast agents are based around 
polydentate cyclen or diethylenetriamine core structures with pendant coordinative 
ligands appended (Figure 3.6).  




Figure 3.6 Commonly used GdIII contrast agents. 
These compounds have shown great utility in a wide number of MRI applications and 
can be used in high doses without complications (except to those with kidney 
disease), and are excreted in the urine with half-lives of 1 – 2 h.23 They have to be 
used at relatively high concentrations (> 0.01 mM) in order to obtain high contrast 
images and, as such, work has focussed on developing contrast agents with a higher 
sensitivity, thus requiring a lower dose. This can be done by increasing the relaxation 
rate by fine-tuning the parameters that affect T1 and T2. 
 
Figure 3.7 Structures of compounds with enhanced r1 values. 
Subtle changes in the functionalisation of commercially available contrast agents have 
been shown to be effective in increasing r1 through modulating the values for q, τM 
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Rudovský et al. was found to have a much shorter water residency time, with a value 
for τM of just 16 ns (cf. 244 ns for [Gd(DOTA)(H2O)]-)  due to the incorporation of a 
bulky phosphinate group creating steric crowding and creating a favourable 
arrangement of second-sphere water molecules.27 Costa et al. developed several 
complexes where q was found to be 2, which all exhibited enhanced r1 values 
compared to compounds where q = 1, such as Magnevist.28 For 
[Gd2{X(dtta)2}(H2O)4]2- r1 values >11 mM-1 s-1 (20 MHz, 37 °C) were observed (cf. 
4.0 mM-1 s-1 for Magnevist),29 which were thought to be a result of an increase in q 
and, because of the increased molecular size and weight and the rigid linker, an 
increase in the rotational correlation time, τR.28 Another paper by Costa outlined the 
development of a dimetallic complex where two Gd-DTTA groups were linked by a 
[Fe(tpy)2] complex to give [Fe(tpy-DTTA)2Gd2}(H2O)4].30 They found that the 
increased size and rigidity of the molecule resulted in an r1 value of 15.7 mM-1 s-1 (20 
MHz, 37 °C), even greater than that found for [Gd2{X(DTTA)2}(H2O)4]2-. 
3.1.6. Photophysical properties of lanthanides 
LnIII ions display low molar absorption coefficients (where ε < 10 dm3 mol-1 cm-1) due 
to the Laporte forbidden nature of f-f transitions resulting in very weak emission upon 
direct excitation of lanthanide ions. The nature of the emission (UV/visible/near-IR 
and fluorescent/phosphorescent/both) varies depending upon the lanthanide ion.31  
In order to combat the inherently weak absorption and, as a result, emission, it is 
possible to sensitise the lanthanide ion by introducing it into an organic matrix, which 
acts efficiently as a light harvester. This energy is transferred from the matrix, the 
‘antenna’, to the metal ion which then emits from the excited LnIII state.32 This results 
in large pseudo-Stokes’ shifts, where the excitation profile is completely independent 
of the LnIII ion, making these compounds ideal candidates for biological imaging as 
the emission can be easily differentiated from autofluorescent biological systems. 
Intersystem crossing from the excited singlet (S1) state results in an excited triplet (T1) 
state, which is facilitated by spin-orbit coupling before energy transfer processes, such 
as Dexter- or Forster-type transfer, result in population of the excited state 4f orbitals, 
which relax to the ground state, resulting in emission (Figure 3.8).  




Figure 3.8 Schematic representation of the energy pathways within organically and inorganically 
sensitised lanthanide(III) complexes. Sn = excited singlet state, ILCT = intra-ligand charge transfer, T1 
= excited triplet state, LMCT = ligand-to-metal charge transfer, S = singlet energy transfer, ISC = 
intersystem crossing, IL = intra-ligand energy transfer, LM = ligand-metal energy transfer, 4f * = 
excited 4f electronic state. Back transfer processes are omitted for clarity.33 
Metal complexes, including those incorporating PtII, can also be utilised as antennae 
and often result in more efficient transfer, as emission from metal complexes is often 
longer-lived and lower energy than emission from organic species due to the spin-
orbit coupling-facilitated intersystem crossing to the triplet state (Figure 3.8). This 
lower energy emission is especially important when trying to sensitise LnIII ions, such 
as Nd, Yb and Er, which emit in the near-IR region at ca. 885, 980 and 1540 nm, 
respectively. Suitable sensitisers should emit around 750, 820 and 1200 nm for the 
three LnIII ions in order to facilitate efficient energy transfer, which is too low in 
energy even for the excited T1 state of most organic chromophores.  
Complexes incorporating ReI, RuII, IrIII, PtII, amongst others, are all reported to be 
capable of sensitising LnIII emission. A d-f-d complex (Re2-Ln) (Figure 3.9) 
incorporating two [Re(diimine)(CO)3Cl] units linked to a Ln-DTPA (DTPA = 
diethylenetriaminepentacetic acid) core was found to sensitise Nd, Yb and Er. A 
reduction in the emission of the 3MLCT state is in line with other reports that the 
sensitisation invokes quenching in the d-centred emissive state.34 Similar 
photophysical properties were found in (Ru-Ln),35 (Ir-Ln) and (Pt-Ln) (Figure 3.9),36, 
37 where the d-centred excited triplet state undergoes energy transfer to LnIII, resulting 
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Figure 3.9 Structures of dimetallic complexes incorporating transition metals and a LnIII ions. 
3.1.7. Bimodal contrast agents 
Given the need for LnIII ions to be sensitised in order to display emissive properties, it 
seems logical that these compounds could posses bimodal imaging properties, 
especially if compounds with poly-acid functionalisation are involved as these are, for 
the most part, water soluble, which is often one of the major problems with many 
luminescent transition metal complexes. Jones et al. developed a water soluble IrIII-
GdIII complex (Figure 3.9), whose structure shows promise as a contrast agent given 
the increased size by the introduction of a cyclometallated IrIII core and the rigid 
nature of the diimine linker.36 Despite this, relaxivity measurements were not carried 
out however, from an imaging perspective, the complex showed broad emission ca. 
600 nm, making it possible to utilise the complex for cellular imaging.  
Other research has focused on utilising an organic sensitiser with a metal binding site 
to detect metal ions, whilst incorporating a GdIII ion to invoke greater relaxivity of 
water molecules in order to create more dynamic MR images. Jang et al. developed a 
complex (Figure 3.10), which shows enhanced MRI relaxivity and a diminished 
optical signal in the presence of CuII ions.38 A cyclodextrin-based bimodal fluorescent 
contrast agent (Figure 3.10) has also been developed that shows excellent promise 
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Cell imaging of mesenchymal stem cells also showed that the compound localised in 
intracellular spaces for long periods of time.39 
 
Figure 3.10 Three functionalised MRI contrast agents exhibiting bimodal properties. 
As well as bimodal imaging with fluorescence and MRI contrast agents, there are also 
examples of bimodal medical imaging compounds that incorporate MRI with positron 
emission tomography (PET) imaging. Gros et al. linked a DO3A-Gd complex with a 
porphyrin moiety incorporating a ‘hot’ 64Cu atom, a positron-emitting tracer for PET 
scans.40 Incorporating the imaging agents for both techniques into one molecule 
would allow for successive scans using just one drug, which could reduce waiting 
















































































= CuII binding site
MRI / PET  
MRI / CuII sensing  
MRI / fluorescence microscopy  




Chapter 3 outlines the development of tuning the solubility of 2-phenylquinoline 
ligands in order to obtain PtII complexes that might show solubility in aqueous media 
and possess suitable amphoteric nature to be granted access inside cells by the 
lipophilic membranes. The synthesis of a series of alkyl-functionalised ligands is 
discussed as well as the problems associated coordinating the highly lipophilic ligands 
under aqueous conditions.  
The development of more hydrophilic ligands is also discussed, along with the 
coordination to PtII to form a versatile [Pt(L)(DMSO)Cl] with sufficient hydrophilic 
nature to perform subsequent chemistry in aqueous media for various applications. To 
exploit the chemistry, a pendant pyridine-appended DO3A analogue was synthesised 
in order to bind an encapsulated LnIII ion to [Pt(L)(DMSO)Cl] to give [Pt(L)(L′-
Gd)Cl] so that the Pt-based emissive state might act as an antenna to generated an 
electronically excited LnIII ion. 
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3.3. Results and Discussion 
3.3.1. Development and synthesis of 2-phenylquinoline ligand functionalisation 
Given the facile coordination of functionalised 2-phenylquinolines to PtII, described in 
Chapter 2, and the interest towards the coordination of [Pt(ppy)(DMSO)Cl] to 
amyloid-β peptide, the ligand functionalisation was focussed on developing suitable 
characteristics for biological application, including solubility. 
Initially, investigations were based on increasing the amphoteric nature due to 
increased diffusion of more greasy compounds across cell membranes. To this end, 2-
phenyl-4-quinolinecarboxylic acyl chloride was reacted with a series of n-alkyl 
amines, with C8, C12 and C16 chains, to give LH5, LH6 and LH7 (Figure 3.11), 
respectively. They were all prepared following the methodology outlined in Chapter 2 
for the related amide-functionalised ligands. LH5 is known and had previously been 
coordinated to IrIII by Routledge et al. LH6 and LH7 are unreported and, as such, 
were fully characterised.  
 
Figure 3.11 Structures of ligands LH5 to LH9. 
The need for high water solubility is also crucial if the interaction of the PtII 
complexes with peptides and DNA is to be investigated. For this reason, a 
polyethyleneglycol (PEG) derived reagent was used to functionalise the ligand to 
increase the water solubility. It is known that esters are not particularly stable to 
excessively high or low pHs, or to high temperatures so 2-(2-aminoethoxy)ethanol 
was used to form the corresponding amide upon reaction with the acyl chloride to 
give LH8 (Figure 3.11), which was synthesised in the same way as the other amides 
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complexes of L8, which were thought to be due to the primary alcohol and its 
intermolecular interaction with the PtII. To combat this, diethylene glycol 
monomethyl ether was used to synthesise the corresponding ester; despite esters’ 
relatively low stability, the ester was thought to be to stable enough to tolerate the 
conditions it would be exposed to. The ester, LH9 (Figure 3.11), was synthesised 
following the same technique used for the synthesis of the amides but, instead, using 
an excess of the alcohol, which could be extracted into the aqueous phase during the 
workup.  
3.3.2. Synthesis and characterisation of platinum (II) complexes 
The complexes were all synthesised in the same manner as those in Chapter 2. The 
solubility of the ligands started to pose issues in the synthesis of the µ-dichloro-
bridged dimers for LH6 and LH7 due to the added hydrophobicity of the longer alkyl 
chains in the aqueous reaction mixture. In order to combat this, extra 2-ethoxyethanol 
could be added to try to encourage greater solubility of the ligands. Despite this, the 
yields were lower for the dimer of L7 than for those of L5 and L6. Unreacted ligand 
was removed by washing the crude product with dichloromethane. The subsequent 
reactions to form [Pt(L)(DMSO)Cl] complexes of L5 – L7 were successful and the 
compounds were obtained in high spectroscopic purity. The insolubility in aqueous 
media rendered the compounds unsuitable for investigations with peptides or DNA so 
the subsequent reactions with 2,4-pentanediketonate and 8-hydroxyquinoline were 
carried out based on the methods used in Chapter 2.  
There were complications with the complexes of L8, as mentioned, presumed to be 
from the intermolecular interactions between the hydroxyl group and PtII metal centre 
in the presence of the labile DMSO ligand. Despite attempts to synthesise 
[Pt(L8)(acac)] from the dimer, avoiding the DMSO precursor, the compound was still 
unobtainable so efforts were focussed on the altered PEG-type ligand, L9. This 
compound was purified through removal of an unknown brown impurity by 
precipitating it from dichloromethane with diethyl ether. The product was then 
triturated with diethyl ether to give the pure [Pt(L9)(DMSO)Cl] as an orange solid.  
Unfortunately, despite the more hydrophilic PEG-type functionalisation, 
[Pt(L9)(DMSO)Cl] was not soluble in water and only soluble in H2O/DMSO (9:1) at 
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low concentrations (50 µM) for short periods of time. Due to the synthetic route used 
to obtain the complexes, excessively hydrophilic compounds would be unable to be 
isolated due to the need to precipitate them from solution using aqueous media. 
Despite this, micromolar concentrations are still useful for analysis by NMR and UV 
spectroscopies and luminescence so this compound was targeted as being the most 
likely to show promise in subsequent studies with bioactive compounds. The β-
diketonate complex, [Pt(L9)(acac)] was also formed so that the photophysical 
characteristics of these classes of compounds could be assessed and compared to 
related compounds synthesised in Chapter 2.  
195Pt NMR spetra of the complexes revealed very similar results to those observed in 
Chapter 2. Altering the alkyl chain length had very little effect on the electronic 
distribution at the PtII centre. The [Pt(L)(acac)] complexes all showed a shift of 
around -2775 ppm. 
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3.3.3. X-ray crystal structures 
The bond lengths around the Pt centre for [Pt(L5)(acac)] were found to be 1.952(6) 
and 2.041(5) Å for the Pt-C and Pt-N bonds, respectively, and 2.006(4) and 2.089(4) 
Å for the Pt-O bond lengths (where the shorter bond is trans to the coordinated N 
atom). These are very similar to the [Pt(L1)(acac)] complex and the [Pt(ppy)(acac)] 
complex recorded by Bossi et. al. in 2013.41 These findings further support those in 
Chapter 2 that alterations within the ligand have very minor implications on the bond 
length, especially when comparing the two acac complexes of L1 and L5, where the 
differences in ligand are very subtle and removed from the immediate coordination 
sphere. The formation of dyads through Pt-Pt interactions is also evident with a 
distance between two Pt atoms of around 3.3 Å, almost identical to that found in the 
analogous complex of L1 (and therefore also below the sum of van der Waal’s radii). 
As seen with other complexes, there is a head-to-tail packing arrangement within the 
crystal.  
The X-ray crystal structure of [Pt(L9)(DMSO)Cl] has a similarly distorted 
arrangement as was found for [Pt(L1)(DMSO)Cl]. The bond lengths of 2.003(3), 
2.078(2), 2.4135(7) and 2.2141(8) Å, corresponding to the Pt-C, Pt-N, Pt-Cl and Pt-S 
bonds, are all very similar to the comparable complex of L1. As with the analogous 
structure, there is a large out of plane twist by both the chloride and the naphthyl 
moiety; this results in more than a 45° angle between the plane of the quinoline 
(specifically the carbon atoms in the 5- to 8-positions on the quinoline ring) and the 
plane of the Pt-Cl bond. This, again, appears to be as a result of the close proximity of 
the proton’s proximity to the chloride. No Pt-Pt contacts are observed, however π-π 
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3.3.4. X-ray crystal structure of [Pt(L5)(acac)]  
 
Figure 3.12 Ball and stick X-ray crystal structure of [Pt(L5)(acac)] (top), the Pt-Pt interaction (middle) 
and the unit cell packing (bottom). 
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3.3.5. X-ray crystal structure of [Pt(L9)(DMSO)Cl]  
Figure 3.13 Ball and stick X-ray crystal structure of [Pt(L9)(DMSO)Cl] (top) and the unit cell packing 
(bottom). 
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3.3.7. Photophysical properties of complexes 
Compound λabs / nm λem / nm τ / ns 
[Pt(L5)(DMSO)Cl] 272, 281, 341, 368, 422  609 24 
[Pt(L5)(acac)] 300, 349, 368, 417 618 380 
[Pt(L5)(8-Q)] 263, 370, 505 606 211 
[Pt(L6)(DMSO)Cl]  281, 363, 430 615 54 
[Pt(L6)(acac)] 284, 345, 368, 415 617 406 
[Pt(L6)(8-Q)] 265, 269, 368, 502 606 238 
[Pt(L7)(DMSO)Cl] 365, 284, 265, 426 592 28 
[Pt(L7)(acac)] 259, 286, 295, 344, 361, 414 617 439 
[Pt(L7)(8-Q)] 283, 346, 362, 429, 496 593 227 
[Pt(L9)(DMSO)Cl] 253, 291, 362, 424 625 116 
 [Pt(L9)(acac)] 253, 300, 365, 431 639 316 
a excited at 372 nm. b excited at 459 nm. 
Table 3.2 Photophysical properties, in chloroform solutions, of the complexes synthesised in Chapter 3. 
The data show similar characteristics to the complexes in Chapter 2; they all exhibit 
1MLCT absorption at ca. 420 nm (although some are not defined enough to assign an 
absorption maxima), emission from the 3MLCT state occurs ca. 590 – 640 nm and the 
lifetimes of the [Pt(L)(DMSO)Cl] and [Pt(L1)(8-Q)] complexes are notably shorter 
than the corresponding [Pt(L)(acac)] complexes. Of interest is the red-shifted 1MLCT 
absorption for the 8-Q complexes, which was not observed to such an extent in the 
complex for L1. There do not appear to be any trends in the photophysical properties 
as the chain length is extended from C8 to C12 and C16, except for the apparent 
increase in lifetimes of 380, 406 and 439, respectively. This could be due to the 
longer chain’s increased ability to reduce the quenching by dissolved oxygen through 
some means.  
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3.3.8. Development of a bimodal contrast agent incorporating platinum (II)  
3.3.8.1. Macrocyclic ligand synthesis and incorporation of lanthanide (III) ions 
The facile coordination reported by Esmaeilbeig et al. for appending N-heterocycles 
to [Pt(L)(DMSO)Cl] complexes and the work by Koullourou et al. in the development 
of a DO3A-type macrocycle with a pendant pyridine outlined a simple method for 
forming a dimetallic complex with bimodal imaging properties.42, 43 Despite this, 
there is only one report of dimetallic PtII–LnIII complexes being developed for their 
paramagnetic relaxation properties and, within the patent, there is no information 
about the relaxivity measurements, including r1 values.44 A handful of papers 
facilitate LnIII emission through using a Pt antenna but have not investigated their 
utility as a contrast agent for MRI.37, 45-49   
 
Figure 3.14 Synthetic route for a pyridine functionalised DO3A as used by Koullourou et al.43 
To this end, attempts were made to resynthesise (Figure 3.14) the ligand outlined by 
Koullourou et al., which had been coordinated to ReI as the axial ligand. Strangely, 
despite various attempts, the reaction of 2- ,3- and 4-chloromethylpyridine, with the 
triester, were unsuccessful and yielded a dark red solution, which was thought to be 
due to intermolecular reaction of chloride moiety with the pyridine-N to form the 
cationic pyridonium salt. After numerous failed attempts, a new route was utilised 
based on the methods of Crich and Andre et al. who utilised an ethylene diimine 
linker to give biologically relevant functionalisation.50, 51 The N-terminus was 
alkylated with ethyl bromoacetate to give the ethyl protected ester (Figure 3.15). This 
was then deprotected in situ with ethylene diamine to give the corresponding 
ethylamine amide. Subsequent reaction with 4-pyridinecarboxaldehyde using a 
reductive amination and deprotection of the t-butyl esters with trifluoroacetic acid 
(TFA) yielded the target compound (L10) in high purity and good yield. The 
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with the literature. P3 and L10 were fully characterised by 1H and 13C NMR 
spectroscopies as well as MS.  
 
Figure 3.15 Synthetic route to L10 based on work by Crich and Andre et al.50, 51 
L10 was then reacted with Gd(OTf)3 and Yb(OTf)3 in methanol at 50 °C overnight, 
cooled and precipitated with diethyl ether to give the [Gd(L10)] and [Yb(L10)] 
complexes as white powders, which were characterised by UV-vis and IR 
spectroscopy as well as by HR-MS.  
3.3.8.2. Synthesis and characterisation of platinum (II) / lanthanide (III) dyads 
The two complexes, [Ln(L10)] and [Pt(L9)(DMSO)Cl] were dissolved in a minimum 
volume of acetone and reacted at 40 °C for 48 h to ensure complete coordination. 
Diethyl ether was used to precipitate the complexes from acetonitrile, which were 
filtered and washed with dichloromethane to remove any unreacted PtII complex. 
Comparison of [Pt(L9)(DMSO)Cl] and [Pt(L9){Ln(L10)}Cl] revealed a shift in the 
absorption maxima at 253 and 291 nm to 247 and 286 nm, respectively. This slight 
blue-shift, along with the reduced extinction coefficient of the 1MLCT absorption, the 
MS data, IR spectra and the water solubility confirm the successful synthesis of the 






































































Figure 3.16 Structure (top left) and MALDI-TOF MS spectrum (top right) of [Pt(L9){(L10)Gd}] and 
the UV-vis spectra of (L10), [Gd(L10)], [Yb(L10)], [Pt(L9)(DMSO)Cl], [Pt(L9){Gd(L10)}Cl] and 
[Pt(L9){Gd(L10)}Cl] (bottom). 
The steady state luminescence of [Pt(L9){Yb(L10)}Cl] displayed dual emission upon 
excitation at 360 nm comprised of  3MLCT character at ca. 630 nm and YbIII radiative 
decay in the near-IR region around 1000 nm, corresponding to (2F5/2 →  2F7/2) 
transitions sensitised by emission from the PtII component. 
Figure 3.17 Excitation and emission profiles for [Pt(L9){Yb(L10)}Cl] where excitation is in black, 
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The lifetime measurements of the two dimetallic complexes were recorded in order to 
ascertain values for the Pt →  Yb energy-transfer rates, kET, using equation (19), and 
the inner sphere hydration, q, using equation (20). kET was calculated by obtaining the 
lifetime of the donor component (3MLCT) emission in the quenched system (where 
Ln is YbIII) and an ‘unquenched’ analogue (where Ln is GdIII). The value for kET was 
calculated to be 3 x 106 s-1, which is similar to the rate of 2 x 106 s-1 reported by 
Ronson et al. for a PtII–YbIII complex.46 The rate for the energy transfer is relatively 
low due to the weak overlap of the tail of the emission profile of the 3MLCT 
component and the absorption spectrum of the YbIII acceptor, which has one f-f 
absorption at around 980 nm.  
Table 3.3 Photophysical data for the PtII / LnIII complexes. 
q can be calculated by comparing the lifetime of the YbIII emission in H2O and D2O 
due to the inefficient vibronic quenching of the excited state by deuterium oxide 
compared to water (D2O is more than 200 times less effective than H2O).52, 53 The 
data from the lifetime measurements gave a value for q of 0.8, which is consistent for 
an octadentate YbIII complex, suggesting that the amide carbonyl participates in the 
coordination to the LnIII, which has also been observed in other lanthanide complexes 











Compound λem / nm τ / ns λem / nm τ (H2O) / µs τ (D2O) / µs q 
[Pt(L9){Gd(L10)Cl] 617 59 - - - - 
[Pt(L9){Yb(L10)Cl] 619 50 ca. 1000 0.90 5.46 0.8 
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3.3.8.3. Relaxivity studies of compounds containing gadolinium (III) 
1H nuclear magnetic relaxation dispersion (NMRD) plots were obtained for 
[Pt(L9){Gd(L10)}Cl] and [Gd(L10)]. The plots (Figure 3.18) illustrate the 
relationship between the field strength (1 x 10-2 – 3 x 101 MHz) and r1, the relaxation 
rate of water per mM of complex per second.  
 
Figure 3.18 Fitted 1H NMRD plots of [Gd(L10)] and [Pt(L9){Gd(L10)}Cl]. 
The relaxivity of [Gd(L10)] was 3.8 mM-1 s-1 (30 MHz, 37 °C), which is in 
accordance with literature values for [Gd(DOTA)(H2O)]-1, a commonly used contrast 
agent (marketed as Dotarem), where r1 was recorded as 3.8 mM-1 s-1 (20 MHz, 37 
°C).28 Interestingly, the r1 value for [Pt(L9){Gd(L10)}Cl] was 7.1 mM-1 s-1 (30 MHz, 
37 °C), which shows that, upon formation of the dimetallic species, the r1 almost 
doubles; (values for r1 had an error of < 2% and results were reproducible within 5% 
error). This could be due to the increase in the molecular size and weight resulting in 
a reduced tumbling rate, τR, which would lead to an elongated r1. The plots also 
demonstrate the temperature dependence of r1 in the case of both compounds, with 
relaxivities at 25 °C approximately 10 – 25% greater at the lower temperature across 

























Three n-alkyl functionalised phenylquinoline ligands were synthesised with C8, C12 
and C16 chain lengths. The solubility in the solvent system used for coordination was 
poor for the longer chain ligands so the ratio of 2-ethoxyethanol was increased from 
3:1 to 4:1 however, the yield of the C16 dimer was noticeably lower than the 
complexes of the C8 and C12 chains due to the insoluble nature of the long chain in 
aqueous media. In order to increase the hydrophilic nature of the ligand, a PEG-like 
moiety was introduced however, due to the interaction of the primary alcohol with the 
PtII centre, complexes using this ligand were unobtainable. A methyl ether 
functionalised moiety was introduced in order to combat the proposed problem with 
the primary alcohol, which led to the successful coordination but the complexes were 
still found to be poorly soluble in aqueous media. The ligands and complexes were all 
fully characterised and X-ray crystal structures of [Pt(L5)(acac)] and 
[Pt(L9)(DMSO)Cl] were obtained.  
[Pt(L9)(DMSO)Cl] was reacted with a pendant pyridine-functionalised DO3A ligand 
(L10) containing GdIII and YbIII to form two dimetallic complexes, 
[Pt(L9){Gd(L10)}Cl] and [Pt(L9){Yb(L10)}Cl], which were characterised by UV-
vis and IR spectroscopy and MS. The 1H NMRD data for both GdIII complexes were 
obtained to give r1 values of 3.8 and 7.1 mM-1 s-1 (30 MHz, 37 °C) for [Gd(L10)] and 
the GdIII / PtII dyad, respectively. 
  




3.5.1. General physical measurements 
All physical measurements were carried out as outlined in Chapter 2.  
Relaxivity measurements were recorded on a Stelar Spinmaster FFC-2000 
relaxometer, typically covering magnetic fields from 2.3 x10-4 to 7.1 x10-1 T 
(corresponding to a proton Larmor frequency range 1 x10-2 – 3 x101 MHz). A 
Spinmaster Variable Temperature Controller allowed the setting and monitoring of 
the sample temperature to 25 and 37 °C with a resolution of 0.1 °C. For field strengths 
less than 10 MHz, a pre-polarising field sequence was used with the sample polarised 
at 30 MHz before being allowed to relax at the field of interest.  
3.5.2. Precursor synthesis 
Synthesis of P1: Prepared from literature methodology.50 K2CO3 (0.788 g, 5.710 
mmol) was added to a solution of the HBr salt of tris-1,4,7-tert-
butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane (0.500 g, 0.841 mmol) in 
acetonitrile (7 mL) and the mixture was stirred for 1 h at room temperature under 
dinitrogen. The suspension was cooled in an ice bath and ethyl bromoacetate (0.157 g, 
0.940 mmol) in acetonitrile (3 mL) was added dropwise over 1 h. The reaction was 
stirred overnight at room temperature before the suspended salts were removed by 
filtration and the solvent evaporated under reduced pressure. Yield = 0.424 g, (84%).  
1H NMR (400 MHz, CDCl3): δH 4.26 – 4.11 (2H, br. m), 3.62 – 1.95 (18H, br. m), 
1.77 – 1.67 (2H, br. m), 1.46, 1.45 (27H, s), 1.28 (3H, t, 3JHH = 7.2 Hz) ppm. 
Synthesis of P2: Prepared from literature methodology.51 P1 (0.410 g, 0.683 mmol) 
was dissolved in ethylenediamine (3 mL, exess) and stirred under dinitrogen for 72 h. 
The solvent was removed in vacuo. Yield = 0.378 g, (90%). 1H NMR (400 MHz, 
CDCl3): δH 8.74 (1H, br. m), 3.65 – 1.68 (30H, br. m), 1.45 – 1.42 (27H, m) ppm.  
Synthesis of P3: 4-pyridinecarboxaldehyde (0.083 g, 0.779 mmol) was added to a 
stirring solution of P2 (0.476 g, 0.779 mmol) in 1,2-dichloroethane (8 mL) and was 
stirred under dintrogen. After 16 h, Na(OAc)3BH (0.500 g, excess) was added and the 
reaction was left stirring for 16 h. NaHCO3 (sat. soln, 10 mL) was added and the 
product was extracted with dichloromethane (20 mL). The organic phase was washed 
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with water (2 x 20 mL) and brine (20 mL) before being dried over MgSO4, filtered 
and dried in vacuo. Yield = 0.505 g, (92%). 1H NMR (400 MHz, CDCl3): δH 8.99 
(1H, m), 8.47 (2H, d, 3JHH = 6.0 Hz), 7.46 (2H, d, 3JHH = 6.0 Hz), 4.80 – 4.69 (2H, br. 
m), 3.97 – 3.86 (2H, br. m), 3.67 – 1.87 (27H, br. m), 1.39, 1.36 (27H, s) ppm. 
13C{1H} NMR (125.8 MHz, CDCl3): δC 171.3, 171.1, 148.7, 145.6, 123.1, 81.0, 81.0, 
55.1, 54.8, 54.7, 50.3, 46.8, 37.1, 27.2, 27.0, 27.0 ppm. MS(ES) found m/z = 728.45 
for [M + Na]+. 
3.5.3. Ligand synthesis 
Synthesis of LH5: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.465 g, 1.869 mmol) and 1-octylamine (0.219 g, 1.699 mmol). Yield = 0.434 g, 
(71%). 1H NMR (400 MHz, CDCl3): δH 7.98 (1H, d, 3JHH = 8.4 Hz), 7.94 - 7.91 (2H, 
m), 7.84 (1H, d, 3JHH = 8.0 Hz), 7.60 – 7.56 (1H, m), 7.51 (1H, s), 7.42 - 7.40 (3H, 
m), 7.33 – 7.29 (1H, m), 6.93 (1H, br. t, 3JHH = 4.4 Hz), 3.35 - 3.30 (2H, m), 1.59 – 
1.52 (2H, m), 1.34 – 1.19 (10H, m), 0.90 (3H, t, 3JHH = 6.4 Hz) ppm. 
Synthesis of LH6: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.370 g, 1.486 mmol) and 1-dodecylamine (0.250 g, 1.351 mmol). Yield = 
0.416 g, (74%). 1H NMR (400 MHz, CDCl3): δH 8.13 (1H, d, 3JHH = 8.0 Hz), 8.09 – 
8.06 (3H, m), 7.77 (1H, s), 7.73 – 7.69 (1H, m), 7.52 – 7.46 (4H, m), 6.37 (1H, br. t, 
3JHH = 4.4 Hz), 3.54 – 3.49 (2H, m), 1.71 – 1.63 (2H, m), 1.42 – 1.22 (18H, m), 0.88 
(3H, t, 3JHH = 6.4 Hz) ppm.  
Synthesis of LH7: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.454 g, 1.826 mmol) and 1-hexadecylamine (0.400 g, 1.660 mmol). Yield = 
0.572 g, (73%). 1H NMR (400 MHz, CDCl3): δH 8.12 – 8.04 (4H, m), 7.75 (1H, s), 
7.72 – 7.68 (1H, m), 7.51 – 7.45 (4H, m), 6.50 (1H, br. t, 3JHH = 4.4 Hz), 3.52 – 3.46 
(2H, m), 1.69 – 1.61 (2H, m), 1.41 – 1.19 (24H, m), 0.87 (3H, t, 3JHH = 6.8 Hz) ppm. 
13C{1H} NMR (75.6 MHz, CDCl3): δC 167.6, 156.6, 148.5, 143.3, 138.7, 130.1, 
129.9, 129.8, 128.9, 127.6, 127.5, 127.2, 125.1, 123.4, 116.3, 53.5, 40.3, 32.0, 29.8, 
29.7, 29.5, 29.1, 27.1, 22.8, 14.2 ppm.  MS(ES) found m/z = 473.34 for [M + H]+. 
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UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 257 (76000), 324 (28500) nm. IR (thin 
film): νmax 3306, 1633, 1531 cm-1. 
Synthesis of LH8: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.521 g, 2.095 mmol) and 2-(2-aminoethoxy)ethanol (0.200 g, 1.905 mmol). 
Yield = 0.416 g, (65%). 1H NMR (400 MHz, CDCl3): δH 8.10 (1H, d, 3JHH = 8.8 Hz), 
8.06 – 8.03 (3H, m), 7.76 (1H, s), 7.69 – 7.66 (1H, m), 7.50 – 7.43 (4H, m), 7.14 (1H, 
br. t, 3JHH = 4.4 Hz), 3.71 – 3.64 (6H, m), 3.56 – 3.54 (2H, m), 2.77 (1H, br. s) ppm. 
13C{1H} NMR (75.6 MHz, CDCl3): δC 167.7, 156.6, 148.2, 143.0, 138.4, 130.9, 
130.3, 129.9, 129.6, 128.9, 127.5, 127.3, 125.1, 123.4, 72.4, 69.6, 61.7, 39.9 ppm. 
MS(ES) found m/z = 359.14 for [M + H]+. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 
261 (30500), 329 (69900) nm. IR (thin film): νmax 3404, 3273, 1643, 1546 cm-1.  
Synthesis of LH9: Following a modified procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid chloride (0.200 g, 0.748 mmol) and diethylene glycol monomethyl ether (0.135 
g, 1.121 mmol). Yield = 0.252 g, (96%). 1H NMR (400 MHz, CDCl3): δH 8.75 (1H, 
dd, 3JHH = 8.4 Hz, 4JHH = 1.2 Hz), 8.42 (1H, s), 8.24 – 8.19 (3H, m), 7.80 – 7.75 (1H, 
m), 7.65 – 7.61 (1H, m), 7.57 – 7.48 (3H, m), 4.66 (2H, m), 3.93 (2H, m), 3.74 (2H, 
m), 3.60 (2H, m), 3.39 (3H, s) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 166.5, 
156.8, 149.3, 138.8, 135.9, 130.3, 129.9, 129.7, 128.9, 128.8, 127.8, 127.6, 127.5, 
125.5, 124.0, 120.4, 72.0, 70.7, 69.1, 64.8, 59.1 ppm. HR-MS: calcd. for 
[C24H40N7O7]+ 538.2984, found 538.2974 and cald. for [C24H39N7O7]+ 560.2803, 
found 560.2792. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 265 (29900), 339 (7680) 
nm. IR (thin film): νmax 3061, 2876, 1723, 1591, 1549, 1495, 1447, 1343, 1246, 1231, 
1194, 1107, 1020, 770, 692 cm-1. 
Synthesis of L10: Trifluoroacetic acid (3 mL, excess) was added to a stirring solution 
of P3 (0.505 g, 0.717 mmol) in dichloromethane (3 mL). The reaction was stirred for 
48 h before the solvent was removed in vacuo. The residue was dissolved in a 
minimal acetonitrile and added, dropwise, to a vigorously stirred vessel of cold 
diethyl ether (20 mL). The resultant precipitate was filtered under dinitrogen to yield 
a white solid. Yield = 0.350 g, (91%). 1H NMR (500 MHz, D2O): δH 8.87 (2H, d, 3JHH 
= 7.0 Hz), 8.21 (2H, br. m), 4.70 (2H, s), 3.97 – 2.88 (28H, br. m) ppm. 13C{1H} 
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NMR (125.8 MHz, D2O): δC 162.2, 161.9, 150.8, 141.1, 126.7, 116.7, 114.4, 54.2, 
48.4, 47.3, 34.6 ppm. HR-MS: calcd. for [C35H37N2O]+ 501.2900, found 501.2889 
3.5.4. Synthesis of platinum (II) complexes 
Synthesis of [Pt(L5)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.057 g, 
0.137 mmol) and LH5 (0.050 g, 0.139 mmol). The precipitate was washed with 
dichloromethane to remove any unreacted ligand. Yield = 0.070 g, (87%). 
Synthesis of [Pt(L6)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.050 g, 
0.120 mmol) and LH6 (0.050 g, 0.120 mmol). The solvent ratio was adjusted to 4:1 
by using 8 mL of 2-ethoxyethanol. The precipitate was washed with dichloromethane 
to remove any unreacted ligand. Yield = 0.068 g, (87%). 
Synthesis of [Pt(L7)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.097 g, 
0.233 mmol) and LH7 (0100 g, 0.212 mmol). The solvent ratio was adjusted to 4:1 by 
using 8 mL of 2-ethoxyethanol.  The precipitate was washed with dichloromethane to 
remove any unreacted ligand. Yield = 0.095 g, (64%). 
Synthesis of [Pt(L9)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.100 g, 
0.241 mmol) and LH9 (0.064 g, 0.182 mmol). Yield = 0.062 g, (59%). 
Synthesis of [Pt(L5)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L5)Cl]2 (0.070 g, 0.059 mmol). 
Yield = 0.044 g (55 %). 1H NMR (400 MHz, CDCl3): δH 8.95 (1H, d, 3JHH = 8.8 Hz), 
8.29 – 8.27 (1H, m (with satellites)), 7.94 (1H, d, 3JHH = 8.0 Hz), 7.75 (1H, s), 7.71 – 
7.47 (1H, m), 7.58 – 7.56 (1H, m), 7.51 – 7.47 (1H, d), 7.21 – 7.19 (2H, m), 6.51 (1H, 
br. t, 3JHH = 5.6 Hz), 3.60 (6H, s (with satellites), 3.55 – 3.50 (2H, m), 1.72-1.65 (2H, 
m), 1.43 – 1.25 (10H, m), 0.89 (3H, t, 3JHH = 7.2 Hz) ppm. 13C{1H} NMR (75.6 MHz, 
CDCl3): δC 166.7, 166.2, 147.1, 146.7, 145.6, 142.8, 133.7, 130.8, 130.0, 128.6, 
127.9, 126.1, 125.5, 124.8, 124.5, 114.3, 46.2, 41.0, 40.4, 31.9, 29.6, 29.3, 27.1, 22.7, 
14.2 ppm. 195Pt NMR (107.51 MHz, CDCl3): δPt -2672 ppm.  MS(ES) found m/z = 
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306.18 for [M + Cl – DMSO + MeOH + MeOH]-. UV-vis (CHCl3): λmax (ε / dm
3 mol-
1 cm-1) 272 (1844), 281 (1698), 368 (419), nm. IR (thin film): νmax 3281, 1647 cm-1.   
Synthesis of [Pt(L6)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L6)(Cl)]2 (0.068 g, 0.026 mmol). 
Yield = 0.035 g, (93%). 1H NMR (400 MHz, CDCl3): δH 8.92 (1H, d, 3JHH = 8.8 Hz), 
8.28 – 8.25 (1H, m), 7.91 (1H, d, 3JHH = 8.0 Hz), 7.70 (1H, s), 7.68 – 7.64 (1H, m), 
7.55 – 7.53 (1H, m), 7.47 – 7.43 (1H, m), 7.19 – 7.17 (2H, m), 6.66 (1H, br. t, 3JHH = 
5.6 Hz), 3.59 (6H, s (with satellites)), 3.52 – 3.47 (2H, m), 1.71 – 1.64 (2H, m), 1.43 – 
1.22 (18H, m), 0.87 (3H, t, 6.8 Hz) ppm. 13C{1H} NMR (75.6 MHz, CDCl3): δC 
207.1, 166.6, 166.1, 147.0, 146.6, 145.6, 142.5, 129.9, 128.5, 127.8, 126.1, 125.4, 
124.8, 114.2, 53.5, 46.2, 41.0, 40.3, 31.0, 29.7, 29.6, 29.6, 29.4, 29.3, 14.2 ppm. 
MS(ES) found m/z = 683.3 for [M – DMSO – Cl + MeCN + MeOH]+. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 281 (2000), 363 (548) nm. IR (thin film): νmax 
3283, 1645, 1543 cm-1. 
Synthesis of [Pt(L7)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L7)Cl]2 (0.095 g, 0.068 mmol). 
Yield = 0.071 g, (67%). 1H NMR (400 MHz, CDCl3): δH 8.91 (1H, d, 3JHH = 8.8 Hz), 
8.27 – 8.25 (1H, m ), 7.91 (1H, d, 3JHH = 8.4 Hz), 7.71 (1H, s),  7.68 – 7.64 (1H, m),  
7.55 – 7.53 (1H, m), 7.47 – 7.43 (1H, m), 7.19 – 7.17 (2H, m), 6.90 (1H, br. t, 3JHH = 
6.0 Hz), 3.58 (6H, s (with satellites)), 3.51 – 3.46 (2H, m), 1.70 – 1.63 (2H, m), 1.42 – 
1.18 (26H, m), 0.86 (3H, t, 3JHH = 6.8 Hz) ppm. MS(ES) found m/z = 739.4 for [M – 
DMSO – Cl + MeCN + MeOH]-. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 265 
(1013), 284 (964), 365 (446) nm. IR (thin film): νmax 3283, 1639, 1543 cm-1.  
Synthesis of [Pt(L9)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L9)Cl]2 (0.062 g, 0.053 mmol). The 
dark brown compound was purified by dissolving in a minimum volume of 
dichloromethane and precipitating dark brown impurities by slow addition of diethyl 
ether. The filtrate was then dried and triturated with diethyl ether until the sticky oil 
formed a bright orange precipitate. Yield = 0.049 g, (70%). 1H NMR (400 MHz, 
CDCl3): δH 9.06 (1H, d, 3JHH = 8.8 Hz), 8.58 (1H, dd, 3JHH = 8.8 Hz, 4JHH = 1.2 Hz), 
8.37 – 8.34 (1H, m), 8.32 (1H, s), 7.78 – 7.73 (1H, m), 7.71 – 7.69 (1H, m), 7.65 – 
7.61 (1H, m), 7.29 – 7.26 (2H, m), 4.70 – 4.67 (2H, m), 3.95 – 3.92 (2H, m), 3.76 – 
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3.74 (2H, m), 3.67 (6H, s (with satellites 3JHPt = 21.2 Hz)), 3.62 – 3.60 (2H, m), 3.41 
(3H, s) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 166.5, 165.2, 147.6, 145.6, 
143.0, 139.7, 133.8, 130.8, 129.7, 128.5, 128.3, 126.0, 125.4, 125.2, 124.9, 117.7, 
72.0, 70.7, 68.9, 65.3, 59.1, 46.2 ppm. 195Pt (107.5 MHz, CDCl3): δPt -3665 ppm. 
MS(ES) found m/z = 586.08 for [M – SO(CH3)2 – Cl + CH3CN]+ and 627.10 for [M – 
SO(CH3)2 – Cl + 2CH3CN]+. HR-MS: calcd. for [C25H26N3O4194Pt]+ 626.1550, found 
626.1567. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 253, (12500), 291 (8790), 362 
(4130), 424 (1410) nm. IR (thin film): νmax 2876, 1728, 1597, 1580, 1545, 1454, 
1379, 1294, 1275, 1250, 1198, 1138, 1022, 766, 731 cm-1. 
Synthesis of [Pt(L5)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L5)(DMSO)Cl] 
(0.044 g, 0.066 mmol) and sodium acetylaceonate monohydrate (0.080 g, 0.660 
mmol). Obtained as a dark yellow solid. Yield = 0.038 g, (89%). 1H NMR (400 MHz, 
CDCl3): δH 9.43 (1H, d, 3JHH = 8.8 Hz), 8.00 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 1.2 Hz), 
7.70 – 7.64 (2H, m), 7.57 (1H, s), 7.51 – 7.47 (1H, m), 7.33 (1H, dd, 3JHH = 8.0 Hz, 
4JHH = 1.2 Hz), 7.17 – 7.13 (1H, m), 7.02 – 6.98 (1H, m), 6.66 (1H, br. t, 3JHH = 6.0 
Hz), 5.57 (1H, s), 3.55 – 3.50 (2H, m), 2.04 (3H, s), 2.03 (3H, s), 1.75 – 1.67 (2H, m), 
1.45 – 1.28 (10H, m), 0.91 (3H, t, 3JHH = 6.8 Hz) ppm. 13C{1H} NMR (75.6 MHz, 
CDCl3): δC 185.7, 184.0, 169.3, 166.8, 149.4, 145.7, 144.7, 139.8, 131.0, 129.7, 
129.6, 127.1, 126.5, 125.2, 125.1, 124.5, 124.0, 114.2, 101.9, 40.3, 31.9, 29.8, 29.4, 
28.5, 27.3, 27.2, 22.8, 14.2 ppm. 195Pt NMR (107.51 MHz, CDCl3): -2776 ppm.  
MS(ES) found m/z = 652.2 for [M - H]-. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 
300 (9920), 349 (2810), 368 (3126), 423 (2420) nm. IR (thin film): νmax 3268, 1738, 
1643, 1582 cm-1.    
Synthesis of [Pt(L6)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L6)(DMSO)Cl] 
(0.035 g, 0.048 mmol) and sodium acetylacetonate monohydrate (0.059 g, 0.484 
mmol). Obtained as a dark yellow solid. Yield = 0.031 g, (90%). 1H NMR (500 MHz, 
CDCl3): δH 9.48 (1H, d, 3JHH = 9.0 Hz), 8.03 (1H, d, 3JHH = 8.0 Hz), 7.72 – 7.67 (2H, 
m), 7.63 (1H, s), 7.53 – 7.50 (1H, m), 7.40 – 7.38 (1H, d, 3JHH = 7.5 Hz), 7.19 – 7.16 
(1H, m), 7.05 – 7.02 (1H, m), 6.48 (1H, br. t, 3JHH = 6.0 Hz), 5.57 (1H, s), 3.56 – 3.52 
(2H, m), 2.04 (3H, s), 2.03 (3H, s), 1.73 – 1.67 (2H, m), 1.35 – 1.22 (18H, m), 0.83 – 
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0.89 (3H, t, 3JHH = 7.5 Hz) ppm. 13C{1H} NMR (75.6 MHz, CDCl3): δC 185.7, 184.1, 
169.5, 166.8, 149.5, 145.7, 144.7, 139.9, 131.1, 129.8, 129.6, 127.2, 126.6, 125.2, 
125.1, 124.5, 124.0, 114.2, 101.9, 40.4, 32.0, 29.7, 29.4, 28.5, 27.3, 27.2, 22.8, 14.2 
ppm. 195Pt NMR (107.51 MHz, CDCl3): -2779 ppm. MS(ES) found m/z = 708.46 for 
[M – H]-. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 284 (418), 368 (291) nm. IR (thin 
film): νmax 3306, 1668, 1523 cm-1.    
Synthesis of [Pt(L7)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L7)(DMSO)Cl] 
(0.071 g, 0.091 mmol) and sodium acetylacetonate monohydrate (0.111 g, 0.911 
mmol). Yield = 0.034 g, (49%). 1H NMR (400 MHz, CDCl3): δH 9.53 (1H, d, 3JHH = 
8.8 Hz), 8.07 (1H, d, 3JHH = 8.4 Hz), 7.77 – 7.70 (3H, m), 7.57 – 7.53 (1H, m), 7.47 
(1H, dd, 3JHH = 7.2 Hz, 4JHH = 1.2 Hz), 7.24 – 7.20 (1H, m), 7.12 – 7.08 (1H, m), 6.29 
(1H, br. t, 3JHH = 5.6 Hz), 5.58 (1H, s), 3.59 – 3.54 (2H, m), 2.05 (3H, s), 2.04 (3H, s), 
1.74 – 1.67 (2H, m), 1.46 – 1.24 (26H, m), 0.88 (3H, t, 3JHH = 7.2 Hz) ppm. MS(ES) 
found m/z = 764.4 for [M - H]-. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 263 (795), 
293 (758), 348 (241), 357 (272), 421 (156) nm. IR (thin film): νmax 3300, 1669, 1548 
cm-1.    
Synthesis of [Pt(L9)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L9)(DMSO)Cl] 
(0.049 g, 0.075 mmol) and sodium acetylacetonate monohydrate (0.091 g, 0.748 
mmol). Obtained as a dark yellow solid. Yield = 0.042 g, (88%). 1H NMR (400 MHz, 
CDCl3): δH 9.58 (1H, d, 3JHH = 9.2 Hz), 8.68 (1H, dd, 3JHH = 8.4 Hz, 4JHH = 1.6 Hz), 
8.27 (1H, s), 7.81 – 7.75 (2H, m), 7.65 – 7.59 (2H, m), 7.28 – 7.25 (1H, m), 7.20 – 
7.16 (1H, m), 5.58 (1H, s), 4.67 – 4.65 (2H, m), 3.95 – 3.92 (2H, m), 3.76 – 3.74 (2H, 
m), 3.62 – 3.60 (2H, m), 3.40 (3H, s), 2.06 (3H, s), 2.04 (3H, s) ppm. 13C{1H} NMR 
(125.8 MHz, CDCl3): δC 185.7, 184.2, 169.5, 165.7, 149.9, 145.7, 140.3, 137.3, 130.8, 
130.0, 129.7, 127.6, 126.8, 125.4, 125.2, 125.0, 124.0, 118.2, 101.8, 72.0, 70.7, 68.9, 
65.1, 59.1, 28.4, 27.2 ppm. 195Pt NMR (107.51 MHz, CDCl3): δPt -2770 ppm. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 252 (42800), 301 (36300), 366 (11500), 431 (9980) 
nm. IR (thin film): νmax 2905, 1721, 1578, 1522, 1383, 1240, 1267, 1194, 1136, 1024, 
760 cm-1.    
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Synthesis of [Gd(L10)]: Gadolinium(III) triflate (0.112 g, 0.186 mmol) and L10 
(0.100 g, 0.186 mmol) were dissolved in methanol (10 mL) and heated to 50 °C for 
24 h under dinitrogen. The solution was cooled and diethyl ether (20 mL) was added. 
The precipitate was filtered under dinitrogen to yield an off-white solid. Yield = 0.112 
g,  (87%). HR-MS: calcd. for [C24H37152GdN7O7]+ 687.1947 found 687.1941. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 201 (7240), 256 (1840) nm. IR (thin film): νmax 
3397, 1582, 1402, 1244, 1225, 1165, 1082, 1026, 635 cm-1.    
Synthesis of [Yb(L10)]: Ytterbium(III) triflate (0.115 g, 0.186 mmol) and L10 (0.100 
g, 0.186 mmol) were dissolved in methanol (10 mL) and heated to 50 °C for 24 h 
under dinitrogen. The solution was cooled and diethyl ether (20 mL) was added. The 
precipitate was filtered under dinitrogen to yield an off-white solid. Yield = 0.121 g,  
(92%). HR-MS: calcd. for [C24H37N7O7170Yb]+ 705.2102 found 705.2110. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 201 (7800), 256 (1430) nm. IR (thin film): νmax 
3408, 1601, 1410, 1258, 1167, 1084, 1026, 800, 640 cm-1.    
Synthesis of [Pt(L9){Gd(L10)}Cl]: [Pt(L9)(DMSO)Cl] (0.052 g, 0.079 mmol) and 
GdL10 (0.050 g, 0.072 mmol) were dissolved in acetone and heated to 40 °C for 48 h 
under dinitrogen. The solvent was removed in vacuo and the solid dissolved in 
minimal acetonitrile and precipitated with diethyl ether. The solid was filtered and 
washed with dichloromethane to yield a bright orange solid. Yield = 0.062 g, (68%). 
HR-MS: calcd. for [C45H56N8O11155Gd194Pt]+ 1233.2922 found 1233.2953. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 203 (25000), 246 (13300), 285 (9320), 364 (4450) 
nm. IR (thin film): νmax 3433, 1732, 1591, 1456, 1404, 1246, 1167, 1084, 1028, 941, 
903, 841, 762, 723, 637 cm-1.    
Synthesis of [Pt(L9){Yb(L10)}Cl]: [Pt(L9)(DMSO)Cl] (0.051 g, 0.078 mmol) and 
YbL10 (0.050 g, 0.071 mmol) were dissolved in acetone and heated to 40 °C for 48 h 
under dinitrogen. The solvent was removed in vacuo and the solid dissolved in 
minimal acetonitrile and precipitated with diethyl ether. The solid was filtered and 
washed with dichloromethane to yield a bright orange solid. Yield = 0.072 g, (79%). 
HR-MS: calcd. for [C45H56N8O11171Yb194Pt]+ 1249.3059 found 1249.3076. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 203 (26300), 248 (14100), 284 (9920), 364 (4640) 
nm. IR (thin film): νmax 3408, 1730, 1595, 1458, 1400, 1389, 1248, 1165, 1084, 1028, 
943, 909, 843, 762, 727, 638 cm-1.    
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Synthesis of [Pt(L5)(8-Q)]: Following the general procedure outlined in Chapter 2 
for coordinating 8-hydroxyquinoline to platinum complexes using [Pt(L5)(DMSO)Cl] 
(0.033 g, 0.049 mmol), Na2CO3 (0.010 g, 0.099 mmol) and 8-hydroxyquinoline 
(0.008 g, 0.054 mmol). The red solution was dried in vacuo and diethyl ether (5 mL) 
was added to remove excess 8-hydroxyquinoline. The precipitate was filtered, washed 
with diethyl ether (2 x 10 mL) and methanol (1 x 5 mL). The solid was dissolved in 
dichloromethane and dried in vacuo to afford a red solid. Yield = 0.026 g, (76%). 1H 
NMR (400 MHz, CDCl3): δH 9.64 (1H, d, 3JHH = 8.4 Hz), 8.95 (1H, m (with 
satellites)), 8.32 (1H, d, 3JHH = 8.4 Hz), 7.90 (1H, d, 3JHH = 8.0 Hz), 7.75 – 7.71 (1H, 
m), 7.57 – 7.52 (2H, m), 7.43 – 7.38 (2H, m), 7.30 – 7.25 (2H, m), 7.18 – 7.12 (2H, 
m), 7.07 – 7.04 (1H, m), 6.97 (H, d, 3JHH = 7.6 Hz), 6.88 – 6.85 (1H, m), 3.58 – 3.48 
(2H, m), 1.81 – 1.72 (2H, m), 1.49 – 1.25 (10H, m), 0.92 (3H, t, 3JHH = 6.8 Hz) ppm. 
MS(ES) found m/z = 753.25 for [M + MeOH + Na]+. UV-vis (CHCl3): λmax (ε / dm
3 
mol-1 cm-1) 280 (1023), 370 (253), 505 (75) nm. IR (thin film): νmax 3257, 1645, 1539 
cm-1.   
Synthesis of [Pt(L6)(8-Q)]: Following the general procedure outlined in Chapter 2 
for coordinating 8-hydroxyquinoline to platinum complexes using [Pt(L6)(DMSO)Cl] 
(0.052 g, 0.072 mmol), Na2CO3 (0.038 g, 0.360 mmol) and 8-hydroxyquinoline 
(0.021 g, 0.145 mmol). The red solution was dried in vacuo and diethyl ether (5 mL) 
was added to remove excess 8-hydroxyquinoline. The precipitate was filtered, washed 
with diethyl ether (2 x 10 mL) and methanol (1 x 5 mL). The solid was dissolved in 
dichloromethane and dried in vacuo. Yield = 0.033 g, (61%). 1H NMR (400 MHz, 
CDCl3): δH 9.61 (1H, d, 3JHH = 8.4 Hz), 8.94 – 8.88 (1H, m (with satellites)), 8.31 
(1H, d, 3JHH = 8.0 Hz), 7.86 (1H, d, 3JHH = 8.0 Hz), 7.71 – 7.67 (1H, m), 7.56 – 7.50 
(3H, m), 7.39 – 7.35 (2H, m), 7.27 – 7.24 (1H, m) 7.14 – 6.97 (4H, m), 6.82 – 6.79 
(1H, m), 3.57 - 3.49 (2H, m), 1.81 – 1.75 (2H, m), 1.48 – 1.25 (18H, m), 0.89 (3H, t, 
3JHH = 6.8 Hz) ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 265 (864), 368 (264), 
506 (75) nm. IR (thin film): νmax 3289, 1646, 1539 cm-1.    
Synthesis of [Pt(L7)(8-Q)]: Following the general procedure outlined in Chapter 2 
for coordinating 8-hydroxyquinoline to platinum complexes using [Pt(L7)(DMSO)Cl] 
(0.029 g, 0.037 mmol), Na2CO3 (0.020 g, 0.186 mmol) and 8-hydroxyquinoline 
(0.011 g, 0.074 mmol). The red solution was dried in vacuo and diethyl ether (5 mL) 
was added to remove excess 8-hydroxyquinoline. The precipitate was filtered, washed 
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with diethyl ether (2 x 10 mL) and methanol (1 x 5 mL). The solid was dissolved in 
dichloromethane and dried in vacuo to obtain a red solid. Yield = 0.021 g, (68%). 1H 
NMR (400 MHz, CDCl3): δH 9.64 (1H, d, 3JHH = 8.8 Hz), 8.93 (1H, d (with satellites), 
3JHH = 3.2 Hz), 8.31 (1H, d, 3JHH = 8.0 Hz), 7.88 (1H, d, 3JHH = 8.0 Hz), 7.74 – 7.70 
(1H, m), 7.56 – 7.52 (2H, m), 7.41 – 7.36 (3H, m), 7.29 – 7.24 (1H, m) 7.14 – 7.13 
(2H, m), 7.06 – 7.03 (1H, m), 6.97 (1H, d, 3JHH = 7.6 Hz), 6.85 – 6.82 (1H, m), 3.56 - 
3.45 (2H, m), 1.80 – 1.71 (2H, m), 1.45 – 1.19 (26H, m), 0.88 (3H, t, 3JHH = 7.2 Hz) 
ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 504 (119), 438 (108), 369 (259), 352 
(275) nm. IR (thin film): νmax 3292, 1670, 1597 cm-1. 
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Chapter 4: Examining the photophysical properties of 
chromophore appended platinum (II) complexes 
  




Chapter 4 discusses the development of ligands incorporating pendant chromophores 
in order to assess the impact of the chromophores on the 3MLCT-derived emission. 
Given previous examples in the literature, as outlined below, the chromophore of 
greatest interest in this investigation is pyrene and, in order to discuss the results, it is 
important to have an appreciation of the physical and photophysical properties of 
pyrene and its prior utility in transition metal complexes. 
4.1.1. Photophysical properties of pyrene monomers 
Due to the planar aromatic nature of pyrene, it readily interacts with other pyrene 
moieties through π–stacking. It is, however, important to have an appreciation of the 
monomeric properties before discussing the properties of excimers.  
 
Figure 4.1 Absorption spectrum of pyrene in cyclohexane with transitional assignments (left)1 and 
structure of pyrene (right). 
Monomeric pyrene shows four bands in the absorption spectrum (Figure 4.1) between 
200 and 400 nm, which can be assigned to (S4 ← S0), (S3 ← S0), (S2 ← S0) and (S1 ← 
S0) transitions.1 Vibrations from ν′′ = 0 to ν′ = 1, 2, 3, 4, … results in the vibronic 
structure observed within each Sn ← S0 excitation. The emission also exhibits this 
characteristic structure due to the mirror-image rule and Franck-Condon factors and 
emits predominantly in the region ca. 370 nm.2 The fluorescence from pyrene (pyr) 
compounds can possess extraordinarily long fluorescence lifetimes due to the 
symmetry of the molecule. This can often be in the hundreds of ns range, which is of 
the same magnitude as many coordination complexes’ phosphorescent lifetime.1 As 
well as desirable fluorescent properties, pyrene can also undergo intersystem crossing 
Chapter 4: Examining the photophysical properties of chromophore appended platinum (II) complexes 
 
126 
from the S1 to the T1 state. The emission of the triplet can be observed at ca. 600 nm 
at low temperature (77 K) in frozen solvent mixtures.3  
4.1.2. Photophysical properties of pyrene excimers 
Excimers, or excited state dimers, of pyrene readily form through the favourable 
interaction between the two planar aromatic ‘sheets’ leading to the formation of 
charge transfer complexes. The interaction results in π-stacking that perturbs both the 
emission wavelength and lifetime without affecting the absorption profile.4 The 
reduced energy of the excimers’ emission leads to a shift in λmax from ca. 380 nm for 
the monomer to nearly 500 nm. The excimer emission does not exhibit the vibronic 
structure of its parental monomer. The formation of excimers usually results in faster 
relaxation of the excited state, resulting in shortened lifetimes compared to that of the 
monomeric compound. This is the case with pyrene, as lifetimes for excimer species 
are reported ca. 90 ns.5 Despite the reduction in lifetime, this is still much longer than 
the emissive decay of most organic chromophores, rendering it extremely useful as a 
biological tool.  
 
Figure 4.2 Pyrene excimer emission (λem = 492 nm).6 
4.1.3. Pyrene in biological imaging 
Pyrene-based systems have been well studied for many years due to their important 
photophysical properties. The long-lived fluorescence lifetimes and capacity to 
readily form excimers in solution and solid state have resulted in a plethora of 
applications. They have seen use in determining the concentration of dissolved 
oxygen in biological studies,7, 8 as biological labelling applications,9, 10 as probes for 
the intracellular delivery of molecules and as labels on nucleotide bases to study DNA 
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charge transfer, non-covalent interactions between nucleotides and the detection of 
defects.11-16  
 
Figure 4.3 Pyrene-labelled mRNA bases leading to the formation of pyrene excimers.17  
Excimers have also been utilised in biological imaging due to their long lifetimes and 
the ability to differentiate between excimer and monomer emission through time-
gated fluorescence mapping and time-resolved emission spectra.17 Marti et al.’s 
technique allows for the detection of specific mRNA in vivo so that the onset of 
molecular interactions by stimuli can be studied.18 
4.1.4. Development of long lifetime complexes using pyrene 
Pyrene has long been incorporated into metal complexes for various applications. The 
majority of these complexes centre on RuII due to the good energetic matching of the 
two emissive triplet states (ca. 600 nm). This has led to a wide range of investigations 
into extending the lifetime of the 3MLCT emissive state for applications in 
photodynamic therapy (PDT), where extended lifetimes of the emission tend to lend 
themselves to greater quantum yields of singlet oxygen.  




Figure 4.4 RuII complexes incorporating pyrene functionalisation. 
Lincoln et al. recently developed a RuII trisimine complex ([Ru(bpy)2(5-EPP)]2+)  
with an ethynyl pyrene unit appended and investigated the change in photophysical 
properties when the pyrene unit was moved to different positions on the coordinated 
1,10-phenanthroline moiety. They found that, at room temperature, emissive lifetimes 
could be tuned between 22 and 220 µs depending upon the position of attachment of 
the chromophore.19 Similar RuII pyrene dyads ([Ru(bpy)2(ippy)]2+) have also 
displayed long-lived lifetimes and have consequently shown promise as 
photosensitizers. Stephenson et al. quote lifetimes in excess of 80 µs, 100 times 
longer than lifetimes of polypyridyl RuII complexes lacking pyrene association.20 
These examples have all shown relatively short distances between the RuII and pyrene 
moieties. Morales et al. investigated whether the extended lifetimes could be observed 
across larger distances and probed whether the antenna effects (Figure 4.5) are 
affected by the nature of the connectors.21 They found that, even with a separation 
distance of up to 21 Å, excitation of the 1pyr state results only in emission from the 
3MLCT state in their trisimine complex ([Ru(bpy)2(bpy-O6-pyr)]2+), which was put 
down to a Förster-type step where energy is transferred through non-radiative dipole-
dipole coupling.22 The long lifetimes were found to be a result of energy equilibration 
































Figure 4.5 Energy pathways associated with pyrene acting as an antenna.23 
Pyrene has also been incorporated in IrIII and ReI complexes. Ragone et al. found that 
the ReI pyrene dyad showed promise as a photosensitizer for singlet oxygen. The ReI 
complex does not display equilibration of states as was seen in the RuUU complexes 
due to the raised energy of the 3MLCT. It does, however, display 3LC emission from 
intersystem crossing of the pyrene excited state. The T1 state was found to be 
extremely efficient at generating singlet oxygen with quantum yields close to unity.24 
The IrIII complex displays electronic energy transfer between the metal-centred and 
pyrene excited states, much like [Ru(bpy)2(pyr-phen)], resulting in lifetimes 
exceeding 200 µs, compared to a lifetime of < 10 µs for the analogous compound 
without pyrene.25 This is, as with the RuII complexes, due to the energy overlap of the 
two T1 energy states and demonstrates that the equilibration of the 3pyr and 3MLCT 
states is not limited to RuII-based complexes. 
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4.1.5. Pyrene in platinum (II) complexes 
Hissler et al. developed pyr-ethynylene-Ru and pyr-Pt-Ru (Figure 4.7) complexes to 
study the equilibration of the RuII and pyr triplet excited states. The platinum centre 
was utilised to compare the efficiency of electronic conductivity from the pyrene to 
the RuII compared to a simple ethynylene linker. They found that, in the presence of 
the PtII, the emissive lifetime was nearly three times shorter than was observed for the 
monometallic species, which has a lifetime of more than 40 µs.26 They subsequently 
investigated the monometallic pyr-Pt-bpy complex (Pt-pyr-3) (Figure 4.7) and found 
that there was no interplay between the 3pyr and 3MLCT states.27 
 
Figure 4.7 Examples of pyrene incorporated into PtII complexes for photophysical 
investigations. 
Observations of various other platinum complexes incorporating pyrene all suggest 
that low energy emission (ca. 600 nm) is a result of phosphorescence associated with 
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literature of PtII-based 3MLCT equilibration with the 3pyr excited state, unlike those 
found for IrIII and RuII. Despite this, the PtII pyrene dyads have shown promise for 
applications in organic light emitting diodes (OLEDs) (Pt-pyr-2) and as 
photosensitizers (Pt-pyr-1) due to the long-lived emission of the 3pyr state, in the 
region of 5 µs for the 3IL emission.28 Wu et al. tried to cyclometallate pyrene directly 
(Pt-pyr-4) in the hope of visualising 3pyr emission at room temperature. They found 
that this could be achieved and also presented the first observable pyrene 
phosphorescence at room temperature without direct cyclometallation (Pt-pyr-5).29 
  




Chapter 4 outlines the development of a series of PtII complexes with pendant 
chromophores attached. The ligands were based on the 2-phenylquinoline structure 
utilised in previous chapters. Naphthyl, anthracenyl and pyrenyl moieties were 
incorporated in the hope that there might be observable changes to the photophysical 
properties due to interplay between the excited states of the metal centre and 
chromophore. In depth photophysical studies, including low temperature and 
degassed measurements were utilised to reveal the relevant energies of the various 
states in order to link observable trends with the relative energy levels. 
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4.3. Results and Discussion 
4.3.1. Ligand development and synthesis 
Figure 4.8 Structure of LH11 (left) and the development of a suitably soluble ligand with an appended 
anthracene chromophore from LH12 to eventually give LH15 (right). 
To append a chromophore in close proximity to the metal centre, 1-naphthylamine 
and 2-aminoanthracene were reacted with the acid chloride of 2-phenyl-4-
quinolinecarboxylic acid using the methodology outlined in Chapter 2. LH11 (Figure 
4.8) is commercially available from small suppliers, however there is no literature 
associated with the compound and, as such, it was characterised by 1H and 13C NMR 
spectroscopies as well as mass spectrometry in order to confirm its synthesis. Whilst 
LH11 showed good levels of solubility, LH12 (Figure 4.8) was found to be insoluble 
in all common solvents except for DMSO. Attempts to synthesise the PtII dimer 
incorporating L12 were unsuccessful using the methodologies outlined in Chapter 2, 
which is most likely due to the highly insoluble nature of the ligand in the solvent 
system used for the synthesis.  
 
Figure 4.9 Structures of the precursors, P6 – P9. 
In order to accommodate the larger chromophore, the ligand structure was altered by 
replacing 2-aminoanthracene with 9-aminomethylanthracene, P6, hopefully reducing 
the insolubility, which was thought to be a result of the increased π-stacking 
interactions formed upon addition of extra planar aromatic character. This was 














P7 P8 P9 
Chapter 4: Examining the photophysical properties of chromophore appended platinum (II) complexes 
 
134 
conditions were based on previous synthesis of the target compound by Mallard et al. 
and Sun et al. 33, 34 Despite the successful synthesis of the ligand by reacting P6 with 
the acid chloride, the reaction with tetrachloroplatinate (II) was non-yielding.  
The incorporation of an alkyl chain was thought to help with solubility, which would 
hopefully overcome the difficulties in isolating a chromophore-appended ligand 
coordinated to PtII. A means of incorporating an octyl chain into the ligand system 
was developed, given the utility of the C8 chain in Chapter 3 at generating highly 
soluble complexes. 
Secondary amines were formed in a two-step synthesis from the aldehyde of the 
corresponding chromophore and octylamine. Initial attempts using a reductive 
amination process adopted for other similar reactions were unsuccessful as the imine 
proved to be too stable to be reduced by the trisacetoxyborohydride salt 
(Na(OAc)3BH),35 presumably through the stability presented by extension of the 
conjugated aromatic systems. A different method was then found which had been 
used previously for the synthesis of the alkylated anthracene precursor, P8.36 The 
immines were formed in refluxing ethanol before sodium borohydride (NaBH4) was 
used to reduce the intermediates to give P7 – P9. 
  
Figure 4.10 Structures of LH14, LH15 and LH16. 
The secondary amines were then reacted with the acid chloride, in the same manner as 
the primary amines in Chapters 2 and 3, to form ligands LH14, LH15 and LH16 
(Figure 4.10) in good yields. Although LH15 was isolated as a spectroscopically pure 
product, the compounds incorporating naphthalene and pyrene were found to contain 
more than one product. It was not until coordination to PtII and characterisation of the 
corresponding β-diketonate complexes that the cause for the impurity was discovered: 
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purification techniques, including recrystallisation, column chromatography and 
precipitation, separation of the two forms was unsuccessful. Ligands LH14 and LH16 
were used as the mixtures with the hope that they might become isolatable in a 
coordinated state.  
Analysis of the 1H NMR spectrum of LH16 (Figure 4.11) reveals that the CH2 group 
adjacent to the chromophore in both isomers is diastereotopic, suggesting that there is 
a degree of fixed rotation, which results in the coupling of one proton to the other. 
The major product appears to have a much greater inequivalence than the minor as the 
separation of the two environments is much larger. The major product displays two 
distinct doublets with a coupling constant of 2JHH = 14.4 Hz, whilst the minor isomer 
is not clearly defined enough to assign any multiplicity or coupling constants. 
 
Figure 4.11 5 – 6 ppm region of the 1H NMR spectrum of LH16 demonstrating the inequivalence of 
the protons on the methyl linker between the amide and the pyrene chromophore (left). Geometrically 
optimised structures for the two isomers of LH16 (right). 
Avogadro was used to build structures of LH16 so that the two structural isomers 
could be optimised using Universal force field (UFF).37, 38 The structures (Figure 
4.11) suggest that a degree of π-stacking between the pyrene and phenylquinoline 
moieties is probable in one arrangement, whilst the other structure displays no 
possibility of intramolecular interaction between the two aromatic units. Whilst the 
reason for the restricted movement, preventing the equilibration to one isomer, is 
unclear, the spectroscopic data all suggest this is a possibility.   
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4.3.2. Synthesis and characterisation of cyclometallated platinum (II) complexes 
 [Pt(L11)(acac)] was successfully accessed using the methodology described in 
Chapter 2 through synthesis of the dimer, [Pt(L11)(µ-Cl)]2, followed by the DMSO 
adduct, [Pt(L11)(DMSO)Cl], which was then reacted with the β-diketonate. After 
competing against the decreased solubility associated with the larger chromophores, 
complexes [Pt(L14)(acac)], [Pt(L15)(acac)] and [Pt(L16)(acac)] were all synthesised 
in the same manner.  
  
Figure 4.12 1H NMR spectrum of [Pt(L16)(acac)] highlighting evidence of the two isomers. 
The complexes incorporating L14 and L16 were still found to contain a mixture of 
two isomers. This was clear, mostly through analysis by 1H NMR spectroscopy 
(Figure 4.12), which showed the presence of two singlets at ca. 5.5 ppm for the proton 
in the 3-position of the 2,4-pentanediketonate. This was strengthened by the doubling 
up of the two singlets for the acac methyl groups, in the 1- and 5-positions, at ca. 2.0 
ppm and the two downfield doublets at ca. 9.5 ppm corresponding to the 
phenylquinoline ligand. The most telling indicator was that all three sets of peaks had 
a major and minor component, which integrated to the major and minor component of 
each of the other peaks.  
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These isomers were again inseparable using the purification techniques available 
however, despite the mixture, the compounds were obtained in high purity. Variable 
temperature (VT) NMR spectroscopy was also employed to see whether the signals 
converged at higher temperatures (up to 90°C in d8-toluene) but the only apparent 
effect this had on the spectrum was the broadening of signals.  
The 195Pt NMR spectra for the acac complexes of L14, L15 and L16 revealed a δPt at -
2784, -2786 and -2788 ppm, respectively. This is consistent with the data found in 
Chapter 2 for functionalised cyclometallated 2-phenylquinoline PtII complexes with 
an appended acetylacetonate ancillary ligand (cf. -2779 ppm for [Pt(L2)(acac)]). 
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4.3.3. X-ray crystal structures  
The X-ray crystal structure of [Pt(L15)(acac)] has inner-sphere coordination bond 
lengths of 1.962(3) and 2.0551(16) Å for the Pt-C and Pt-N bonds and 2.0031(17) and 
2.1057(18) Å for the Pt-O bonds, where the shorter length is trans to the coordinated 
N atom. As with the other acac structures, the coordinative bond lengths are 
comparable to the [Pt(ppy)(acac)] complex.39 The anthracene moiety is almost 
perpendicular to the plane of the phenylquinoline providing a very organised packing 
arrangement. This head-to-tail formation results in both π-π and Pt-Pt interactions, 
with a Pt-Pt bond length of just 3.2365(2) Å, the shortest of all the Pt-Pt distances 
reported in this thesis. This compares to a bond distance of nearly 3.7 Å for the 
[Pt(ppy)(acac)] complex, which is greater in length by more than 10%. This may be 
as a result of the bulky anthracenyl component forcing the overlap to be more aligned 
than has been observed in other structures, where the two molecules have been 
slightly offset from one another. The resultant structure is far less out of plane than 
has been observed in the other phenylquinoline complexes and is much more like the 
planar nature of the [Pt(ppy)(acac)] complex. 
In contrast, the X-ray structure of [Pt(L16)(acac)] displays a packing arrangement 
resulting in very little π-stacking interactions between phenylquinoline units and none 
between pyrene, which is unexpected given the large planar aromatic pyrene 
substituent. This is probably due to the bulky nature of the pyrenyl ligand in 
combination with the octyl chain, which can be seen lying between the pyrene units. 
Unlike the other complexes, there is also no formation of dimer substructures from 
metallophilic interactions, presumably due to the bulk of the ligand preventing such 
interactions. As with the other structures, bond lengths of 1.970(3), 2.056(3), 1.998(2) 
and 2.098(2) Å for Pt-C, Pt-N and Pt-O are all comparable to [Pt(ppy)(acac)].  
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4.3.4. X-ray crystal structure of [Pt(L15)(acac)] 
 
Figure 4.13 Ball and stick X-ray crystal structure of [Pt(L15)(acac)] (top), the Pt-Pt interaction 
(middle) and the packing arrangement (bottom). 
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4.3.5. X-ray crystal structure of [Pt(L16)(acac)] 
 
Figure 4.14 Ball and stick X-ray crystal structure of [Pt(L16)(acac)] (top) and the packing arrangement 
(bottom).  
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4.3.7. Electronic absorption spectroscopy 
The ligands appear as colourless solutions in chloroform and absorb between 250 and 
400 nm. The complexes are all pale yellow solutions, absorbing between 250 and 450 
nm in chloroform. 
Compound λmax / nm 
LH14 263, 282, 293, 312, 325, 336 
LH15 258, 333, 350, 368, 389 
LH16 259, 264, 277, 302, 314, 328, 345 
[Pt(L14)(acac)] 261, 273, 284, 294, 342, 359, 378, 406 
[Pt(L15)(acac)] 257, 298, 350, 362, 368, 389, 413 
[Pt(L16)(acac)] 256, 266, 278, 297, 314, 329, 345, 361, 408 
Table 4.2 Absorption maxima (λmax) for ligands and complexes. 
The ligands all exhibit absorption assigned to 1IL(π → π*) transitions of the 
phenylquinoline at shorter wavelengths ca. 250 – 300 nm. The naphthyl component of 
LH14 and [Pt(L14)(acac)] absorbs between around 300 and 350 nm and can be 
assigned as 1IL(π → π*). The anthracenyl absorption in LH15 and [Pt(L15)(acac)] 
occurs between 350 and 400 nm, again assigned as 1IL(π → π*) and exhibits vibronic 
structure with the lowest energy absorption at 389 nm corresponding to (S1 ← S0). 
The pyrenyl moiety absorbs between 250 and 350 nm for LH16 and [Pt(L16)(acac)], 
again expressing vibronic structure relating to excitation into different vibronic 
energy levels. The complexes all absorb relatively weakly between 400 and 480 nm, 
which corresponds to spin-allowed 1MLCT(d → π*) excitation. 
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4.3.8. Luminescence spectroscopy 
Compound λexa / nm 1IL λema / nm 1IL τb / ns 3IL λemc / nm 
LH14 273, 327 377 1.1d 483, 518, 556 
     
LH15 354, 369, 388 392, 414, 438 1.9e 487, 529 
     
LH16 251, 271, 284, 317, 334, 353 
392, 412 
754, 774, 793 
2.8 (50%), 7.2 (50%)e 602, 616, 632, 
649, 665 
     
[Pt(L14)(acac)] - 357, 391 < 1d  485, 520, 571 
     
[Pt(L15)(acac)] - 393, 414, 438 3.3e 453, 488, 529, 578 
     
[Pt(L16)(acac)] - 400 3.9 (95%), 0.3 (5%)e 601, 616, 652, 666 
a in 1:1 chloroform and ethanol. b in chloroform. c 1:1 chloroform and ethanol glass at 77 K. d excited at 295 nm. e 
excited at 372 nm. 
Table 4.3 Excitation, emission and lifetime data for the 1IL and 3IL components of the ligands and 
complexes. Excited at 350 nm unless otherwise stated. 
 
 
Compound λexa / nm 3MLCT λemb / nm 3MLCT τb / ns 3MLCT τc / µs 
[Pt(L5)(acac)] 337, 403, 466 618 380d 3.4 
     
[Pt(L14)(acac)] 281, 299, 342, 363, 413 603 543
d 6.6 
     
[Pt(L15)(acac)] 281, 319, 341, 361, 380, 428 606 356
e 2.9 
     
[Pt(L16)(acac)] 272, 288, 305, 320, 338, 365, 405 603 258
d 42 (95%), 
3.7 (5%) 
a in 1:1 chloroform and ethanol. b in chloroform. c excited at 355 nm in degassed chloroform. d excited at 459 nm. e 
excited at 295 nm. f not strongly emissive enough for reliable data to be obtained. 
Table 4.4 Excitation, emission and lifetime data for the 3MLCT component of the complexes. Excited 
at 350 nm unless otherwise stated. 
 
The excitation profiles for complexes of L14 to L16 all exhibit excitation of both the 
chromophore and the 1MLCT band. This suggests that the 3MLCT is of chromophoric 
parentage as well as the expected 1MLCT component. This indicates that, upon 
excitation to S1, all the ligands undergo a degree of energy transfer to the 1MLCT.  
  
Chapter 4: Examining the photophysical properties of chromophore appended platinum (II) complexes 
 
144 
4.3.8.1. Naphthyl system 
 
Figure 4.16 Comparison of the aerated and degassed emission in chloroform (left) and room 
temperature and low temperature emission in 1:1 chloroform and ethanol (right) of [Pt(L14)(acac)]. 
Room temperature and low temperature emission of LH14 is also included with dashed lines (right). 
 
The photophysical data for [Pt(L14)(acac)] and LH14 reveal the presence of triplet 
emission from the naphthyl moiety in both the complex and the ligand between 470 
and 630 nm at low temperature. The emissive energy from the 3nap state just overlaps 
that of the 3MLCT state. Both room and low temperature measurements show very 
weakly emissive 1nap states even in contrast to the 3MLCT in aerated chloroform. The 
lifetime of the emission in aerated chloroform is in excess of 540 ns, which is much 
longer than the lifetimes of the L5, L15 and L16 complexes, which do not exceed 380 
ns. The degassed lifetime is almost double that of [Pt(L5)(acac)], at 6.6 µs. 
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Figure 4.17 Comparison of the aerated and degassed emission in chloroform (left) and room 
temperature and low temperature emission in 1:1 chloroform and ethanol (right) of [Pt(L15)(acac)]. 
Room temperature and low temperature emission of LH15 is also included with dashed lines (right). 
 
[Pt(L15)(acac)] exhibits emission from both the anthracene and the 3MLCT in 
chloroform at room temperature. The degassed solution shows the expected increase 
in intensity of the 3MLCT emission, due to the lack of quenching by dissolved 
oxygen, but still shows emission from the anthracenyl component. Most literature 
reports anthracene phosphorescence at around 700 nm.3 Despite the literature, there is 
no visible emission beyond the emission ca. 600 nm from the 3MLCT state. In order 
to be sure that the anthracenyl triplet state was not masked by the 3MLCT, the low 
temperature measurements were run on both P8 and LH15. They both confirmed a 
lack of emission at 700 nm and suggest that the triplet state has a much higher energy, 
which was also found by Melo et al. for 9-(methylaminomethyl)anthracene.40 The 
lifetimes in aerated and degassed solvents are 356 ns and 2.9 µs, respectively, which 
are both very similar to that of [Pt(L5)(acac)]. 
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4.3.8.3. Pyrenyl system 
 
Figure 4.18 Comparison of the aerated and degassed emission in chloroform (left) and room 
temperature and low temperature emission in 1:1 chloroform and ethanol (right) of [Pt(L16)(acac)]. 
Room temperature and low temperature emission of LH16 is also included with dashed lines (right). 
Insert: Expanded section of LH16 at low temperature to show evidence of 3IL emission. 
Measurements at 77 K of [Pt(L16)(acac)] and LH16 reveal emission from 3pyr from 
590 to 680 nm, which is in accordance with literary values for the pyrene triplet state. 
The 3pyr state for the free ligand is barely visible compared to 1pyr emission, in 
contrast to the dominating 3pyr emission in the presence of the heavy platinum atom. 
The 3MLCT emission is more quenched in aerated solvent than is observed for the 
naphthyl and anthracenyl complexes. The lifetime in aerated solvent was significantly 
shorter than the other aerated lifetimes, at just 258 ns, whilst the degassed solution 
exhibits a lifetime in chloroform of 42 µs, which is over an order of magnitude longer 
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4.3.8.4. Energy pathways 
The very weakly emissive 1nap state in [Pt(L14)(acac)] suggests that there is a high 
degree of energy transfer from the 1nap to the 1MLCT state. The extended lifetime in 
aerated chloroform is most likely due to population of the 3MLCT state by partial 
energy transfer from 3nap, although much of the 3nap state is likely to be quenched by 
oxygen so the two deactivation pathways to S0 are competitive. The extended lifetime 
of the 3MLCT in degassed chloroform is likely a result of partial equilibration of the 
3nap and 3MLCT states due to limited overlying of the two T1 states, resulting in an 
energy pathway as shown in Figure 4.19.  
There is very little overlap of the 3anthr and 3MLCT states in [Pt(L15)(acac)], which 
gives rise to the shortest degassed lifetime observed for the three complexes. The 
lifetime is similar to that of [Pt(L5)(acac)] where there is no appended chromophore 
suggesting no equilibration is occurring between the triplet states and each of the two 
systems is unaffected by the other, as shown in Figure 4.20. Having said this, the 
graphs show that intersystem crossing to the 3anthr state is much more dominant in 
the complex than the free ligand, due to the spin orbit coupling facilitated by the 
presence of the heavy PtII atom. The lack of quenched anthracenyl emission further 
suggests that energy transfer from the 1anthr to the 1MLCT state is not efficient. 
There is strong spectral overlap of the 3MLCT state emission and the 3pyr state 
emission for [Pt(L16)(acac)], which suggests that interplay between the two states 
may be possible. The dramatically augmented lifetime suggests that, given the 
proximate energies of the 3pyr and 3MLCT states, interplay between the two states is 
resulting in the equilibration of the energies, which is leading to a much longer 
lifetime of 42 µs. The aerated system appears much shorter due to energy transfer into 
the 3pyr state from the 3MLCT state, which is then rapidly quenched by dissolved 
oxygen. The resultant interplay between the states can be seen in the energy diagram 
in Figure 4.21. 
 
 




Figure 4.19 Energy level diagram of the relevant excited states of [Pt(L14)(acac)] 
 
Figure 4.20 Energy level diagram of the relevant excited states of [Pt(L15)(acac)] 
 
 











































































A novel set of ligands with an appended chromophore were developed with adequate 
solubility to successfully cyclometallate to PtII. The ligands incorporating pyrene and 
naphthalene exhibited evidence for two structural isomers, which were believed to 
form one where the chromophore interacts with the phenylquinoline through π-
stacking interactions and one in which there is no intramolecular interactions of this 
type. The abundance of these isomers was found to be roughly 3:1 whilst the 
anthracenyl ligand was found to be dominated by one structural isomer with an 
abundance of > 95%.  
The β-diketonate complexes were synthesised to give [Pt(L)(acac)] systems to aid 
solubility and stability so that the photophysical properties could be measured. The 
complexes of L14 and L16 were again found to possess two isomers, which was 
confirmed through the presence of two coordinated acac species. This was visible 
both in the 1H and 13C NMR spectra and, although 195Pt NMR spectra were acquired, 
the broadness of the signals prevented observation of two 195Pt environments.  
Photophysical studies revealed that there is interplay between the chromophoric and 
metal-based excitation and emission pathways. Energy transfer from the S1 state of 
the chromophore to the 1/3MLCT excited state was observed, as well as deactivation 
from the S1 state of the chromophores as fluorescence. Low temperature (77 K) 
measurements revealed the T1 states of the naphthyl, anthracenyl and pyrenyl 
moieties, with the 3pyr and 3nap states being close in energy to 3MLCT. Aerated and 
degassed lifetime data revealed equilibration of the 3pyr and 3MLCT states, resulting 
in a lifetime of 42 µs, partial interplay between 3nap and 3MLCT and no observable 
energy transfer between 3anthr and 3MLCT.  
  




4.5.1. General physical measurements 
All physical measurements were carried out as outlined in Chapter 2.  
The µs lifetimes were collected using a Hamamatsu R5509-73 detector (cooled to −80 
°C using a C9940 housing). The pulsed laser source was a Continuum Minilite 
Nd:YAG configured for 355 nm output. All lifetime data were collected using the JY-
Horiba FluoroHub single photon counting module in multi-channel scalar mode. 
Lifetimes were obtained using the provided software, DAS6.  
4.5.2. Molecular structure calculations 
The two proposed structures were refined in Avogadro using the UFF optimisation.37, 
38 
4.5.3. Precursor synthesis 
Synthesis of P4: Based on a modified literature methodology.33 To a stirring 
suspension of anthracene methanol (0.500 g, 2.404 mmol) in chloroform (50 mL) was 
added, dropwise, thionyl chloride (0.35 mL, 4.808 mmol) and DMF (1 drop). The 
reaction was heated at reflux for 3 h under dinitrogen before being cooled and the 
solvent and volatile reagents removed in vacuo. The residue was dissolved in 
dichloromethane (20 mL) and washed with water (2 x 10 mL) and brine (1 x 10 mL) 
before being dried over MgSO4 and dried in vacuo. Yield 0.516, (95%). 1H NMR 
(400 MHz, CDCl3): δH 8.47 (1H, s), 8.31 (2H, dd, 3JHH = 8.8 Hz, 4JHH = 0.8 Hz), 8.02 
(2H, d, 3JHH = 8.4 Hz), 7.62 (2H, ddd, 3JHH = 9.2 Hz, 3JHH = 6.8 Hz, 4JHH = 1.6 Hz), 
7.51 (2H, ddd, 3JHH = 8.4 Hz, 3JHH = 6.8 Hz, 4JHH = 1.2 Hz), 5.97 (2H, s) ppm. 
Synthesis of P5: Based on a literature methodology.34 P4 (0.500 g, 2.208 mmol) and 
potassium phthalimide (0.450 g, 2.432 mmol) were dissolved in DMF (10 mL) and 
heated to 100 °C for 48 h under dinitrogen. The solution was cooled in the freezer, 
yielding a light yellow precipitate, which was filtered and washed with cold DMF (2 
mL) and water (2 x 20 mL). The resulting precipitation in the filtrate was collected 
separately and treated in the same manner. The second crop was combined with the 
first if it was found to be spectroscopically pure. Yield = 0.618 g, (83%). 1H NMR 
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(400 MHz, CDCl3): δH 8.66 (2H, dd, 3JHH = 8.8 Hz, 4JHH = 0.8 Hz), 8.49 (1H, s), 8.02 
(2H, dd, 3JHH = 8.4 Hz, 4JHH = 0.4 Hz), 7.78 – 7.74 (2H, m), 7.77 – 7.63 (2H, m), 7.60 
(2H, ddd, 3JHH = 6.8 Hz, 3JHH = 9.2 Hz, 4JHH = 1.6 Hz), 7.48 (2H, ddd, 3JHH = 6.4 Hz, 
3JHH = 8.4 Hz, 4JHH = 0.8 Hz), 5.87 (2H, s) ppm. 
Synthesis of P6: Based on a literature methodology.34 P5 (0.230 g, 0.682 mmol) was 
dissolved in ethanol (17 mL) to which, hydrazine monohydrate (0.17 mL, 3.410 
mmol) was added dropwise. The solution was heated at reflux for 24 h under 
dinitrogen before being cooled to give a white precipitate. The solid was filtered and 
water (10 mL) was added to the filtrate. The ethanol was removed in vacuo leaving an 
aqueous solution to which dichloromethane (2 x 20 mL) and sodium hydroxide (2 M 
soln, 10 mL) were added. The organic layer was collected and acidified with 
hydrochloric acid (1 M soln, 2 x 10 mL). The aqueous layer was collected and 
neutralised with sodium hydroxide (2 M soln). The product was extracted into 
dichloromethane (2 x 20 mL), which was washed with brine (10 mL) and dried over 
MgSO4. The solvent was removed in vacuo. Yield = 0.136 g, (96%). 1H NMR (400 
MHz, CDCl3): δH 8.31 (1H, s), 8.25 (2H, d, 3JHH = 8.8 Hz), 7.94 (2H, d, 3JHH = 8.0 
Hz), 7.48 – 7.45 (2H, m), 7.41 – 7.38 (2H, m), 4.74 (2H, s), 1.60 (2H, br. s) ppm. 
General procedure for reductive alkylations: Based on a modified literature 
methodology.36 The aldehyde (1 eq) and octylamine (1 eq) were dissolved in ethanol 
(20 mL) and heated at reflux for 16 h under dinitrogen. The reaction was cooled and 
NaBH4 (excess) was added in portions. The reaction was stirred for a further 16 h 
before being diluted with dichloromethane (20 mL) and washed with water (2 x 20 
mL) and brine (20 mL). The organic phase was dried over MgSO4 before the solvent 
was removed in vacuo.  
Synthesis of P7: Following the general procedure for reductive alkylations using 1-
naphthaldehyde (0.254 g, 1.628 mmol), 1-octylamine (0.210 g, 1.628 mmol) and 
NaBH4 (0.124 g, 3.256 mmol). Obtained as a light yellow oil. Yield = 0.358 g, (82%). 
1H NMR (400 MHz, CDCl3): δH 8.04 (1H, d, 3JHH = 8.0 Hz), 7.85 (1H, dd, 3JHH = 8.0 
Hz, 4JHH = 1.6 Hz), 7.77 (1H, dd, 3JHH = 7.6 Hz, 4JHH = 1.6 Hz), 7.54 – 7.39 (4H, m), 
4.21 (2H, s), 2.70 (2H, t, 3JHH = 7.2 Hz), 1.56 – 1.49 (2H, m), 1.33 – 1.19 (10H, m), 
0.86 (3H, t, 3JHH = 7.2 Hz) ppm. 
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Synthesis of P8: Following the general procedure for reductive alkylations using 9-
anthraldehyde (0.163 g, 0.789 mmol), 1-octylamine (0.102 g, 0.789 mmol) and 
NaBH4 (0.060 g, 1.577 mmol. The product was purified by column chromatography 
(silica, dichloromethane) and was eluted with dichloromethane/methanol (9:1). Yield 
= 0.242 g, (96%). 1H NMR (400 MHz, CDCl3): δH 8.41 (1H, s), 8.34 (2H, dd, 3JHH = 
8.8 Hz, 4JHH = 0.8 Hz), 8.01 (2H, d, 3JHH = 8.4 Hz), 7.54 (2H, ddd, 3JHH = 8.8 Hz, 
3JHH = 6.4 Hz), 4JHH = 1.2 Hz), 7.47 (2H, m), 4.73 (2H, s), 2.87 (2H, t, 3JHH = 7.2 Hz), 
1.62 – 1.55 (2H, m), 1.35 – 1.23 (10H, m), 0.88 (3H, t, 3JHH = 1.6 Hz) ppm. 
Synthesis of P9: Following the general procedure for reductive alkylations using 1-
pyrenecarboxaldehyde (0.169 g, 0.733 mmol), 1-octylamine (0.095 g, 0.733 mmol) 
and NaBH4 (0.056 g, 1.466 mmol). The product was purified by column 
chromatography (silica, dichloromethane) and was eluted with 
dichloromethane/methanol (9:1). Yield = 0.246 g, (98%). 1H NMR (400 MHz, 
CDCl3): δH 8.35 (1H, d, 3JHH = 9.2 Hz), 8.20 – 8.16 (2H, m), 8.15 – 8.12 (2H, m), 
8.04 – 7.98 (4H, m), 4.49 (2H, s), 2.79 (2H, t, 3JHH = 7.2 Hz), 1.62 – 1.54 (2H, m), 
1.35 – 1.22 (10H, m), 0.88 (3H, t, 3JHH = 6.8 Hz) ppm. 13C{1H} NMR (125.8 MHz, 
CDCl3): δC 131.3, 130.9, 130.8, 129.2, 127.9, 127.5, 127.4, 127.4, 127.3, 125.9, 
125.2, 125.1, 124.7, 122.9, 50.9, 49.3, 31.8, 29.4, 29.3, 29.2, 27.3, 22.6, 14.1 ppm. 
MS(ES) found m/z = 344.2 for [M + H]+. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 
266 (23400), 277 (39600), 300 (4720), 314 (11400), 327 (26700), 344 (39000) nm. IR 
(thin film): νmax 3040, 2953, 2928, 2855, 2816, 1603, 1587, 1458, 1443, 1184, 1096, 
841, 802, 710 cm-1. 
4.5.4. Ligand synthesis 
Synthesis of LH11: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.479 g, 1.923 mmol) and 1-naphthylamine (0.250 g, 1.748 mmol). Obtained as 
an off-white solid. Yield = 0.588 g, (90%). 1H NMR (400 MHz, CDCl3): δH 8.24 (1H, 
d, 3JHH = 8.4 Hz), 8.20 – 8.17 (2H, m), 8.12 – 8.09 (3H, m), 8.06 (1H, s), 7.87 – 7.84 
(1H, m), 7.81 – 7.79 (1H, m), 7.75 – 7.71 (2H, m), 7.54 – 7.41 (7H, m) ppm. 13C{1H} 
NMR (125.8 MHz, CDCl3): δC 166.3, 156.9, 148.9, 142.8, 138.8, 134.2, 131.8, 130.4, 
130.3, 129.9, 129.0, 127.6, 127.5, 127.1, 126.7, 126.3, 125.8, 124.9, 123.3, 121.2, 
120.5, 116.6 ppm. 
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Synthesis of LH12: Following a modified procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarbonyl 
chloride (0.280 g, 1.047 mmol) and 2-aminoanthracene (0.200 g, 1.036 mmol) were 
heated to reflux in chloroform (20 mL) under dinitrogen for 16 h before being cooled 
and the product collected by filtration. The solid was washed with water (2 x 20 mL) 
and dried to obtain an off-white solid. Yield = 0.588 g, (90%). 1H NMR (400 MHz, 
d6-DMSO): δH 8.79 (1H, s), 8.58 – 8.55 (2H, m), 8.44 (1H, s), 8.39 (2H, d, 3JHH = 7.2 
Hz), 8.25 (1H, d, 3JHH = 8.0 Hz), 8.20 (1H, d, 3JHH = 8.8 Hz), 8.14 (1H, d, 3JHH = 9.2 
Hz), 8.10 – 8.07 (2H, m), 7.90 – 7.86 (1H, m), 7.76 (1H, d, 3JHH = 9.2 Hz), 7.72 – 
7.68 (1H, m), 7.62 – 7.48 (5H, m) ppm. 13C{1H} NMR (125.8 MHz, d6-DMSO): δC 
165.7, 155.9, 148.0, 145.8, 142.9, 138.1, 135.9, 131.8, 130.7, 130.3, 130.0, 129.7, 
128.9, 128.8, 128.1, 127.8, 127.5, 127.4, 126.0, 125.7, 125.4, 125.2, 125.1, 123.2, 
121.3, 116.9, 115.3 ppm. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 263 (90200), 333 
(15100), 370 (6760), 391 (4940) nm. IR (thin film): νmax 2916, 1724, 1688, 1641, 
1586, 1512, 1445, 1346, 1306, 1277, 1250, 1177, 750, 691 cm-1. 
Synthesis of LH13: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.114 g, 0.457 mmol) and P6 (0.086 g, 0.415 mmol). Yield = 0.162 g, (89%). 1H 
NMR (400 MHz, CDCl3): δH 8.51 (1H, s), 8.44 (2H, d, 3JHH = 9.2 Hz), 8.20 (1H, dd, 
3JHH = 8.4 Hz, 4JHH = 0.4 Hz), 8.10 – 8.05 (3H, m), 8.02 – 7.99 (2H, m), 7.80 (1H, s), 
7.71 – 7.62 (3H, m), 7.54 – 7.41 (6H, m), 6.37 (1H, br. s), 5.78 (2H, d, 3JHH = 5.2 Hz) 
ppm. 13C{1H} NMR (125.8 MHz, d6-DMSO): δC 167.4, 156.7, 148.7, 142.5, 138.7, 
131.6, 130.5, 130.1, 129.6, 129.4, 128.8, 128.6, 127.7, 127.4, 127.3, 127.0, 125.3, 
124.9, 123.6, 123.3, 116.5, 36.7 ppm. HR-MS: calcd. for [C31H23N2O]+ 439.1805, 
found 439.1803. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 257 (78500), 332 (8960), 
346 (8270), 367 (8520), 388 (7720) nm. IR (thin film): νmax 3285, 1626, 1587, 1518, 
1493, 1445, 1344, 1275, 1260, 1179, 1153, 1080, 1022, 893, 885, 799, 766, 750, 745, 
689 cm-1. 
Synthesis of LH14: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.235 g, 0.941 mmol) and P7 (0.231 g, 0.855 mmol. Column chromatography 
(silica) was used with various mobile phases to attempt separation of a mixture of 
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structural isomers however this was unsuccessful and resulted in a pure mixture of the 
product’s two isomeric forms.  Yield = 0.268 g, (89%). 1H NMR (400 MHz, CDCl3): 
δH 8.42 (1H, d, 3JHH = 8.4 Hz), 8.19 – 7.32 (33H, m), 5.72 (1H, d, 2JHH = 14.4 Hz), 
5.18 (1H, d, 2JHH = 14.4 Hz), 4.92 – 4.72 (2H, br. m), 3.38 – 3.16 (1H, br. m), 2.94 – 
2.80 (2H, m), 4.31 – 4.11 (1H, br. m), 1.92 – 1.79 (2H, br. m), 1.47 – 0.86 (25H, m), 
0.79 (3H, t, 3JHH = 6.8 Hz) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 167.7, 
155.8, 147.4, 142.7, 138.1, 130.5, 130.4, 129.2, 129.1, 128.6, 128.5, 127.9, 127.7, 
126.4, 126.4, 126.1, 125.8, 124.3, 123.7, 123.1, 122.2, 114.9, 45.7, 38.0, 30.4, 28.1, 
27.6, 27.4, 25.2, 21.4, 13.0 ppm. HR-MS: calcd. for [C35H37N2O]+ 501.2900, found 
501.2889. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 263 (46500), 282 (19400), 293 
(15600), 312 (8980), 325 (8880), 336 (7570) nm. IR (thin film): νmax 3059, 2926, 
2853, 1638, 1597, 1549, 1510, 1466, 1460, 1406, 1377, 1348, 1248, 1028, 793, 772, 
760, 741, 694, 665 cm-1. 
Synthesis of LH15: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.163 g, 0.656 mmol) and P8 (0.190 g, 0.596 mmol). Yield = 0.282 g, (86%). 1H 
NMR (400 MHz, CDCl3): δH 8.58 – 8.54 (3H, s), 8.17 – 8.08 (5H, m), 7.84 (1H, s), 
7.80 (1H, d, 3JHH = 7.2 Hz), 7.71 – 7.65 (3H, m), 7.58 – 7.46 (5H, m), 7.39 (1H, m), 
6.28 (1H, d, 2JHH = 15.2 Hz), 5.82 (1H, d, 2JHH = 15.2 Hz), 1.39 – 1.25 (2H, m), 1.08 
– 1.00 (2H, m), 0.92 – 0.73 (8H, m), 0.68 – 0.53 (3H, m) ppm. 13C{1H} NMR (125.8 
MHz, d6-DMSO): δC 167.7, 155.8, 147.4, 142.7, 138.1, 130.5, 130.4, 130.2, 129.2, 
129.1, 128.6, 128.5, 128.0, 127.9, 127.7, 126.6, 126.4, 126.4, 126.2, 126.1, 125.8, 
125.6, 124.3, 124.0, 123.7, 123.1, 122.2, 114.9, 45.7, 38.0, 30.6, 30.4, 28.1, 27.9, 
27.8, 27.6, 27.4, 26.9, 25.8, 25.2, 21.5, 21.4, 13.1, 12.9 ppm. HR-MS: calcd. for 
[C39H39N2O]+ 551.3057, found 551.3051. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 
258 (55700), 333 (7980), 350 (5680), 6960 (368), 389 (6320) nm. IR (thin film): νmax 
3057, 2955, 2924, 2855, 1628, 1593, 1549, 1495, 1462, 1447, 1431, 1406, 1373, 
1343, 1263, 1240, 1180, 1159, 1123, 1028, 889, 767, 759 cm-1. 
Synthesis of LH16: Following the general procedure outlined in Chapter 2 for the 
synthesis of 2-phenyl-4-quinolinecarboxamides using 2-phenyl-4-quinolinecarboxylic 
acid (0.235 g, 0.941 mmol) and P9 (0.231 g, 0.855 mmol). Column chromatography 
(silica) was used with various mobile phases to attempt separation of a mixture of 
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structural isomers however this was unsuccessful and resulted in a pure mixture of the 
product’s two isomeric forms.  Yield = 0.268 g, (89%). 1H NMR (400 MHz, CDCl3): 
δH 8.42 (1H, d, 3JHH = 8.4 Hz), 8.19 – 7.32 (33H, m), 5.72 (1H, d, 2JHH = 14.4 Hz), 
5.18 (1H, d, 2JHH = 14.4 Hz), 4.92 – 4.72 (2H, br. m), 3.38 – 3.16 (1H, br. m), 2.94 – 
2.80 (2H, m), 4.31 – 4.11 (1H, br. m), 1.92 – 1.79 (2H, br. m), 1.47 – 0.86 (25H, m), 
0.79 (3H, t, 3JHH = 6.8 Hz) ppm. HR-MS: calcd. for [C41H39N2O]+ 575.3057, found 
575.3046. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 259 (46000), 264 (49000), 277 
(47800), 302 (12200), 314 (18600), 328 (32800), 345 (38100) nm. IR (thin film): νmax 
3045, 2926, 2855, 1634, 1628, 1593, 1549, 1435, 1406, 1373, 1344, 1296, 1263, 
1238, 1198, 1184, 1155, 1123, 1028, 889, 847, 768, 733, 694 cm-1. 
4.5.5. Synthesis of platinum (II) complexes 
Synthesis of [Pt(L11)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.055 g, 
0.133 mmol) and LH11 (0.050 g, 0.134 mmol). Yield = 0.062 g, (77%). 
Synthesis of [Pt(L14)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.030 g, 
0.072 mmol) and LH14 (0.040 g, 0.070 mmol). Yield = 0.050 g, (86%). 
Synthesis of [Pt(L15)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.074 g, 
0.176 mmol) and LH15 (0.085 g, 0.177 mmol). Yield = 0.099 g, (72%). 
Synthesis of [Pt(L16)Cl]2: Following the general procedure outlined in Chapter 2 for 
the synthesis of platinum dimers using potassium tetrachloroplatinate (II) (0.030 g, 
0.072 mmol) and LH16 (0.040 g, 0.070 mmol). Yield = 0.050 g, (86%). 
Synthesis of [Pt(L11)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L11)Cl]2 (0.062 g, 0.051 mmol). 
Yield = 0.063 g, (91%). 
Synthesis of [Pt(L14)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L14)Cl]2 (0.047 g, 0.032 mmol). 
Yield = 0.041 g, (78%).  
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Synthesis of [Pt(L15)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L15)(Cl)]2 (0.099 g, 0.064 mmol). 
Yield = 0.095 g, (87%). 
Synthesis of [Pt(L16)(DMSO)Cl]: Following the general procedure outlined in 
Chapter 2 for splitting platinum dimers using [Pt(L16)Cl]2 (0.050 g, 0.031 mmol). 
Yield = 0.050 g, (91%). 
Synthesis of [Pt(L11)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L11)(DMSO)Cl] 
(0.063 g, 0.093 mmol) and sodium acetylacetonate monohydrate (0.113 g, 0.928 
mmol). The product was purified by column chromatography (silica, 
dichloromethane) and was eluted as the first yellow band with dichloromethane and 
dried to yield a dark yellow solid. Yield = 0.056 g, (91%). 1H NMR (400 MHz, 
CDCl3): δH 9.47 (1H, d, 3JHH = 8.8 Hz, 4JHH = 0.4 Hz), 9.07 (1H, br. s), 8.17 (1H, dd, 
3JHH = 8.4 Hz, 4JHH = 1.2 Hz), 8.05 (1H, d, 3JHH = 8.0 Hz), 7.99 (1H, d, 3JHH = 7.2 
Hz), 7.92 (1H, dd, 3JHH = 7.6 Hz, 4JHH = 1.6 Hz), 7.85 – 7.82 (2H, m), 7.74 – 7.70 
(1H, m), 7.62 – 7.53 (5H, m), 7.28 (1H, d 3JHH = 7.6 Hz), 7.15 – 7.11 (1H, m), 6.93 – 
6.89 (1H, m), 5.30 (1H, s), 1.97 (3H, s), 1.51 (3H, s) ppm. 13C{1H} NMR (151.2 
MHz, CDCl3): δC 185.6, 184.2, 169.5, 165.6, 152.8, 149.6, 145.4, 144.1, 139.4, 137.4, 
134.2, 131.2, 129.8, 128.9, 127.4, 127.0, 126.8, 126.3, 125.8, 125.2, 124.0, 122.0. 
120.9, 114.5, 101.8, 30.9, 28.4 ppm. 3239, 2922, 2853, 1674, 1655, 1597, 1580, 1543, 
1522, 1497, 1464, 1454, 1435, 1391, 1377, 1344, 1296, 1277, 1198, 1148, 1020, 795, 
762, 735 cm-1. IR (thin film): νmax 2922, 2853, 1674, 1655, 1597, 1580, 1543, 1522, 
1497, 1391, 1377, 1344, 1296, 1277, 1198, 1148, 1020, 941, 795, 762, 735 cm-1. 
Synthesis of [Pt(L14)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L14)(DMSO)Cl] 
(0.041 g, 0.051 mmol) and sodium acetylacetonate monohydrate (0.062 g, 0.508 
mmol). The product was purified by column chromatography (silica, 
dichloromethane) and was eluted as the first yellow band with dichloromethane and 
dried to yield a dark yellow solid. Subsequent columns to isolate the two isomers of 
the product were attempted with no success. The products were isolated as a mixture 
(roughly 1:2). Yield = 0.034 g, (85%). 1H NMR (400 MHz, CDCl3): δH 9.59 (1H, d, 
3JHH = 8.4 Hz), 9.56 (1H, d, 3JHH = 8.8 Hz), 8.39 (1H, d, 3JHH = 8.0 Hz), 7.97 (1H, d, 
Chapter 4: Examining the photophysical properties of chromophore appended platinum (II) complexes 
 
157 
3JHH = 7.6 Hz), 7.91 (1H, d, 3JHH = 8.0 Hz), 7.90 (1H, d, 3JHH = 8.4 Hz), 7.82 – 7.36 
(21H, m), 7.27 – 7.23 (1H, m), 7.17 – 7.11 (3H, m), 7.03 – 7.00 (1H, m), 5.71 (1H, d, 
2JHH = 14.8 Hz), 5.57 (1H, s), 5.53 (1H, s), 5.15 (1H, d, 2JHH = 14.8 Hz), 4.89 – 4.78 
(2H, br. m), 4.22 – 4.05 (1H, br. m), 3.35 – 3.20 (1H, m), 2.92 – 2.80 (2H, m), 2.05 
(3H, s), 2.03 (3H, s), 2.01 (3H, s), 2.00 (3H, s), 1.91 – 1.77 (2H, br. m), 1.50 – 0.90 
(22H, m), 0.89 (3H, t, 3JHH = 6.8 Hz), 0.80 (3H, t, 3JHH = 7.2 Hz) ppm. 13C{1H} NMR 
(151.2 MHz, CDCl3): δC 184.5, 184.4, 183.2, 183.1, 168.8, 168.6, 167.3, 166.7, 
148.5, 148.5, 144.8, 144.7, 144.6, 143.8, 139.1, 133.1, 132.8, 130.9, 130.8, 130.3, 
130.2, 130.2, 129.7, 129.0, 128.9, 128.6, 128.5, 128.2, 128.0, 128.0, 127.9, 127.9, 
127.7, 127.2, 126.5, 126.2, 126.1, 126.0, 125.9, 125.6, 125.4, 123.9, 123.8, 123.7, 
123.3, 123.1, 123.0, 123.0, 122.8, 121.0, 114.8, 112.6, 112.1, 100.8, 100.7, 49.1, 46.1, 
44.8, 43.9, 34.4, 30.8, 30.6, 28.3, 28.2, 27.9, 27.9, 27.3, 27.3, 27.0, 26.6, 26.2, 26.1, 
25.4, 21.6, 21.5, 13.1, 13.0 ppm. 195Pt (107.51 MHz, CDCl3): δPt -2784 ppm. UV-vis 
(CHCl3): λmax (ε / dm
3 mol-1 cm-1) 261 (12500), 273 (12500), 284 (13600), 294 
(12700), 342 (4140), 359 (4370), 378 (3070), 406 (2450) nm. IR (thin film): νmax 
3059, 2953, 2926, 2855, 1638, 1580, 1541, 1522, 1470, 1433, 1393, 1373, 1296, 
1277, 1202, 1159, 1030, 1022, 937, 883, 791, 779, 765, 729 cm-1. 
Synthesis of [Pt(L15)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L15)(DMSO)Cl] 
(0.095 g, 0.111 mmol) and sodium acetylacetonate monohydrate (0.135 g, 1.109 
mmol). The product was purified by column chromatography (silica, 
dichloromethane). The product was eluted as the first yellow band with 
dichloromethane and dried to yield a dark yellow solid. Yield = 0.068 g, (73%). 1H 
NMR (400 MHz, CDCl3): δH 9.58 (1H, d, 3JHH = 8.8 Hz), 8.56 – 8.54 (3H, m), 8.11 
(2H, dd, 3JHH = 8.4 Hz, 4JHH = 0.8 Hz), 7.74 – 7.65 (6H, m), 7.59 – 7.55 (2H, m), 7.49 
(1H, dd, 3JHH = 7.6 Hz, 4JHH = 0.8 Hz), 7.38 – 7.34 (1H, m), 7.26 – 7.23 (1H, m), 7.17 
– 7.14 (1H, m), 6.27 (1H, d, 2JHH = 15.2 Hz), 5.81 (1H, d, 2JHH = 15. 2 Hz), 5.56 (1H, 
s), 2.56 (2H, t, 3JHH = 8.0 Hz), 2.04 (3H, s), 2.02 (3H, s), 1.42 – 1.22 (2H, m), 1.13 – 
1.04 (2H, m), 0.99 – 0.82 (6H, m), 0.77 (3H, t, 3JHH =  7.2 Hz), 0.75 – 0.68 (2H, m), 
0.65 – 0.55 (2H, m) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 184.5, 184.4, 
183.2, 183.1, 168.8, 168.7, 167.2, 166.7, 148.5, 144.8, 144.6, 144.5, 144.0, 139.1, 
138.9, 130.6, 130.3, 130.2, 130.2, 130.1, 129.9, 129.5, 129.0, 128.8, 128.7, 128.6, 
128.5, 128.4, 127.5, 127.4, 126.9, 126.8, 126.3, 126.2, 126.0, 125.8, 125.3, 125.1, 
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124.6, 124.6, 124.5, 124.3, 123.9, 123.8, 123.8, 123.7, 123.6, 123.5, 123.4, 123.2, 
122.9, 122.7, 122.4, 120.2, 112.7, 112.3, 100.8, 100.7, 49.2, 46.0, 44.7, 43.9, 30.7, 
30.5, 28.7, 28.3, 28.2, 27.9, 27.9, 27.3, 27.0, 26.5, 26.2, 26.1, 25.4, 21.6, 21.5, 13.1, 
13.0 ppm. 195Pt (107.51 MHz, CDCl3): δPt -2786 ppm. HR-MS: calcd. for 
[C44H44N2O4194Pt]+ 859.3001, found 859.3009. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 
cm-1) 257 (44000), 298 (14800), 350 (6870), 362 (6930), 368 (7440), 389 (6850), 413 
(3860) nm. IR (thin film): νmax 2959, 2924, 2855, 2369, 1734, 1674, 1636, 1582, 
1524, 1458, 1433, 1391, 1302, 1279, 1262, 1024, 939, 885, 806, 760, 731 cm-1. 
Synthesis of [Pt(L16)(acac)]: Following the general procedure outlined in Chapter 2 
for coordinating β-diketonates to platinum complexes using [Pt(L16)(DMSO)Cl] 
(0.050 g, 0.057 mmol) and sodium acetylacetonate monohydrate (0.069 g, 0.568 
mmol). The product was purified by column chromatography (silica, 
dichloromethane) and was eluted as the first yellow band with dichloromethane and 
dried to yield a dark yellow solid. Subsequent columns to isolate the two isomers of 
the product were attempted with no success. The products were isolated as a mixture 
(roughly 1:2). Yield = 0.068 g, (73%). 1H NMR (400 MHz, CDCl3): δH 9.59 (1H, d, 
3JHH = 8.4 Hz), 9.55 (1H, d, 3JHH = 8.8 Hz), 8.63 (1H, d, 3JHH = 9.2 Hz), 8.32 – 7.67 
(24H, m), 7.63 – 7.59 (2H, m), 7.51 (1H, dd, 3JHH = 7.6 Hz, 4JHH = 1.2 Hz), 7.40 – 
7.36 (1H, m), 7.26 – 7.22 (1H, m), 7.16 – 7.08 (3H, m), 6.93 – 6.89 (1H, m), 6.01 
(1H, d, 2JHH = 14.4 Hz), 5.56 (1H, s), 5.53 (1H, s), 5.40 (1H, d, 2JHH = 14.8 Hz), 5.16 
– 5.05 (2H, br. m), 4.13 – 4.02 (1H, br. m), 3.44 – 3.33 (1H, br. m), 2.89 – 2.83 (2H, 
m), 2.04 (3H, s), 2.02 (3H, s), 2.01 (3H, s), 2.00 (3H, s), 1.90 – 1.80 (2H, br. m), 1.56 
– 1.46 (2H, m), 1.41 – 0.90 (20H, m), 0.87 (3H, t, 3JHH = 7.2 Hz), 0.78 (3H, t, 3JHH = 
7.2 Hz) ppm. 13C{1H} NMR (125.8 MHz, CDCl3): δC 184.5, 184.4, 183.2, 183.1, 
168.8, 168.7, 167.2, 166.7, 148.5, 144.8, 144.6, 144.5, 144.0, 139.1, 130.6, 130.3, 
130.2, 130.2, 130.1, 129.9, 129.5, 129.0, 128.8, 128.7, 128.6, 128.5, 128.4, 127.5, 
127.5, 127.4, 127.4, 126.9, 126.8, 126.3, 126.2, 126.0, 125.8, 125.3, 125.1, 124.6, 
124.6, 124.5, 124.3, 123.9, 123.9, 123.8, 123.8, 123.7, 123.6, 123.5, 123.4, 123.2, 
122.9, 122.7, 122.4, 120.3, 112. 7, 112.4, 100.8, 100.7, 49.3, 46.1, 44.7, 43.9, 30.8, 
30.5, 28.3, 28.2, 27.9, 27.9, 27.3, 27.1, 26.5, 26.2, 25.4, 21.6, 21.5, 13.1, 13.0 ppm. 
195Pt (107.51 MHz, CDCl3): δPt -2788 ppm. HR-MS: calcd. for [C46H45N2O4194Pt]+ 
883.3001, found 883.3010. UV-vis (CHCl3): λmax (ε / dm
3 mol-1 cm-1) 256 (32100), 
266 (39400), 278 (48200), 297 (25000), 314 (19900), 329(30300), 345 (38300), 361 
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(10600), 408 (5330) nm. IR (thin film): νmax 3080, 3046, 2951, 2924, 2853, 2245, 
1634, 1601, 1580, 1559, 1520, 1470, 1456, 1435, 1393, 1371, 1277, 1198, 1184, 
1157, 1022, 907, 847, 762, 731 cm-1. 
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Chapter 5: Development of anthraquinone-derived scaffolds 
for lanthanide (III) ion coordination 
  




This chapter discusses the development of anthraquinone-based polydentate ligand 
architectures for the incorporation of LnIII ions in order to study the photophysical 
properties and assess the relaxivity of the compounds towards potential bimodal 
contrast agents. 
5.1.1. Anthraquinone 
It is important to firstly understand some fundamental properties of anthraquinones 
and their prior incorporation into metal complexes. Anthraquinones (AQs) are 
naturally occurring products, which can be found in both plants and animals.1-3 
Anthraquinone (AQ) is a polycyclic compound made up of two benzene rings fused 
together by carbonyl groups at the 9- and 10-positions (Figure 5.1). It is usually 
synthesised through the oxidation of anthracene although it can be prepared via a 
Friedel-Crafts reaction using benzene and phthalic anhydride with AlCl3.4 AQs have 
long been functionalised and studied for a plethora of applications ranging from dyes 
and pigments through to biological and medicinal uses.  
 
Figure 5.1 Structure and numbering of anthraquinone. 
Their utility is made more appealing by the facile functionalisation and a large variety 
of commercially available starting materials, which lend themselves to the 
development of more complicated species with various functionalities for a breadth of 
applications. They can undergo functionalisation through nucleophilic substitution at 
the 1-, 4-, 5- and 8-positions to give the amino- derivatives of the chloro- precursors, 
alkoxyl formation from the fluoro- derivatives and Sonogashira couplings from iodo- 

















Figure 5.2 Structures of some naturally occurring (top) and commercially available (bottom) AQs.10 
Their functionalisation can result in dramatic shifts in the absorption and emission 
properties of the compounds: 2-hydroxy-AQ absorbs and emits at 368 and 472/500 
nm whilst 1,4-diamino-AQ absorbs and emits at 592 and 614/641 nm, respectively.11 
This means the compounds can be tuned to emit close to the near-IR region, which 
makes them potential candidates for bioimaging and therapeutics.  
The facility to readily functionalise AQ and the ability to tune the photophysical 
properties have led to the incorporation of AQs into transition metal and lanthanide 
ion coordination chemistry. One of the simplest AQ complexes incorporates alizarin 
into a Ru(bpy)2 complex, where the AQ coordination mode varies depending on the 
conditions (Figure 5.3).12 Upon heating, the complex coordinates to both alkoxide 
moieties in the 1- and 2-positions; in the presence of acid this configuration alters to 
give coordination through the 1-position and to the carbonyl in the 9-position, leaving 
the 2-position as the alcohol, whilst in the presence of base, the alcohol deprotonates 
which can revert back to the 1,2- coordination mode again upon heating. Ruthenium 
complexes have also incorporated AQs to form diimines such as AQ-phen (Figure 
5.3) in order to exploit the redox potential of the quinone core.13 Ji et al. found that, in 
the quinone form, a similar complex was non-emissive, whilst the quinol species 
emitted at ca. 600 nm with a long-lived lifetime (> 800 ns) suggestive of a 3MLCT-
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Figure 5.3 Structures of a Ru-AQ (alizarin) complex under different conditions (left) and the redox 
products of Ru-dppzAQ (right). 
Nishihara et al. utilised the facile synthesis of alkynyl anthraquinones to develop a 
complex with two PtII tpy (2,2′;6′,2′′-terpyridine) moieties in the 1- and 8-position.15 
They proposed the presence of Pt-Pt interactions leading to an MMLCT excited state 
giving a low energy emission.  
 
Figure 5.4 Pt2-AQ complex, which exhibits Pt-Pt interactions resulting in low energy emission. 
As well as their incorporation into d-block metal complexes, AQs have also shown 
promise as antennas for sensitising near-IR emitting LnIII ions due to their tunable 
visible light absorbing properties. Jones et al. developed a series of monometallic and 
dimetallic complexes by functionalising amino-AQs to incorporate DO3A-type 
macrocycles, within which LnIII ions were coordinated to give water soluble AQ-Ln 
complexes.16 These were all found to both fluoresce, from AQ-centred emission, and 
phosphoresce from the Ln-centred near-IR emission. YbIII gave a structured emission 
at 975 nm (2F5/2 → 2F7/2), NdIII was found to emit at 1058 nm (4F3/2 → 4I11/2) with a 
weakly emitting peak at 1340 nm (4F3/2 → 4I13/2) and ErIII emitted weakly at 1540 nm 
for the (4I13/2 → 3H4) transition. The dimetallic complexes, with 1,4- and 1,5-
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x 104 mol-1 dm3 for the 1,4-substituted derivative.17 The GdIII complexes were also 
assessed for their utility as contrast agents by obtaining the 1H NMRDs for the 
complexes in water and also in the presence of DNA. The spectra revealed a reduced 
rotational correlation time upon DNA binding, resulting in an increased value for r1, 
which is consistent with the binding of the AQ-Gd2 complexes to the DNA.  
 
Figure 5.5 Structures of AQ-Ln complexes where AQ acts as a sensitiser for near-IR LnIII metal ion 
emission. 
AQ-Yb complexes have also been developed to act as responsive probes for HgII by 
incorporating a dipicolylamine-type linker between the AQ core and the macrocyclic 
component; the addition of HgII was found to modulate the AQ-centred emission and 
perturb the emissive state of YbIII and quench the lifetime from 11 to 8 µs.18 
 




















































































Chapter 5 discusses the development of novel anthraquinone-based polypyridyl ligand 
architectures for the incorporation of LnIII metal ions (Gd, Yb, Nd, Er). The synthetic 
procedures are outlined along with the characterisation of the ligands and complexes. 
The photophysical analysis of both the ligands and complexes is detailed, along with 
a proposed inner coordination sphere of the LnIII ion for each ligand based on 
calculations of q. The relaxivities of the GdIII complexes are assessed in H2O/DMSO 
mixtures, which are compared to free GdCl3 in the same solvent systems to give an 
insight into the effectiveness of the complexes as contrast agents. 
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5.3. Results and Discussion 
5.3.1. Precursor and ligand synthesis 
 
Figure 5.7 Synthetic pathway to the synthesis of L17, L18 and L19 via P10, P11 and P12, 
respectively, from 1,8-dichloroanthraquinone (left). 
The chromophoric ligands were developed by alkylating 1,8-dichloroanthraquinone 
with an excess of ethylenediamine, 1,3-diaminopropane or 1,3-diaminopropan-2-ol in 
refluxing DMSO based on a similar literature method.19 A colour change from yellow 
to red indicated formation of the monosubstituted compound, followed by a further 
change to purple, indicating the progression of the reaction to the disubstituted 
product. The solution was cooled and precipitated with iced water to yield the 
disubstituted amino intermediates. The sticky precipitate was then dissolved in 
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The precursors were characterised by 1H NMR and IR spectroscopies, however the 
compounds were not soluble enough (especially in the case of P12, which was almost 
completely insoluble in all common solvents other than DMSO) to obtain 13C NMR 
spectra. Attempts to obtain MS data were unsuccessful and, as such, the compounds 
were used in the following steps without full characterisation. Subsequent treatment 
with four equivalents of 2-pyridinecarboxaldehyde under reductive amination reaction 
conditions yielded the three multidentate ligands, L17 – L19. The ligands all possess 
good solubility in a range of common organic solvents and were characterised using 
the usual spectroscopic and analytical techniques. The complexes were characterised 
by 1H and 13C NMR spectroscopy as well as HR-MS and UV-vis and IR 
spectroscopies. Of particular note in the 1H NMR spectra are the characteristic NH 
resonances that indicate formation of the amino-substituted anthraquinone ligands, 
which appear as broadened triplets. 
5.3.2. Complex synthesis 
The complexes were obtained as dark purple coloured solids upon reaction with 
Ln(OTf)3 in methanol in the same manner as the LnIII complexes in Chapter 3. The 
stoichiometry of the complexes was quantitatively confirmed using elemental 
analyses suggesting a 1:1 (Ln:L) ratio, where Ln = Nd and Er (Gd and Yb complexes 
revealed incomplete combustion as indicated by low C, H and N values). MS(LD) 
revealed the appropriate isotopic patterns for the monometallic LnIII species in all 
cases.  
5.3.3. Electronic absorption spectroscopy 
The UV-vis absorption spectra of the free ligands were obtained from acetonitrile 
solutions, revealing absorbing bands throughout the visible and UV regions. The 
anthraquinone 1IL(π → π*) transitions contribute between 260 – 350 nm with pyrdine-
centred absorptions at shorter wavelengths, below 300 nm. The lowest energy 
absorption band peaked at 550, 547 and 542 nm for L17, L18 and L19 respectively, 
with corresponding molar absorptivity of ca. 104 dm3 mol-1 cm-1. These can be 
assigned to a charge transfer (CT) dominated transition that is anthraquinone-centred 
and derived from significant 1IL(n → π*) character due to the donor-substituted 
chromophore.   
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5.3.4. Luminescence spectroscopy 
Following irradiation of the lowest energy band, each of the ligands were visibly 
fluorescent ca. 630 nm as indicated by a modest Stokes’ shift and short lifetime (τ = 1 
– 2 ns). Corresponding excitation spectra revealed a dominant feature at ca. 540 nm. 
Upon complexation of the LnIII, subtle hypsochromic shifts were noted for this 
transition. Luminescence studies on the GdIII complexes revealed a bathochromic 
energy shift of the ligand-based fluorescence to around 670 nm. To assess the 
effectiveness of the ligands as sensitising chromophores, anticipating the most 
common mechanism to involve energy transfer from the triplet state of the 
chromophore to the LnIII excited state, additional low temperature measurements were 
obtained on solvent glasses (ethanol/methanol 5:1) at 77 K (Figure 5.8). In this 
manner, estimation of the ligand-centred triplet energies of the anthraquinone 
chromophores was possible from the onsets of the spectral profiles. It was noted that 
the peak position at 77K resided at higher energy relative to the room temperature 
fluorescence peak, with a subtle hint of vibronic structure suggesting that the lowest 
lying excited state at 77K was 3π → π*. The onset was recorded at ca. 560 nm for all 
three ligand types, and therefore deemed to be of sufficient energy to sensitise the 
near-IR emitting NdIII, ErIII and YbIII ions.  
 
Figure 5.8 Excitation and emission (room temperature and low temperature) of [Gd(L18)](OTf)3. 
 
For the LnIII complexes, the emission characteristics are ascribed to two processes: 
one anthraquinone-centred and one lanthanide-centred. Each of these complexes 
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retained the anthraquinone-based fluorescence at ca. 670 nm, together with additional 
weaker bands in the near-IR region associated with the lanthanide-centred transitions 
consistent with the inclusion of the respective LnIII ion (Figure 5.9). It was possible to 
obtain lifetime-decay profiles for all examples using a cut-off filter (< 850 nm) to 
eliminate ligand-based fluorescence. Time-resolved measurements on the complexes 
confirmed the long-lived nature of the emission and also allowed a qualitative insight 
into the likely binding mode of the ligand with LnIII.  
 
Figure 5.9 Excitation and emission profiles for [Yb(L19)](OTf)3, where excitation is in black, ligand 
emission is in green and 2F5/2 → 2F7/2 YbIII emission is in red. 
The values in methanol for the YbIII complexes showed a large increase in lifetime 
from L18 to L17 to L19. Using the values obtained in CD3OD/CH3OH allowed the 
determination of q, the number of LnIII-bound solvents (Table 5.1). For YbIII, q 
reduces from ca. 4 (L18) to ca. 1 (L19) using equation (21). This suggests that for 
[Yb(L18)](OTf)3 the coordination sphere is probably six coordinate and likely to 
comprise both dipicolyl amine units and not the anthraquinone core (cf. very minor 
changes in the UV-vis spectra of the ligand) (Figure 5.11). For [Yb(L19)](OTf)3 the 
low q value suggests an effective exclusion of solvent and an eight-coordinate ligand 
encapsulating YbIII. This is attributed to the coordinative participation of the alcohol 
donors of the propan-2-ol moiety (Figure 5.11). For the analogous parameters 
obtained from the NdIII species, using equation (22), the trend is the same with respect 
to the obtained q values although they are generally larger, as expected for ionic radii.  
q = 2{(kMeOH − kMeOD )− 0.05]   (21)                q = 290(kMeOH − kMeOD )− 0.4  (22)20 
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Figure 5.10 Decay profiles, with fit residuals, for YbIII (left), NdIII (middle) and ErIII (right) complexes 
in CD3OD, λex at 355 nm. 
Table 5.1 Summary of the photophysical data for the ligands and complexes in Chapter 5. 
Near-IR steady state spectra were unobtainable for the complexes of L17 and L18 
with the LnIII peaks appearing as extremely weak and often superimposed by the tail 
of the anthraquinone fluorescence. However, for the complexes of L19, which 
possessed a lower q value, the LnIII-based peaks were more easily observed. The NdIII 
complex revealed near-IR emission with a peak at 1058 nm (4F3/2 → 4I11/2) with a 
much weaker feature at ca. 1340 nm, corresponding to (4F3/2 → 4I13/2). The steady 
state emission spectra of [Yb(L19)](OTf)3 gave a spectral profile typical of YbIII with 
a structured peak at 975 nm (2F5/2 → 2F7/2), whilst [Er(L19)](OTf)3 gave a very weak 
broad emission feature centred around 1540 nm assigned to the (4I13/2 → 3H4) 
transition. 
Compound λex / nm λem / nm  Near-IR τ / ns q 
 (n → π*) MeOH CD3OD  
L17 547 636 - - - 
[Gd(L17)](OTf)3 538 664 - - - 
[Yb(L17)](OTf)3 539 - 699 5680 2.4 
[Nd(L17)](OTf)3 539 - 60 409 3.7 
[Er(L17)](OTf)3 540 - - 448  
L18 550 632 - - - 
[Gd(L18)](OTf)3 546 679 - - - 
[Yb(L18)](OTf)3 543 - 441 6350 4.1 
[Nd(L18)](OTf)3 545 - 48 378 4.9 
[Er(L18)](OTf)3 548 - - 597 - 
L19 542 633 - - - 
[Gd(L19)](OTf)3 535 672 - - - 
[Yb(L19)](OTf)3 534 - 1300 5360 1.1 
[Nd(L19)](OTf)3 532 - 65 415 3.4 



















































Figure 5.11 Proposed coordination modes of [Ln(L17-L19)](OTf)3 based on q values. 
5.3.5. Relaxivity  
The solubility of the cationic complexes was not sufficient to allow for relaxometric 
1H NMRD studies to be completed in water. However, a suitable solvent system was 
obtained from a H2O/DMSO 50/50 mixture. For reference purposes, a number of 
comparative spectra were undertaken on GdCl3 in various H2O/DMSO mixtures.  
 
Figure 5.12 1H NMRD profiles for GdCl3 in various H2O/DMSO ratios at 37 °C with various field 
strengths (left) and change in relaxivity at 30 and 0.01 MHz and the change in viscosity of a 
water/DMSO solution at solvent ratios (right).21 
The data from the measurements in various H2O/DMSO mixtures suggest that the 
viscosity of the solvent mixture plays a vital role in the relaxivities of GdCl3. Whilst 
the viscosities of water and DMSO are 0.89 and 1.99 cP, respectively, the viscosity of 
a mixture of the two solvents is as much as 3.73 cP with around 33% DMSO (Figure 
5.12).22 This means that the molar ratio at the maximum viscocity for H2O/DMSO is 
2:1, which has been proposed by Cowie et al. to be due to a strong association 
complex of the two components and a complicated network of resultant hydrogen 
bonding, leading to a much greater viscosity than the sum of the two component 
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reduced rotational correlation time τR, however they also make movement of water 
around the system more difficult resulting in a potentially longer residency time, τM, 
which would have the opposite effect on the relaxation rate. The Gd-H distances, r 
and r′, are also different due to the presence of both Gd-HH2O and Gd-HDMSO, again 
affecting the relaxation rates of protons. These factors make it extremely difficult to 
calculate exactly what is happening in the binary systems, and prevented fitting of the 
NMRD data to obtain parameters such as residency times and rotational correlation 
times. The only comparison that can be made is the relaxivity of GdCl3 in the two 
solvent systems: r1 value of ca. 10.9 mM-1 s-1 (30 MHz, 37 °C, H2O) compared to 




Table 5.2 r1 values for GdCl3 in water and GdCl3 and the anthraquinone complexes in a 1:1 mixture of 
H2O/DMSO. 
The values for the anthraquinone-based GdIII complexes all lie below the value for 
GdCl3 (Table 5.2); this is to be expected, given that r1 for the free gadolinium is much 
higher than the anticipated values would be for multidentate GdIII complexes. The 
complex of L19 has the highest relaxation rate, which was suggested to be from the 
interaction of the –OH groups facilitating a more effective second coordination 
sphere, and potentially reducing the residency time of coordinated solvent molecules 
as was seen for the phosphinate group in Rudovsky et al’s [Gd(DO3APABn)]- 
complex.24 The value for r1 of [Gd(L17)] was greater than that of [Gd(L18)], despite 
the latter having a greater q value; this was thought to be due to the more polar 
coordination sphere with the proposed participation of the carbonyl moiety and, 
therefore, the closer proximity of the –NH groups, facilitating hydrogen bonding in 
the second sphere, invoking a similar effect to that of L19. It is assumed that the 
inner-sphere solvation is the same across the complexes for these proposals, although 
it is likely that the solvation around the different complexes is different and, as such, 
the data are not comparable. 
Compound  r1 (mM-1 s-1) (30 MHz, 25 °C) 
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It would not be logical to apply the relative difference in the relaxivity found from the 
two solvent systems for GdCl3 to the AQ systems as this would wrongly assume that 
the parameters for these species are the same for those of the free GdIII ion. It does, 
however, act as a guide to suggest how efficient the novel systems are at generating 
greater relaxation rates compared to the known standard. 
 
Figure 5.13 1H NMRD profiles of GdCl3 in H2O and H2O/DMSO (1:1) and [Gd(L17-L19)](OTf)3 in 
H2O/DMSO (1:1) at 37 °C. 
The 1H NMRD profile (Figure 5.13) of the binary system compared to H2O for GdCl3 
shows that, whilst the relaxivity at high field strengths is much greater in the binary 
system, the relative difference at lower field strengths is considerably smaller due to a 
significant inflexion of the binary solvent profile. This inflexion is also observed in 
























Chapter 5 summarises the synthesis of a series of novel polydentate ligands with an 
anthraquinone backbone, along with the subsequent coordination chemistry with a 
series of LnIII metal ions (Gd, Nd, Yb and Er). The characterisation of precursors, 
ligands and complexes is detailed along with a detailed photophysical study on the 
emissive properties of the ligands and complexes. The lifetimes of the Yb and Nd 
complexes were recorded in both methanol and CD3OD in order to ascertain the 
inner-sphere coordination value, q, in order to give a greater understanding of the 
coordination modes of each of the three ligands.  
A relaxometric investigation was also carried out, despite the insolubility of the 
anthraquinone complexes in aqueous media. Comparative studies on GdCl3 are 
detailed in a range of ratios of H2O:DMSO before measurements were taken on 
[Gd(L17)] to [Gd(L19)] in order  to determine values for r1 of the three complexes, 
relative to GdCl3. 
  




5.5.1. General physical measurements 
All physical measurements were carried out as outlined in previous chapters.  
5.5.2. Precursor synthesis 
General procedure for diaminoanthraquinone alkylations: Based on a modified 
literature methodology.19 The amine (10 eq) was added to a stirring suspension of 1,8-
dichloroanthraquinone (1 eq) in DMSO (5 mL). Cold water was added to the hot 
solution and the resultant suspension was stirred for 1 h before the product was 
collected by filtration. 
Synthesis of P10: Following the general procedure for diaminoanthraquinone 
alkylations using ethylene diamine (4.5 mL, 18.1 mmol) and 1,8-
dichloroanthraquinone (0.500 g, 1.81 mmol). The product was purified by column 
chromatography (silica, dichloromethane) and was eluted as the purple band with 
dichloromethane/ethyl acetate (9:1). The solvent was removed in vacuo and the 
product was re-precipitated from methanol/diethyl ether, filtered and dried to give a 
dark purple solid. Yield = 0.79 g, (34%). 1H NMR (250 MHz, CDCl3): δH 9.68 (2H, t, 
3JHH = 5.0 Hz), 7.50 – 7.36 (4H, m), 6.98 (2H, m) 3.35 (4H, q, 3JHH = 5.8 Hz), 3.00 
(4H, t, 3JHH = 6.3 Hz) ppm. IR (solid): νmax 3271, 1736, 1657, 1612, 1566, 1512, 1379, 
1298, 1277, 1260, 1209, 1177, 1076, 1020, 745 cm-1. 
Synthesis of P11: Following the general procedure for diaminoanthraquinone 
alkylations using 1,3-diaminopropane (1.5 mL, 18.1 mmol) and 1,8-
dichloroanthraquinone (0.500 g, 1.81 mmol). The precipitate was re-dissolved in 
methanol before being precipitated with ether and collected by filtration to afford a 
dark purple solid. Yield = 0.15 g (23%). 1H NMR (400 MHz, CDCl3): δH 7.46 – 7.44 
(2H, m), 7.38 – 7.34 (m, 2H), 7.01 – 6.97 (m, 2H), 3.23 (4H, q, 3JHH = 5.2 Hz), 2.64 
(4H, t, 3JHH = 6.8 Hz), 1.89 (4H, m) ppm. IR (solid): νmax 3275, 1661, 1612, 1591, 
1564, 1508, 1450, 1395, 1342, 1296, 1215, 1198, 1173, 1076, 1030, 833, 819, 741 
cm-1. 
Synthesis of P12: Following the general procedure for diaminoanthraquinone 
alkylations using 1,3-diamino-2-propanol (1.63 g, 18.1 mmol) and 1,8-
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dichloroanthraquinone (0.500 g, 1.81 mmol). The precipitate was re-precipitated from 
methanol/diethyl ether, before being collected by filtration and dried to afford a dark 
purple solid (yield 0.54 g, 78 %). 1H NMR (250 MHz, DMSO): δH 9.72 (2H, t, 3JHH = 
5.05 Hz), 7.56 (2H, m), 7.37 (2H, d, 3JHH = 7.1 Hz), 7.25 (2H, d, 3JHH = 8.5 Hz), 3.68 
(2H, br. m), 3.46 (4H, m), 3.22 (4H, m) ppm. IR (solid): νmax 3262, 1736, 1655, 1612, 
1553, 1501, 1449, 1400, 1366, 1296, 1207, 1177, 1138, 1069, 1016 cm-1.  
5.5.3. Ligand synthesis 
General procedure for reductive aminations: Following the general procedure 
outlined in Chapter 3 for the reduction of pyridine carboxaldehyde onto an amine 
(reductive amination). 2-pyridine carboxaldehyde (4 eq) and the alkylated 
anthraquinone precursor (1 eq) was added to a stirring solution of Na(OAc)3BH (6 eq) 
in 1,2-dichloroethane (3.5 mL). The suspension was stirred under dinitrogen for 48 h 
before being neutralised with NaHCO3 (sat. soln, 10 mL) and extracted into ethyl 
acetate (20 mL). The product was washed with water (2 x 20 mL) and brine (1 x 20 
mL) before the solvent was removed in vacuo. 
Synthesis of L17: Following the general procedure for reductive aminations using 
P10 (0.230 g, 0.710 mmol), 2-pyridine carboxaldehyde (0.27 mL, 2.84 mmol) and 
Na(OAc)3BH (0.900 g, 4.25 mmol). Obtained as a dark purple viscid solid. Yield = 
0.41 g, (83%). 1H NMR (400 MHz, CDCl3): δH 9.75 (2H, t, 3JHH = 5.1 Hz), 8.41 (4H, 
d, 3JHH = 4.8 Hz), 7.56 – 7.30 (12H, m), 7.01 (4H, m), 6.85 (2H, m), 3.85 (8H, s), 3.41 
(4H, q, 3JHH = 6.3 Hz), 2.87 (4H, t, 3JHH = 6.5 Hz) ppm. 13C{1H} NMR (75.6 MHz, 
CDCl3): δC 40.8, 52.8, 60.6, 114.5, 115.1, 117.9, 122.0, 122.2, 123.1, 134.2, 136.5, 
149.0, 151.0, 159.2, 184.6, 189.4 ppm. HR-MS: calcd. for [C40H41N8O2]+ 689.3347, 
found 689.3344. UV-vis (MeCN): λmax (ε / dm3 mol-1 cm-1) 260 (17600), 304 (4500), 
550 (7000) nm. IR (MeCN): νmax 3288, 1661, 1612, 1589, 1568, 1512, 1472, 1433, 
1400, 1364, 1298, 1206, 1148, 1076, 1047, 1024, 995 cm-1. 
Synthesis of L18: Following the general procedure for reductive aminations using 
P11 (0.153 g, 0.431 mmol), 2-pyridine carboxaldehyde (0.16 mL, 1.67 mmol) and 
Na(OAc)3BH (0.542 g, 2.56 mmol). Obtained as a dark purple oil. Yield = 0.15 g 
(48%). 1H NMR (250 MHz, CDCl3): δH 9.32 (2H, t, 3JHH = 5.2 Hz), 8.40 (4H, d, 3JHH 
= 4.8 Hz), 7.50-7.31 (12H, m), 6.98 (4H, m), 6.88 (2H, d, 3JHH = 8.4 Hz), 3.76 (8H, s, 
Chapter 5: Development of anthraquinone-derived scaffolds for lanthanide (III) ion coordination 
 
180 
3JHH = 14.4 Hz), 3.22 (4H, q, 3JHH = 6.7 Hz), 2.67 (4H, t, 3JHH = 6.8 Hz), 1.90 (4H, q, 
3JHH = 6.9 Hz) ppm. 13C{1H} NMR (75.6 MHz, CDCl3): δC 26.7, 40.8, 43.5, 51.5, 
114.3, 114.8, 117.7, 122.0, 123.0, 134.1, 134.3, 136.46, 136.72, 148.89, 151.04, 
159.52, 184.72, 188.62 ppm. HR-MS: calcd. for [C44H45N8O2]+ 717.3660, found 
717.3659. UV-vis (MeCN): λmax (ε / dm3 mol-1 cm-1) 238 (38900), 325 (5800), 547 
(9400) nm. IR (MeCN): νmax 3279, 1659, 1612, 1589, 1568, 1512, 1472, 1431, 1398, 
1364, 1298, 1236, 1213, 1202, 1150, 1076, 1047, 1024, 993, 745 cm-1.  
Synthesis of L19: Following the general procedure for reductive aminations using 
P12 (0.352 g, 0.912 mmol), 2-pyridine carboxaldehyde (0.35 mL, 3.66 mmol) and 
Na(OAc)3BH (1.15 g, 5.45 mmol). Obtained as a dark purple oil, which solidified 
upon standing. Yield = 0.460 g, (67%). 1H NMR (400 MHz, CDCl3): δH 9.32 (2H, m), 
8.40 (4H, d, 3JHH = 4.6 Hz), 7.50 – 7.31 (12H, m), 6.98 (4H, m), 6.88 (2H, m), 4.06 
(4H, m), 3.76 (8H, m), 3.22 (4H, br. m), 2.87 – 2.70 (2H, m) ppm. 13C{1H} NMR 
(75.6 MHz, CDCl3): δC 43.6, 47.0, 59.2, 67.8, 114.6, 114.9, 117.9, 122.3, 123.3, 
134.0, 134.3, 136.5, 136.7, 149.0, 151.2, 159.0, 184.7, 188.6 ppm. HR-MS: calcd. for 
[C44H44N8O4]+ 749.3558, found 749.3570. UV-vis (MeCN): λmax (ε / dm3 mol-1 cm-1) 
237 (60100), 313 (10300), 542 (12900) nm. IR (MeCN): νmax 3281, 1659, 1615, 1595, 
1570, 1515, 1475, 1435, 1300, 1265, 1210, 1069, 1047, 1020, 744 cm-1.  
5.5.4. Synthesis of Complexes 
General procedure for complexation of lanthanides: Following the general 
procedure outlined in Chapter 3 for the complexation of lanthanides. The ligand (1 
eq) and Ln(OTf)3 (1 eq) were dissolved in methanol (5 mL) and heated to reflux 
overnight. The reaction mixture was dried in vacuo and re-dissolved in a minimum 
volume of acetonitrile before being precipitated with diethyl ether. 
Synthesis of [Gd(L17)](OTf)3: Following the general procedure for complexation of 
lanthanides using L17 (0.105 g, 0.147 mmol) and Gd(OTf)3 (0.089 g, 0.147 mmol). 
Obtained as a dark purple solid. Yield = 0.177 g, (91%). MS(LD) found m/z = 880.0 
for [M – 3OTf – 2H + 2H2O]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 238 
(54969), 268 (52234), 546 (12266) nm. IR (MeCN): νmax 1654, 1614, 1570, 1514, 
1442, 1400, 1263, 1234, 1215, 1163, 1026, 731 cm-1.   
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 Synthesis of [Yb(L17)](OTf)3: Following the general procedure for complexation of 
lanthanides using L17 (0.081 g, 0.113 mmol) and Yb(OTf)3 (0.072 g, 0.113 mmol). 
Obtained as a dark purple solid. Yield = 0.118 g, (78%). MS(LD) found m/z = 896.1 
for [M – 3OTf – 2H + 2H2O]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 236 
(35900), 543 (7500) nm. IR (MeCN): νmax 1736, 1655, 1614, 1595, 1568, 1512, 1472, 
1437, 1398, 1371, 1238, 1225, 1167, 1028, 746 cm-1. 
Synthesis of [Nd(L17)](OTf)3: Following the general procedure for complexation of 
lanthanides using L17 (0.068 g, 0.095 mmol) and Nd(OTf)3 (0.066 g, 0.095 mmol). 
Obtained as a dark purple solid. Yield = 0.104 g, (84%). MS(LD) found m/z = 886.0 
for [M – 3OTf – 2H + 2H2O]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 236 
(37800), 545 (8200) nm. IR (MeCN): νmax 1736, 1612, 1595, 1570, 1508, 1431, 1371, 
1275, 1227, 1217, 1161, 1053, 1032, 1016, 748 cm-1. Calculated for 
C42H40N8O2Nd(CF3SO3)3: C, 42.22; H, 3.15; N, 8.75; Found C, 42.13; H, 3.09; N, 
8.81 %. 
Synthesis of [Er(L17)](OTf)3: Following the general procedure for complexation of 
lanthanides using L17 (0.060 g, 0.084 mmol) and Er(OTf)3 (0.052 g, 0.084 mmol). 
Obtained as a dark purple solid. Yield = 0.097 g, (87%). MS(LD) found m/z = 890.0 
for [M – 2OTf – H]+. UV-vis  (MeCN): λmax (ε / dm3 mol=1 cm-1) 238 (42500), 272 
(54700), 548 (8000) nm. IR (MeCN): νmax 1722, 1612, 1595, 1568, 1512, 1435, 1400, 
1371, 1248, 1225, 1157, 1078, 1047, 1029, 746 cm-1. Calculated for 
C42H40N8O2Er(CF3SO3)3: C, 41.47; H, 3.09; N, 8.60; Found C, 41.38; H, 3.03; N, 
8.59 %. 
Synthesis of [Gd(L18)](OTf)3: Following the general procedure for complexation of 
lanthanides using L18 (0.050 g, 0.073 mmol) and Gd(OTf)3 (0.044 g, 0.073 mmol). 
Obtained as a dark purple solid. Yield = 0.081 g, (86%). MS(LD) found m/z = 876.1 
for [M – 3OTf – 2H +2H2O]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 259 
(29900), 314 (5600), 538 (9800) nm. IR (MeCN): νmax 1615, 1573, 1515, 1271, 1225, 
1157, 1032, 770, 745 cm-1. 
Synthesis of [Yb(L18)](OTf)3: Following the general procedure for complexation of 
lanthanides using L18 (0.051 g, 0.074 mmol) and Yb(OTf)3 (0.047 g, 0.074 mmol). 
Obtained as a dark purple solid. Yield = 0.040 g, (42%). MS(LD) found m/z = 893.1 
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for [M – 3OTf – 2H + 2H2O]+. UV-vis  (MeCN): λmax (ε / dm3 mol=1 cm-1) 258 
(27100), 315 (5500), 539 (10100) nm. IR (MeCN): νmax 1615, 1573, 1515, 1270, 
1225, 1157, 1032, 766 cm-1. 
Synthesis of [Nd(L18)](OTf)3: Following the general procedure for complexation of 
lanthanides using L18 (0.050 g, 0.073 mmol) and Nd(OTf)3 (0.051 g, 0.073 mmol). 
Obtained as a dark purple solid. Yield = 0.074 g, (80%).  MS(LD) found m/z = 864.0 
for [M – 3OTf – 2H + 2H2O]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 259 
(42000), 315 (7700), 539 (13400) nm. IR (MeCN): νmax 1615, 1515, 1273, 1225, 
1159, 1032 cm-1. Calculated for C42H40N8O2Nd(CF3SO3)3: C, 42.22; H, 3.15; N, 8.75; 
Found C, 42.13; H, 3.09; N, 8.81 %. 
Synthesis of [Er(L18)](OTf)3: Following the general procedure for complexation of 
lanthanides using L18 (0.050 g, 0.073 mmol) and Er(OTf)3 (0.045 g, 0.073 mmol). 
Obtained as a dark purple solid. Yield = 0.062 g, (65%). MS(LD) found m/z = 889.0 
for [M – 3OTf – 2H + 2H2O]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 258 
(30000), 312 (6000), 540 (10700) nm. IR (MeCN): νmax 1615, 1573, 1514, 1270, 
1225, 1158, 1031, 765 cm-1. Calculated for C42H40N8O2Er(CF3SO3)3: C, 41.47; H, 
3.09; N, 8.60; Found C, 41.38; H, 3.03; N, 8.59 %. 
Synthesis of [Gd(L19)](OTf)3: Following the general procedure for complexation of 
lanthanides using L19 (0.053 g, 0.071 mmol) and Gd(OTf)3 (0.043 g, 0.071 mmol). 
Obtained as a dark purple solid. Yield = 0.055 g, (62%). MS(LD) found m/z = 900.2 
for [M – 3OTf – 2H]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 258 (34400), 304 
(9000), 535 (15700) nm. IR (MeCN): νmax 3400, 1616, 1571, 1516, 1445, 1271, 1239, 
1224, 1158, 1032, 766, 751 cm-1. 
Synthesis of [Yb(L19)](OTf)3: Following the general procedure for complexation of 
lanthanides using L19 (0.045 g, 0.074 mmol) and Yb(OTf)3 (0.047 g, 0.074 mmol) 
Obtained as a dark purple solid. Yield = 0.034 g, (34%). MS(LD) found m/z = 916.1 
for [M – 3OTf – 2H]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 258 (20900), 311 
(4800), 534 (9000) nm. IR (MeCN): νmax 3368, 1615, 1572, 1447, 1271, 1238, 1224, 
1160, 1031, 768, 750 cm-1.  
Synthesis of [Nd(L19)](OTf)3: Following the general procedure for complexation of 
lanthanides using L19 (0.059 g, 0.079 mmol) and Nd(OTf)3 (0.055 g, 0.079 mmol). 
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Obtained as a dark purple solid. Yield = 0.083 g, (79%). MS(LD) found m/z = 888.2 
for [M – 3OTf – 2H]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 257 (30300), 302 
(8100), 532 (13400) nm. IR (MeCN): νmax 3457, 1616, 1570, 1516, 1444, 1271, 1238, 
1224, 1159, 1031, 768, 751 cm-1. Calculated for C44H44N8O4Nd(CF3SO3)3: C, 42.12; 
H, 3.31; N, 8.36; Found C, 42.03; H, 3.34; N, 8.25 %. 
Synthesis of [Er(L19)](OTf)3: Following the general procedure for complexation of 
lanthanides using L19 (0.060 g, 0.080 mmol) and Er(OTf)3 (0.049 mg, 0.080 mmol). 
Obtained as a dark purple solid. Yield = 0.090 g, (82%). MS(LD) found m/z = 912.4 
for [M – 3OTf – 2H]+. UV-vis (MeCN): λmax (ε / dm3 mol=1 cm-1) 258 (16900), 303 
(4300), 535 (7600) nm. IR (MeCN): νmax 3452, 1616, 1572, 1445, 1271, 1239, 1222. 
Calculated for C44H44N8O4Er(CF3SO3)3: C, 41.41; H, 3.25; N, 8.22; Found C, 41.38; 
H, 3.34; N, 8.19 %.  
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